0001032220-26-000035.txt : 20260806 0001032220-26-000035.hdr.sgml : 20260806 20260806104734 ACCESSION NUMBER: 0001032220-26-000035 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 68 CONFORMED PERIOD OF REPORT: 20260630 FILED AS OF DATE: 20260806 DATE AS OF CHANGE: 20260806 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MAXIMUS, INC. CENTRAL INDEX KEY: 0001032220 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] ORGANIZATION NAME: 07 Trade & Services EIN: 541000588 STATE OF INCORPORATION: VA FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12997 FILM NUMBER: 261247375 BUSINESS ADDRESS: STREET 1: ATTN: TREASURY DEPT. STREET 2: 1600 TYSONS BLVD, #1400 CITY: MCLEAN STATE: VA ZIP: 22102 BUSINESS PHONE: 7032518500 MAIL ADDRESS: STREET 1: ATTN: TREASURY DEPT. STREET 2: 1600 TYSONS BLVD, #1400 CITY: MCLEAN STATE: VA ZIP: 22102 FORMER COMPANY: FORMER CONFORMED NAME: MAXIMUS INC DATE OF NAME CHANGE: 19970205 10-Q 1 mms-20260630.htm 10-Q mms-20260630
000103222009/302026Q3FALSEhttp://fasb.org/us-gaap/2026#OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParentP3YP1Yxbrli:sharesiso4217:USDiso4217:USDxbrli:sharesmms:citizenmms:segmentxbrli:pure00010322202025-10-012026-06-3000010322202026-08-0300010322202026-04-012026-06-3000010322202025-04-012025-06-3000010322202024-10-012025-06-3000010322202026-06-3000010322202025-09-3000010322202024-09-3000010322202025-06-300001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-09-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-09-300001032220us-gaap:RetainedEarningsMember2025-09-300001032220us-gaap:RetainedEarningsMember2025-10-012025-12-3100010322202025-10-012025-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-10-012025-12-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-10-012025-12-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-12-310001032220us-gaap:RetainedEarningsMember2025-12-3100010322202025-12-310001032220us-gaap:RetainedEarningsMember2026-01-012026-03-3100010322202026-01-012026-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-01-012026-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-01-012026-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-03-310001032220us-gaap:RetainedEarningsMember2026-03-3100010322202026-03-310001032220us-gaap:RetainedEarningsMember2026-04-012026-06-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-04-012026-06-300001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-04-012026-06-300001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2026-06-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2026-06-300001032220us-gaap:RetainedEarningsMember2026-06-300001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-09-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001032220us-gaap:RetainedEarningsMember2024-09-300001032220us-gaap:RetainedEarningsMember2024-10-012024-12-3100010322202024-10-012024-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-10-012024-12-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-10-012024-12-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-12-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-12-310001032220us-gaap:RetainedEarningsMember2024-12-3100010322202024-12-310001032220us-gaap:RetainedEarningsMember2025-01-012025-03-3100010322202025-01-012025-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-01-012025-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-01-012025-03-310001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-03-310001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-03-310001032220us-gaap:RetainedEarningsMember2025-03-3100010322202025-03-310001032220us-gaap:RetainedEarningsMember2025-04-012025-06-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-04-012025-06-300001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-04-012025-06-300001032220us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2025-06-300001032220us-gaap:AccumulatedOtherComprehensiveIncomeMember2025-06-300001032220us-gaap:RetainedEarningsMember2025-06-300001032220mms:USServicesMember2026-06-300001032220us-gaap:TechnologyEquipmentMember2026-01-012026-03-310001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2026-04-012026-06-300001032220us-gaap:OperatingSegmentsMembermms:USServicesMember2026-04-012026-06-300001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2026-04-012026-06-300001032220us-gaap:MaterialReconcilingItemsMember2026-04-012026-06-300001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2025-04-012025-06-300001032220us-gaap:OperatingSegmentsMembermms:USServicesMember2025-04-012025-06-300001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2025-04-012025-06-300001032220us-gaap:MaterialReconcilingItemsMember2025-04-012025-06-300001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2025-10-012026-06-300001032220us-gaap:OperatingSegmentsMembermms:USServicesMember2025-10-012026-06-300001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2025-10-012026-06-300001032220us-gaap:MaterialReconcilingItemsMember2025-10-012026-06-300001032220us-gaap:OperatingSegmentsMembermms:U.S.FederalServicesMember2024-10-012025-06-300001032220us-gaap:OperatingSegmentsMembermms:USServicesMember2024-10-012025-06-300001032220us-gaap:OperatingSegmentsMembermms:OutsideTheUnitedStatesMember2024-10-012025-06-300001032220us-gaap:MaterialReconcilingItemsMember2024-10-012025-06-300001032220mms:ProgramOperationsMember2026-04-012026-06-300001032220mms:ProgramOperationsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300001032220mms:ProgramOperationsMember2025-04-012025-06-300001032220mms:ProgramOperationsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300001032220mms:ProgramOperationsMember2025-10-012026-06-300001032220mms:ProgramOperationsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-06-300001032220mms:ProgramOperationsMember2024-10-012025-06-300001032220mms:ProgramOperationsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-06-300001032220mms:ClinicalServicesMember2026-04-012026-06-300001032220mms:ClinicalServicesMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300001032220mms:ClinicalServicesMember2025-04-012025-06-300001032220mms:ClinicalServicesMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300001032220mms:ClinicalServicesMember2025-10-012026-06-300001032220mms:ClinicalServicesMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-06-300001032220mms:ClinicalServicesMember2024-10-012025-06-300001032220mms:ClinicalServicesMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-06-300001032220mms:EmploymentAndOtherMember2026-04-012026-06-300001032220mms:EmploymentAndOtherMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300001032220mms:EmploymentAndOtherMember2025-04-012025-06-300001032220mms:EmploymentAndOtherMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300001032220mms:EmploymentAndOtherMember2025-10-012026-06-300001032220mms:EmploymentAndOtherMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-06-300001032220mms:EmploymentAndOtherMember2024-10-012025-06-300001032220mms:EmploymentAndOtherMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-06-300001032220mms:TechnologySolutionsMember2026-04-012026-06-300001032220mms:TechnologySolutionsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300001032220mms:TechnologySolutionsMember2025-04-012025-06-300001032220mms:TechnologySolutionsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300001032220mms:TechnologySolutionsMember2025-10-012026-06-300001032220mms:TechnologySolutionsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2025-10-012026-06-300001032220mms:TechnologySolutionsMember2024-10-012025-06-300001032220mms:TechnologySolutionsMembermms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMember2024-10-012025-06-300001032220mms:PerformanceBasedContractsMember2026-04-012026-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMembermms:PerformanceBasedContractsMember2026-04-012026-06-300001032220mms:PerformanceBasedContractsMember2025-04-012025-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMembermms:PerformanceBasedContractsMember2025-04-012025-06-300001032220mms:PerformanceBasedContractsMember2025-10-012026-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMembermms:PerformanceBasedContractsMember2025-10-012026-06-300001032220mms:PerformanceBasedContractsMember2024-10-012025-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMembermms:PerformanceBasedContractsMember2024-10-012025-06-300001032220mms:CostPlusContractsMember2026-04-012026-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMembermms:CostPlusContractsMember2026-04-012026-06-300001032220mms:CostPlusContractsMember2025-04-012025-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMembermms:CostPlusContractsMember2025-04-012025-06-300001032220mms:CostPlusContractsMember2025-10-012026-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMembermms:CostPlusContractsMember2025-10-012026-06-300001032220mms:CostPlusContractsMember2024-10-012025-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMembermms:CostPlusContractsMember2024-10-012025-06-300001032220us-gaap:FixedPriceContractMember2026-04-012026-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMemberus-gaap:FixedPriceContractMember2026-04-012026-06-300001032220us-gaap:FixedPriceContractMember2025-04-012025-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMemberus-gaap:FixedPriceContractMember2025-04-012025-06-300001032220us-gaap:FixedPriceContractMember2025-10-012026-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMemberus-gaap:FixedPriceContractMember2025-10-012026-06-300001032220us-gaap:FixedPriceContractMember2024-10-012025-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMemberus-gaap:FixedPriceContractMember2024-10-012025-06-300001032220us-gaap:TimeAndMaterialsContractMember2026-04-012026-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMemberus-gaap:TimeAndMaterialsContractMember2026-04-012026-06-300001032220us-gaap:TimeAndMaterialsContractMember2025-04-012025-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMemberus-gaap:TimeAndMaterialsContractMember2025-04-012025-06-300001032220us-gaap:TimeAndMaterialsContractMember2025-10-012026-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMemberus-gaap:TimeAndMaterialsContractMember2025-10-012026-06-300001032220us-gaap:TimeAndMaterialsContractMember2024-10-012025-06-300001032220mms:ContractConcentrationRiskMemberus-gaap:SalesRevenueNetMemberus-gaap:TimeAndMaterialsContractMember2024-10-012025-06-300001032220mms:NewYorkStateGovernmentAgenciesMember2026-04-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:NewYorkStateGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300001032220mms:NewYorkStateGovernmentAgenciesMember2025-04-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:NewYorkStateGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300001032220mms:NewYorkStateGovernmentAgenciesMember2025-10-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:NewYorkStateGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2025-10-012026-06-300001032220mms:NewYorkStateGovernmentAgenciesMember2024-10-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:NewYorkStateGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2024-10-012025-06-300001032220mms:OtherUnitedStateGovernmentAgenciesMember2026-04-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:OtherUnitedStateGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300001032220mms:OtherUnitedStateGovernmentAgenciesMember2025-04-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:OtherUnitedStateGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300001032220mms:OtherUnitedStateGovernmentAgenciesMember2025-10-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:OtherUnitedStateGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2025-10-012026-06-300001032220mms:OtherUnitedStateGovernmentAgenciesMember2024-10-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:OtherUnitedStateGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2024-10-012025-06-300001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2026-04-012026-06-300001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2025-04-012025-06-300001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2025-10-012026-06-300001032220mms:TotalUnitedStatesStateGovernmentAgenciesMember2024-10-012025-06-300001032220mms:UnitedStatesFederalGovernmentAgenciesMember2026-04-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:UnitedStatesFederalGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300001032220mms:UnitedStatesFederalGovernmentAgenciesMember2025-04-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:UnitedStatesFederalGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300001032220mms:UnitedStatesFederalGovernmentAgenciesMember2025-10-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:UnitedStatesFederalGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2025-10-012026-06-300001032220mms:UnitedStatesFederalGovernmentAgenciesMember2024-10-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:UnitedStatesFederalGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2024-10-012025-06-300001032220mms:InternationalGovernmentAgenciesMember2026-04-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:InternationalGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300001032220mms:InternationalGovernmentAgenciesMember2025-04-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:InternationalGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300001032220mms:InternationalGovernmentAgenciesMember2025-10-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:InternationalGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2025-10-012026-06-300001032220mms:InternationalGovernmentAgenciesMember2024-10-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:InternationalGovernmentAgenciesMemberus-gaap:SalesRevenueNetMember2024-10-012025-06-300001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2026-04-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMemberus-gaap:SalesRevenueNetMember2026-04-012026-06-300001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2025-04-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMemberus-gaap:SalesRevenueNetMember2025-04-012025-06-300001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2025-10-012026-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMemberus-gaap:SalesRevenueNetMember2025-10-012026-06-300001032220mms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember2024-10-012025-06-300001032220us-gaap:CustomerConcentrationRiskMembermms:OtherIncludingLocalMunicipalitiesAndCommercialCustomersMemberus-gaap:SalesRevenueNetMember2024-10-012025-06-300001032220us-gaap:UnbilledRevenuesMember2026-06-300001032220us-gaap:UnbilledRevenuesMember2025-09-300001032220us-gaap:ChangeInAccountingMethodAccountedForAsChangeInEstimateMember2026-04-012026-06-300001032220us-gaap:ChangeInAccountingMethodAccountedForAsChangeInEstimateMember2025-04-012025-06-300001032220us-gaap:ChangeInAccountingMethodAccountedForAsChangeInEstimateMember2025-10-012026-06-300001032220us-gaap:ChangeInAccountingMethodAccountedForAsChangeInEstimateMember2024-10-012025-06-3000010322202026-07-012026-06-300001032220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembermms:ChildSupportBusinessInTheUnitedStatesMember2025-12-310001032220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembermms:ChildSupportBusinessInTheUnitedStatesMember2025-12-012025-12-310001032220us-gaap:DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMembermms:BusinessesInAustraliaAndKoreaMember2024-12-012024-12-310001032220us-gaap:SecuredDebtMembermms:TermLoanADue2029Member2026-06-300001032220us-gaap:SecuredDebtMembermms:TermLoanADue2029Member2025-09-300001032220us-gaap:SecuredDebtMembermms:TermLoanBMember2026-06-300001032220us-gaap:SecuredDebtMembermms:TermLoanBMember2025-09-300001032220us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2026-06-300001032220us-gaap:LineOfCreditMemberus-gaap:RevolvingCreditFacilityMember2025-09-300001032220us-gaap:SecuredDebtMembermms:TermLoanBMember2026-05-272026-05-270001032220us-gaap:SecuredDebtMembermms:TermLoanBDueSeptember2026Memberus-gaap:InterestRateSwapMember2026-06-300001032220us-gaap:SecuredDebtMembermms:TermLoanBDueSeptember2027Memberus-gaap:InterestRateSwapMember2026-06-300001032220us-gaap:SecuredDebtMembermms:TermLoanADueSeptember2027Memberus-gaap:InterestRateSwapMember2026-06-300001032220us-gaap:SecuredDebtMembermms:TermLoanADueSeptember2028Memberus-gaap:InterestRateSwapMember2026-06-300001032220us-gaap:SecuredDebtMembermms:TermLoanBDueSeptember2028Memberus-gaap:InterestRateSwapMember2026-06-300001032220us-gaap:SecuredDebtMembermms:TermLoanADueMay2029Memberus-gaap:InterestRateSwapMember2026-06-300001032220us-gaap:SecuredDebtMembermms:TermLoanBDueSeptember2029Memberus-gaap:InterestRateSwapMember2026-06-300001032220us-gaap:OtherAssetsNoncurrent2026-06-300001032220us-gaap:OtherLiabilitiesNoncurrent2026-06-300001032220us-gaap:OtherAssetsNoncurrent2025-09-300001032220us-gaap:OtherLiabilitiesNoncurrent2025-09-300001032220us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel1Member2026-06-300001032220us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel2Member2026-06-300001032220us-gaap:MutualFundMemberus-gaap:FairValueInputsLevel3Member2026-06-300001032220us-gaap:MutualFundMember2026-06-300001032220us-gaap:InterestRateSwapMember2026-06-300001032220us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel1Member2026-06-300001032220us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel2Member2026-06-300001032220us-gaap:InterestRateSwapMemberus-gaap:FairValueInputsLevel3Member2026-06-300001032220us-gaap:FairValueInputsLevel1Member2026-06-300001032220us-gaap:FairValueInputsLevel2Member2026-06-300001032220us-gaap:FairValueInputsLevel3Member2026-06-300001032220us-gaap:AccumulatedTranslationAdjustmentMember2025-09-300001032220us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-09-300001032220us-gaap:AccumulatedTranslationAdjustmentMember2025-10-012026-06-300001032220us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2025-10-012026-06-300001032220us-gaap:AccumulatedTranslationAdjustmentMember2026-06-300001032220us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember2026-06-300001032220us-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMembermms:EmployeeMember2025-10-012026-06-300001032220us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMembermms:EmployeeMember2025-10-012026-06-300001032220us-gaap:RestrictedStockUnitsRSUMembermms:EmployeeMember2025-10-012026-06-300001032220us-gaap:RestrictedStockUnitsRSUMembersrt:DirectorMember2025-10-012026-06-300001032220us-gaap:PerformanceSharesMembersrt:MinimumMember2025-10-012026-06-300001032220us-gaap:PerformanceSharesMembersrt:MaximumMember2025-10-012026-06-300001032220us-gaap:PerformanceSharesMember2025-10-012026-06-300001032220us-gaap:RestrictedStockUnitsRSUMember2025-10-012026-06-300001032220us-gaap:RestrictedStockUnitsRSUMembersrt:MinimumMember2025-10-012026-06-300001032220us-gaap:RestrictedStockUnitsRSUMembersrt:MaximumMember2025-10-012026-06-3000010322202026-05-310001032220us-gaap:BilledRevenuesMember2026-06-300001032220us-gaap:BilledRevenuesMember2025-09-300001032220us-gaap:SubsequentEventMember2026-07-062026-07-06
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q
(Mark one)
☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2026
☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________to__________.
Commission file number: 1-12997
Maximus_logo_2022.jpg

Maximus, Inc.
(Exact name of registrant as specified in its charter)
Virginia54-1000588
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification No.)
1600 Tysons Boulevard, McLean, Virginia
22102
(Address of principal executive offices)
(Zip Code)
(703) 251-8500
(Registrant's telephone number, including the area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, no par valueMMSNew York Stock Exchange
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).        Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.
Large accelerated filer ☒
Accelerated filer ☐
Non-accelerated filer ☐
Smaller reporting company ☐
Emerging growth company  ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐ No ☒
There were 52,357,763 shares of the registrant's Common Stock outstanding as of August 3, 2026.


Table of Contents to Third Quarter 2026 Form 10-Q

2

Unless otherwise specified, references in this Quarterly Report on Form 10-Q to "our," "we," "us," "Maximus," the "Company," and "our business" refer to Maximus, Inc. and its subsidiaries.
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS
Included in this Quarterly Report on Form 10-Q are forward-looking statements within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by words such as: "anticipate," "intend," "plan," "goal," "seek," “on track,” "opportunity," "could," "potential," "believe," "project," "estimate," "expect," "continue," "forecast," "strategy," "future," "likely," "may," "should," "will," and similar references to future periods.
Any statements herein that are not historical facts, including statements about our confidence, strategies and initiatives, and our expectations about revenues, results of operations, profitability, future contracts, liquidity, market opportunities, market demand, acceptance of our products and service offerings, or acquisitions and divestitures, are forward-looking statements that are subject to risks and uncertainties. These risks could cause our actual results to differ materially from those indicated by such forward-looking statements. Therefore, you should not rely on any of these forward-looking statements. Important factors that could cause our actual results and financial condition to differ materially from those indicated in the forward-looking statements include, among others, the following:
•a failure to meet performance requirements under our contracts could lead to penalties, liquidated damages, actual damages, adverse settlement agreements, and/or contract termination;
•our ability to successfully compete, bid for, and accurately price contracts to generate our desired profit;
•the effects of future legislative or government budgetary and spending changes, including the impact of a prolonged U.S. government shutdown;
•the impact of the U.S. government on federal procurement, federal funding to states' safety-net programs, and the overall decision-making process related to our industry, including our business and customers;
•the ability of the U.S. government to issue or revise existing rules, regulations, executive orders, and directives at any time, or to take non-routine actions, which creates uncertainty for our business operations and requires significant additional compliance efforts and costs;
•our ability to manage our growth, including acquired businesses;
•difficulties in integrating or achieving projected revenues, earnings, and other benefits associated with acquired businesses;
•the outcome of reviews or audits, which might result in financial penalties and impair our ability to respond to invitations for new work;
•our ability to manage capital investments and other contract startup costs;
•our ability to manage our debt;
•our ability to maintain our technology systems and otherwise protect confidential or protected information;
•our discovery of additional information related to our previously disclosed cybersecurity incident and any potential legal, business, reputational, or financial consequences resulting from that incident or any other cybersecurity incidents;
•our ability to attract and retain executive officers, senior managers, and other qualified personnel to execute our business;
•the effect of union activity and organizing efforts at our U.S. locations;
•the ability of government customers to not exercise options, or to recompete or terminate contracts on short notice, with or without cause;
•our ability to win recompetes and/or succeed in protests on our significant contracts;
•our reliance on a small number of individual contracts and customers;
•our ability to realize the full value of our backlog;
•our ability to maintain relationships with key government entities from whom a substantial portion of our revenue is derived;
•a failure to comply with laws governing our business, which might result in the Company being subject to fines, penalties, suspension, debarment, and other sanctions;
•the costs and outcome of litigation;
•our ability to manage third parties upon whom we depend to provide services to our customers;
•the effects of changes in laws and regulations governing our business, including actions resulting from non-routine government actions or orders, changes in tax laws and applicable interpretations and guidance thereunder, or changes in accounting policies, rules, methodologies, and practices, and our ability to estimate the impact of such
3

changes including shifting macroeconomic conditions and uncertainty;
•the effects of emerging technologies, such as artificial intelligence (AI) and machine learning (ML), on our business;
•matters related to businesses we disposed of or divested; and
•other factors set forth in Item 1A, "Risk Factors" of our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (SEC) on November 20, 2025.
Any forward-looking statement made by us in this report is based only on information currently available to us and speaks only as of the date on which it is made. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments, or otherwise.
4

PART I - Financial Information
Item 1. Financial Statements
Maximus, Inc.
Consolidated Statements of Operations
(Unaudited)
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands, except per share amounts)
Revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Cost of revenue930,168 988,887 2,920,247 3,112,970 
Gross profit348,803 359,513 1,009,737 999,891 
Selling, general, and administrative expenses167,188 170,831 492,827 525,423 
Amortization of intangible assets20,187 23,010 60,785 69,041 
Operating income161,428 165,672 456,125 405,427 
Interest expense23,878 22,657 66,805 61,648 
Other (income)/expense, net(608)48 (1,639)(603)
Income before income taxes138,158 142,967 390,959 344,382 
Provision for income taxes34,565 36,986 95,360 100,636 
Net income$103,593 $105,981 $295,599 $243,746 
Earnings per share:
Basic$1.96 $1.87 $5.48 $4.22 
Diluted$1.95 $1.86 $5.45 $4.20 
Weighted average shares outstanding:
Basic52,854 56,683 53,974 57,776 
Diluted53,057 56,984 54,243 58,100 
Dividends declared per share$0.33 $0.30 $0.96 $0.90 
See accompanying notes to consolidated financial statements.
5

Maximus, Inc.
Consolidated Statements of Comprehensive Income
(Unaudited)
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands)
Net income$103,593 $105,981 $295,599 $243,746 
Other comprehensive (loss)/income, net of tax:
Foreign currency translation adjustments255 7,320 (2,276)21,503 
Net gains/(losses) on cash flow hedges, net of tax provision/(benefit) of $28, $(561), $(206), and $(596), respectively
79 (1,574)(578)(1,672)
Other comprehensive (loss)/income334 5,746 (2,854)19,831 
Comprehensive income$103,927 $111,727 $292,745 $263,577 
See accompanying notes to consolidated financial statements.
6

Maximus, Inc.
Consolidated Balance Sheets
June 30, 2026September 30, 2025
(unaudited)
(in thousands)
Assets:
Cash and cash equivalents$56,953 $222,351 
Accounts receivable, net1,382,014 898,095 
Income taxes receivable31,019 3,904 
Prepaid expenses and other current assets171,377 128,574 
Total current assets1,641,363 1,252,924 
Property and equipment, net28,485 30,972 
Capitalized software, net201,373 214,260 
Operating lease right-of-use assets88,302 100,514 
Goodwill1,780,543 1,782,095 
Intangible assets, net477,031 538,266 
Deferred contract costs, net60,205 63,332 
Deferred compensation plan assets67,877 63,272 
Deferred income taxes8,047 11,491 
Other assets13,553 12,513 
Total assets$4,366,779 $4,069,639 
Liabilities and Shareholders' Equity:
Liabilities:
Accounts payable and accrued liabilities$263,220 $296,888 
Accrued compensation and benefits146,064 236,948 
Deferred revenue, current portion36,626 53,784 
Income taxes payable1,138 17,321 
Long-term debt, current portion71,599 52,680 
Operating lease liabilities, current portion38,280 38,605 
Other current liabilities121,142 68,937 
Total current liabilities678,069 765,163 
Deferred revenue, non-current portion35,863 43,757 
Deferred income taxes199,887 149,020 
Long-term debt, non-current portion1,565,336 1,281,593 
Deferred compensation plan liabilities, non-current portion66,468 62,145 
Operating lease liabilities, non-current portion56,603 71,289 
Other liabilities24,002 22,637 
Total liabilities2,626,228 2,395,604 
Commitments and contingencies (Note 11)
Shareholders' equity:
Common stock, no par value; 100,000 shares authorized; 52,358 and 54,805 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively
647,138 628,118 
Accumulated other comprehensive loss(20,721)(17,867)
Retained earnings1,114,134 1,063,784 
Total shareholders' equity1,740,551 1,674,035 
Total liabilities and shareholders' equity$4,366,779 $4,069,639 
See accompanying notes to consolidated financial statements.
7

Maximus, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
For the Nine Months Ended
June 30, 2026June 30, 2025
(in thousands)
Cash flows from operating activities:
Net income$295,599 $243,746 
Adjustments to reconcile net income to cash flows from operations:
Depreciation and amortization of property, equipment, and capitalized software37,091 27,502 
Capitalized software impairment charges6,914 — 
Amortization of intangible assets60,785 69,041 
Amortization of debt issuance costs and debt discount2,314 2,046 
Deferred income taxes54,416 (5,829)
Stock compensation expense24,274 30,324 
Divestiture-related charges/(gains)(10,147)39,343 
Change in assets and liabilities, net of effects of business combinations and divestitures:
Accounts receivable(489,403)(553,297)
Prepaid expenses and other current assets13,152 9,341 
Deferred contract costs2,748 (856)
Accounts payable and accrued liabilities(33,345)(21,808)
Accrued compensation and benefits(79,734)(50,369)
Deferred revenue(24,658)(8,675)
Income taxes(40,504)5,625 
Operating lease right-of-use assets and liabilities(2,814)(3,508)
Other assets and liabilities3,449 (2,626)
Net cash used in operating activities(179,863)(220,000)
Cash flows from investing activities:
Purchases of property and equipment and capitalized software(28,752)(55,686)
Proceeds from divestitures16,842 736 
Other(2,500)(2,165)
Net cash used in investing activities(14,410)(57,115)
Cash flows from financing activities:
Cash dividends paid to Maximus shareholders(51,437)(51,865)
Purchases of Maximus common stock(204,919)(306,443)
Tax withholding related to RSU vesting(17,325)(16,451)
Payments for debt financing costs(2,393)(1,658)
Proceeds from borrowings1,368,675 1,335,208 
Principal payments for debt(1,065,935)(810,174)
Other, including customer escrowed funds60,841 (1,824)
Net cash provided by financing activities87,507 146,793 
Effect of exchange rate changes on cash, cash equivalents, and restricted cash(444)(65)
Net change in cash, cash equivalents, and restricted cash(107,210)(130,387)
Cash, cash equivalents, and restricted cash, beginning of period260,459 235,763 
Cash, cash equivalents, and restricted cash, end of period$153,249 $105,376 
See accompanying notes to consolidated financial statements.
8

Maximus, Inc.
Consolidated Statements of Changes in Shareholders' Equity
(Unaudited)
Common StockAccumulated
Other
Comprehensive
Loss
Retained
Earnings
Total
Shareholders' Equity
SharesAmount
(in thousands)
Balance as of September 30, 202554,805$628,118 $(17,867)$1,063,784 $1,674,035 
Net income—— — 93,943 93,943 
Foreign currency translation—— 248 — 248 
Cash flow hedge, net of tax—— (1,407)— (1,407)
Cash dividends—— — (16,338)(16,338)
Dividends on RSUs—363 — (363)— 
Purchases of Maximus common stock(353)— — (31,055)(31,055)
Stock compensation expense—7,019 — — 7,019 
Tax withholding adjustment related to RSU vesting—(6,633)— — (6,633)
RSUs vested97— — — — 
Balance as of December 31, 202554,549628,867 (19,026)1,109,971 1,719,812 
Net income—— — 98,063 98,063 
Foreign currency translation—— (2,779)— (2,779)
Cash flow hedge, net of tax—— 750 — 750 
Cash dividends—— — (17,821)(17,821)
Dividends on RSUs—503 — (503)— 
Purchases of Maximus common stock(1,445)— — (110,963)(110,963)
Stock compensation expense—9,899 — — 9,899 
RSUs vested6— — — — 
Balance as of March 31, 202653,110639,269 (21,055)1,078,747 1,696,961 
Net income—— — 103,593 103,593 
Foreign currency translation—— 255 — 255 
Cash flow hedge, net of tax—— 79 — 79 
Cash dividends—— — (17,278)(17,278)
Dividends on RSUs—513 (513)— 
Purchases of Maximus common stock(752)— — (50,415)(50,415)
Stock compensation expense—7,356 — 7,356 
Balance as of June 30, 202652,358$647,138 $(20,721)$1,114,134 $1,740,551 
9

Common StockAccumulated
Other
Comprehensive
Loss
Retained
Earnings
Total
Shareholders' Equity
SharesAmount
(in thousands)
Balance at September 30, 202460,352$598,304 $(32,460)$1,276,971 $1,842,815 
Net income—— — 41,196 41,196 
Foreign currency translation—— 10,452 — 10,452 
Cash flow hedge, net of tax—— 2,454 — 2,454 
Cash dividends—— — (18,060)(18,060)
Dividends on RSUs—301 — (301)— 
Purchases of Maximus common stock(3,113)— — (236,655)(236,655)
Stock compensation expense—6,952 — — 6,952 
Tax withholding adjustment related to RSU vesting—(2,305)— — (2,305)
RSUs vested47— — — — 
Balance as of December 31, 202457,286603,252 (19,554)1,063,151 1,646,849 
Net income—— — 96,569 96,569 
Foreign currency translation—— 3,731 — 3,731 
Cash flow hedge, net of tax—— (2,552)— (2,552)
Cash dividends—— — (16,901)(16,901)
Dividends on RSUs—440 — (440)— 
Purchases of Maximus common stock(947)— — (72,845)(72,845)
Stock compensation expense—12,623 — — 12,623 
RSUs vested10— — — — 
Balance as of March 31, 202556,349616,315 (18,375)1,069,534 1,667,474 
Net income———105,981105,981
Foreign currency translation——7,320—7,320
Cash flow hedge, net of tax——(1,574)—(1,574)
Cash dividends———(16,904)(16,904)
Dividends on RSUs—442—(442)—
Stock compensation expense—10,749——10,749
Tax withholding adjustment related to RSU vesting—(10)——(10)
RSUs vested1————
Balance as of June 30, 202556,350$627,496 $(12,629)$1,158,169 $1,773,036 
See accompanying notes to consolidated financial statements.

10

Maximus, Inc.
Notes to the Consolidated Financial Statements
1. ORGANIZATION
Maximus, a Virginia corporation, is a leading provider of tech-enabled services to government agencies. By moving people, technology, and government forward, Maximus helps improve the delivery of public services for more than 100 million American citizens amid complex technological, health, economic, and social challenges. As a trusted and accountable partner to primarily U.S. federal and state customers, we proudly design, develop, and deliver innovative and efficient programs that are designed to improve government’s effectiveness in serving its citizens.

2. SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements, including the notes, include our accounts and those of our subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP, and the rules and regulations of the Securities and Exchange Commission (SEC). All intercompany balances and transactions have been eliminated in consolidation.
Basis of Presentation for Interim Periods
Certain information and disclosures normally included for the annual financial statements to be prepared in accordance with U.S. GAAP have been condensed or omitted for the interim periods presented. We believe that the unaudited interim financial statements include all adjustments (which are normal and recurring in nature) necessary to present fairly our financial position and the results of operations and cash flows for the periods presented.
The results of operations for the interim periods presented are not necessarily indicative of results that may be expected for the year or future periods. The financial statements should be read in conjunction with our audited consolidated financial statements and the accompanying notes contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025. We have continued to follow the accounting policies set forth in those financial statements.
Use of Estimates
The preparation of these financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. At each reporting period end, we make estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of long-lived assets, and amounts related to income taxes, certain accrued liabilities, and contingencies and litigation.
At June 30, 2026, our capitalized software balance includes $32.3 million related to technology for new services within our U.S. Services Segment. During the second quarter of fiscal year 2026, we recorded an impairment charge of $6.9 million to an asset following a client decision that resulted in its carrying value no longer being recoverable. At this time, we believe that the remaining balance of these assets is recoverable. We continue to monitor these assets, and if circumstances change, we may be required to further adjust the value or useful life of the remaining assets.
11

3. BUSINESS SEGMENTS
We conduct our operations through three business segments: U.S. Federal Services, U.S. Services, and Outside the U.S. Our operating segments represent the manner in which our Chief Executive Officer (CEO), who is our Chief Operating Decision Maker (CODM), reviews our financial results. The CODM reviews segment-level revenue, gross profit, and segment operating income/(loss) on a regular basis to assess performance and manage the business. Revenue is used to evaluate growth trends and performance relative to budget, while gross profit and segment operating income/(loss) are used to assess overall profitability, business efficiency, and the effectiveness of cost-reduction initiatives. These measures also inform the CODM’s decisions regarding the allocation of resources across segments, including allocations of management bonus as well as investments in technology, personnel, and strategic transactions, such as mergers and acquisitions.
Our CODM does not evaluate operating segments using asset or liability information.
U.S. Federal Services
Our U.S. Federal Services Segment delivers solutions that help various U.S. federal government agencies better execute their missions, including program operations and management, clinical services, and advanced technology solutions.
U.S. Services
Our U.S. Services Segment provides a variety of services, such as program operations, clinical services, employment services, and advanced technology solutions and related professional services for U.S. state and local government programs. These services support a variety of programs, including those under Medicaid and the Children's Health Insurance Program (CHIP), the Affordable Care Act (ACA) marketplaces, and Temporary Assistance for Needy Families (TANF).
Outside the U.S.
Our Outside the U.S. Segment provides business process services and other solutions for international governments. These services include health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally-enabled customer services, and advanced technologies for modernization. We support programs and deliver services in the United Kingdom, including the Functional Assessment Services (FAS) contract and the Restart employment program. We also provide services in Canada and the Middle East.
















12


Table 3.1: Results of Operations by Business Segment for the Three Months Ended
For the Three Months Ended June 30, 2026
(dollars in thousands)U.S. Federal Services% (1 )U.S. Services% (1 )Outside the U.S.% (1 )Total
Revenue$720,991 $418,227 $139,753 $1,278,971 
Cost of revenue498,720 69.2 %311,449 74.5 %119,999 85.9 %930,168 
Gross profit222,271 30.8 %106,778 25.5 %19,754 14.1 %348,803 
Other segment items (2)88,231 12.2 %61,589 14.7 %18,548 13.3 %168,368 
Segment operating income$134,040 18.6 %$45,189 10.8 %$1,206 0.9 %180,435 
Divestiture-related gains/(charges) (3)1,162 
Other (4)18 
Amortization of intangible assets(20,187)
Operating income$161,428 
Depreciation and amortization$7,223 1.0 %$3,997 1.0 %$654 0.5 %$11,874 
For the Three Months Ended June 30, 2025
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$761,174 $439,818 $147,408 $1,348,400 
Cost of revenue535,040 70.3 %333,886 75.9 %119,961 81.4 %988,887 
Gross profit226,134 29.7 %105,932 24.1 %27,447 18.6 %359,513 
Other segment items (2)88,272 11.6 %60,975 13.9 %21,507 14.6 %170,754 
Segment operating income$137,862 18.1 %$44,957 10.2 %$5,940 4.0 %188,759 
Other (4)(77)
Amortization of intangible assets(23,010)
Operating income$165,672 
Depreciation and amortization$3,125 0.4 %$4,631 1.1 %$1,851 1.3 %$9,607 

13

Table 3.2: Results of Operations by Business Segment for the Nine Months Ended
For the Nine Months Ended June 30, 2026
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$2,260,735 $1,249,229 $420,020 $3,929,984 
Cost of revenue1,598,084 70.7 %957,548 76.7 %364,615 86.8 %2,920,247 
Gross profit662,651 29.3 %291,681 23.3 %55,405 13.2 %1,009,737 
Other segment items (2)266,174 11.8 %178,616 14.3 %58,664 14.0 %503,454 
Segment operating income/(loss)$396,477 17.5 %$113,065 9.1 %$(3,259)(0.8)%506,283 
Divestiture-related gains/(charges) (3)10,147 
Other (4)480 
Amortization of intangible assets(60,785)
Operating income$456,125 
Depreciation and amortization$21,637 1.0 %$12,381 1.0 %$3,073 0.7 %$37,091 
For the Nine Months Ended June 30, 2025
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$2,319,756 $1,334,418 $458,687 $4,112,861 
Cost of revenue1,718,249 74.1 %1,021,712 76.6 %373,009 81.3 %3,112,970 
Gross profit601,507 25.9 %312,706 23.4 %85,678 18.7 %999,891 
Other segment items (2)245,563 10.6 %173,096 13.0 %66,822 14.6 %485,481 
Segment operating income$355,944 15.3 %$139,610 10.5 %$18,856 4.1 %514,410 
Divestiture-related gains/(charges) (3)(39,343)
Other (4)(599)
Amortization of intangible assets(69,041)
Operating income$405,427 
Depreciation and amortization$9,653 0.4 %$12,603 0.9 %$5,246 1.1 %$27,502 
(1)Percentage of respective revenue, as applicable.
(2)Other segment items are principally selling, general, and administrative expenses allocated to segments.
(3)During fiscal years 2026 and 2025, we divested businesses from our U.S. Services and Outside the U.S. Segments, respectively. See "Note 6. Divestitures" for additional information.
(4)Other expenses include credits and costs that are not allocated to a particular segment.




14

4. REVENUE RECOGNITION
We recognize revenue as, or when, we satisfy performance obligations under a contract. The majority of our contracts have performance obligations that are satisfied over time. In most cases, we view our performance obligations as promises to transfer a series of distinct services to our customers that are substantially the same and which have the same pattern of service. We recognize revenue over the performance period as a customer receives the benefits of our services.
Disaggregation of Revenue
In addition to our segment reporting, we disaggregate our revenues by service type, contract type, and customer type.
Table 4.1: Revenue by Service Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands)
Program Operations$602,807 47.1 %$626,981 46.5 %$1,924,106 49.0 %$2,045,720 49.7 %
Clinical Services553,075 43.2 %560,360 41.6 %1,607,602 40.9 %1,535,849 37.3 %
Employment & Other55,852 4.4 %81,906 6.1 %186,025 4.7 %274,513 6.7 %
Technology Solutions67,237 5.3 %79,153 5.9 %212,251 5.4 %256,779 6.2 %
Total revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Table 4.2: Revenue by Contract Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands)
Performance-based$755,826 59.1 %$761,428 56.5 %$2,209,585 56.2 %$2,193,605 53.3 %
Cost-plus303,486 23.7 %301,385 22.4 %1,033,798 26.3 %1,020,311 24.8 %
Fixed price155,200 12.1 %180,390 13.4 %489,327 12.5 %540,078 13.1 %
Time and materials64,459 5.0 %105,197 7.8 %197,274 5.0 %358,867 8.7 %
Total revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Table 4.3: Revenue by Customer Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands)
New York state government agencies$148,067 11.6 %$148,408 11.0 %$445,548 11.3 %$466,053 11.3 %
Other U.S. state government agencies275,793 21.6 %291,312 21.6 %817,052 20.8 %869,561 21.1 %
Total U.S. state government agencies423,860 439,720 1,262,600 1,335,614 
U.S. federal government agencies701,932 54.9 %743,058 55.1 %2,204,623 56.1 %2,267,078 55.1 %
International government agencies137,462 10.7 %146,018 10.8 %413,321 10.5 %451,608 11.0 %
Other, including local municipalities and commercial customers15,717 1.2 %19,604 1.5 %49,440 1.3 %58,561 1.4 %
Total revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 

15

Contract balances
Differences in timing between revenue recognition and cash collection result in contract assets and contract liabilities. We classify these assets as accounts receivable — billed and billable and unbilled receivables; the liabilities are classified as deferred revenue.
In many contracts, we bill our customers on a monthly basis shortly after the month end for work performed in that month, and such balances are considered collectible and are included within accounts receivable, net.
Exceptions to this pattern will arise for various reasons, including those listed below.
•Under cost-plus contracts, we are typically required to estimate a contract's share of our general and administrative expenses. This share is based upon estimates of total costs, which may vary over time. We typically invoice our customers at an agreed provisional billing rate, which may differ from actual rates incurred. If our actual rates are higher than the provisional billing rates, an asset is recorded for this variance; if the provisional billing rates are higher than our actual rates, we record a liability.
•Certain contracts include retainage balances, whereby revenue is earned, but some portion of cash payments are held back by the customer for a period of time, typically to allow the customer to confirm the objective criteria laid out by the contract have been met. This balance is classified as accounts receivable-unbilled, until restrictions on billing are lifted. As of June 30, 2026, and September 30, 2025, $27.4 million and $24.1 million, respectively, of our unbilled receivables related to amounts pursuant to contractual retainage provisions.
•In certain contracts, we may receive funds from our customers prior to performing operations. These funds are typically referred to as "set-up costs" and reflect the need for us to make investments in infrastructure prior to providing a service. This investment in infrastructure is not a performance obligation that is distinct from the service that is subsequently provided, and, as a result, revenue is not recognized based upon the establishment of this infrastructure, but rather over the course of the contractual relationship. The funds are initially recorded as deferred revenue and recognized over the term of the contract. Other contracts may not include set-up fees but will provide higher fees in earlier periods of the contract. The premium on these fees is deferred.
•Some of our contracts, notably our employment services contracts in the Outside the U.S. Segment, include payments for specific milestones, such as job placement and job retention, and these outcome payments occur over several months. We are required to estimate these outcome fees ahead of their realization and recognize this estimated fee over the period of delivery.
During the three and nine months ended June 30, 2026, we recognized revenue of $2.0 million and $45.2 million, respectively, included in our deferred revenue balances at September 30, 2025. During the three and nine months ended June 30, 2025, we recognized revenue of $13.8 million and $87.0 million, respectively, included in our deferred revenue balances at September 30, 2024.
Contract estimates
We are required to use estimates in recognizing revenue from some of our contracts.
Certain performance-based contracts include variable consideration in the form of penalties and incentives, based upon our performance under the terms of the contract. The calculation of these penalties and incentives requires the evaluation of both objective and subjective criteria, which may require the use of estimates.
Within our employment services business in our Outside the U.S. Segment, some of our performance-based contract revenue is recognized based upon future milestones defined in each contract, which requires us to make estimates about the attainment of those milestones.
We estimate the total variable consideration we will receive using the expected value method. We recognize the revenue over the expected period of performance. At each reporting period, we update our estimates of the variable fees to represent the circumstances present at the end of the reporting period. We include variable consideration in our estimates to the extent it is probable that a subsequent change in the estimate will not result in a significant reversal of cumulative revenue when the uncertainty is resolved. We do not have a history of significant constraints on these contracts.
16

Table 4.4: Effect of Changes in Contract Estimates
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands, except per share data)
Increase/(decrease) in revenue recognized due to changes in contract estimates$(1,291)$607 $5,628 $11,181 
Increase/(decrease) in diluted earnings per share recognized due to changes in contract estimates$(0.02)$0.01 $0.08 $0.14 
Remaining performance obligations
As of June 30, 2026, we had approximately $230 million of remaining performance obligations. We anticipate that we will recognize revenue on approximately 57% of this balance within the next 12 months. This balance excludes contracts with an original duration of twelve months or less, including contracts with a penalty-free termination for convenience clause, and any variable consideration that is allocated entirely to future performance obligations, including variable transaction fees or fees tied directly to costs incurred.

5. EARNINGS PER SHARE
Table 5: Weighted Average Number of Shares - Earnings Per Share
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands)
Basic weighted average shares outstanding52,854 56,683 53,974 57,776 
Dilutive effect of unvested RSUs and PSUs203 301 269 324 
Denominator for diluted earnings per share53,057 56,984 54,243 58,100 
The diluted earnings per share calculations for the three and nine months ended June 30, 2026 exclude approximately 571,000 and 567,000 unvested anti-dilutive restricted stock units, respectively. The diluted earnings per share calculations for the three and nine months ended June 30, 2025 exclude approximately 140,000 and 142,000 unvested anti-dilutive restricted stock units, respectively.
6. DIVESTITURES
U.S. Services Segment
In December 2025, we sold our child support business within the United States for approximately $15.0 million. This business had been reporting approximately $25.0 million of annual revenue. We recorded a gain on sale of $10.1 million.
Outside the U.S. Segment
In December 2024, we sold our businesses in Australia and Korea for a nominal sum. The sale agreement includes up to $5.0 million of contingent consideration based upon future performance. As of June 30, 2026, we have not recorded any potential contingent consideration. Our total divestiture-related charges of $39.5 million included approximately $21.3 million of previously unrealized foreign exchange losses, which we had recorded through other comprehensive income. We also provided an indemnification to the buyer that has been recorded at fair value in our consolidated balance sheets. No tax benefit is anticipated from this transaction.
17

7. DEBT AND DERIVATIVES
Table 7.1: Details of Debt
June 30, 2026September 30, 2025
(in thousands)
Term Loan A (TLA)$819,375 $853,125 
Term Loan B (TLB)814,173 493,750 
Revolver20,000 — 
Total debt principal1,653,548 1,346,875 
Less: Unamortized debt-issuance costs and discounts(16,613)(12,602)
Total debt1,636,935 1,334,273 
Less: Current portion of long-term debt(71,599)(52,680)
Long-term debt$1,565,336 $1,281,593 
On May 27, 2026, we amended our existing credit agreement (the "Amendment") with J.P. Morgan Chase Bank, N.A. The Amendment increased our TLB by $325 million.
Our credit agreements require us to comply with a number of covenants, including leverage and interest coverage ratios. At June 30, 2026, we are in compliance with all covenants. We do not believe that the covenants represent a significant restriction on our ability to successfully operate the business or to pay dividends.
The following table sets forth future minimum principal payments due under our debt obligations as of June 30, 2026 for the remainder of fiscal year 2026 through fiscal year 2031:
Table 7.2: Details of Future Minimum Principal Payments Due
Amount Due
(in thousands)
July 1, 2026 through September 30, 2026$18,952 
Year ended September 30, 202775,809 
Year ended September 30, 202881,434 
Year ended September 30, 2029690,184 
Year ended September 30, 20308,309 
Years ended thereafter778,860 
Total payments$1,653,548 
Interest Rate Derivative Instruments
Both our TLA and TLB interest payments are comprised of an applicable margin rate and a floating rate, the latter being based on SOFR. We utilize interest rate swaps that are designed to reduce our risk from changes in floating rates, which we have designated as cash flow hedges. Effective June 1, 2026, we entered into new interest rate swap agreements to reduce interest rate risks in both our TLA and TLB. The following table presents our active interest rate swaps:
Table 7.3: Interest Rate Derivative Instruments
As of June 30, 2026
Debt Principal HedgedNotional AmountFixed Interest RateExpiry
(in thousands)
Term Loan B$75,000 3.72 %September 2026
Term Loan B$75,000 3.62 %September 2027
Term Loan A$150,000 3.14 %September 2027
Term Loan A$200,000 3.47 %September 2028
Term Loan B$75,000 4.04 %September 2028
Term Loan A$50,000 4.05 %May 2029
Term Loan B$50,000 4.06 %September 2029
18

The fixed interest rate on the table above identifies the payment rate to our counterparties in lieu of the floating rate.
The balance of the debt pays interest based upon the Secured Overnight Financing Rate (SOFR). At June 30, 2026, our effective interest rate, including the original issuance costs and discount rate, was 5.6%.
At June 30, 2026, we recorded an asset of $3.9 million and a liability of $0.8 million to reflect the fair value of our interest rate swap agreements, compared to an asset of $5.5 million and a liability of $1.7 million at September 30, 2025. The assets and liabilities are recorded as "other assets" and "other liabilities," respectively, within our consolidated balance sheets. As these instruments are effective cash flow hedges, gains and losses based upon interest rate fluctuations are recorded within "accumulated other comprehensive loss" on our consolidated financial statements.
8. FAIR VALUE MEASUREMENTS
We record the following assets and liabilities at fair value on a recurring basis.
•We hold mutual fund assets within a Rabbi Trust to cover liabilities in our deferred compensation plan. These assets have prices quoted within active markets and, accordingly, are classified as level 1 within the fair value hierarchy.
•We have interest rate swap agreements that are designed to manage our interest rate exposure. These agreements can be valued using observable data and, accordingly, are classified as level 2 within the fair value hierarchy.
•In connection with the businesses sold in Australia and Korea, we indemnified the buyer related to certain potential losses, which are recorded at fair value, based on an assessment of probability-weighted outcomes. Accordingly, these inputs are not observable and are classified as level 3 within the fair value hierarchy. Changes in the fair value of the indemnification liability are recorded in the consolidated statements of operations.
The table below presents assets and liabilities measured and recorded at fair value in our consolidated balance sheets on a recurring basis, along with their corresponding level within the fair value hierarchy. No transfers between Level 1, Level 2, and Level 3 fair value measurements occurred for the nine months ended June 30, 2026.
Table 8.1: Fair Value Measurements
As of June 30, 2026
Level 1Level 2Level 3Balance
(in thousands)
Assets:
Deferred compensation assets - Rabbi Trust$46,375 $— $— $46,375 
Interest rate swap - $450 million notional value
— 3,898 — 3,898 
Total assets$46,375 $3,898 $— $50,273 
Liabilities:
Interest rate swap - $225 million notional value
$— $829 $— $829 
Indemnification liabilities— — 8,767 8,767 
Total liabilities$— $829 $8,767 $9,596 
The fair values of receivables, prepaid assets, other assets, accounts payable, accrued costs, and other current liabilities approximate the carrying values as a result of the short-term nature of these instruments. The carrying value of our debt is consistent with the fair value, as the stated interest rates in the agreements are consistent with the current market rates used in notes with similar terms in the markets (Level 2 inputs).
19

Accumulated Other Comprehensive Loss
All amounts recorded in accumulated other comprehensive loss are related to our foreign currency translations and interest rate swaps, net of tax. The following table shows changes in accumulated other comprehensive loss. Amounts reclassified from other comprehensive income were recorded within our selling, general, and administrative expenses (for foreign currency translation adjustments) and within interest expense (for gains on derivatives).
Table 8.2: Details of Changes in Accumulated Other Comprehensive Loss by Category
Foreign currency translation adjustmentsNet unrealized gain on derivatives, net of taxTotal
(in thousands)
Balance as of September 30, 2025$(20,706)$2,839 $(17,867)
Other comprehensive income before reclassifications(2,276)3,223 947 
Amounts reclassified from accumulated other comprehensive loss— (3,801)(3,801)
Net current period other comprehensive income/(loss)(2,276)(578)(2,854)
Balance as of June 30, 2026$(22,982)$2,261 $(20,721)
Indemnification Liability
The fair value of our indemnification liability is recorded at fair value as of the disposal date, based on an assessment of probability-weighted outcomes. This liability is reviewed on a quarterly basis. Changes in estimates are recorded to selling and general administrative expenses and foreign currency translation adjustments are recorded in other income/expenses on our Consolidated Statement of Operations.
Movement in our indemnification liability balance is as follows:
Table 8.3: Fair Value Measurement Using Significant Unobservable Inputs (Level 3)
Indemnification Liability
(in thousands)
Opening indemnification liability as of September 30, 2025$11,342 
Cash payments(2,264)
Foreign currency translation adjustments(311)
Closing indemnification liability as of June 30, 2026$8,767 

20

9. EQUITY
Stock Compensation
We grant restricted stock units (RSUs) and performance stock units (PSUs) to eligible participants under our 2021 Omnibus Incentive Plan, which was approved by our Board of Directors and stockholders. The RSUs granted to employees vest ratably over three to four years, with a small number that cliff vest after three years. The RSUs granted to directors cliff vest one year from the grant date. PSU vesting is subject to the achievement of certain performance and market conditions, and the number of PSUs earned could vary from 0% to 200% of the number of PSUs awarded. The PSUs will vest at the end of a three-year performance period if the performance conditions are met. We issue new shares to satisfy our obligations under these plans. The fair value of each RSU and PSU is calculated at the date of the grant.
During the nine months ended June 30, 2026, we issued approximately 341,000 RSUs, which will vest ratably over one to four years, and approximately 146,000 PSUs, which will vest after three years if the performance conditions are met.
Stock Repurchase Programs
In May 2026, our Board of Directors authorized an increase to our existing stock repurchase program that allows us to repurchase, at management's discretion, up to $400 million of our common stock; this resolution superseded a similar resolution authorized in September 2025.
During the nine months ended June 30, 2026, we purchased approximately 2.6 million common shares at a cost of $192.4 million, which includes an additional charge from the 1% excise tax on share repurchases. During the nine months ended June 30, 2025, we repurchased approximately 4.1 million common shares at a cost of $309.5 million under a similar program.
At June 30, 2026, approximately $400.0 million remained available for future stock repurchases.
10. OTHER ITEMS
Cash, Cash Equivalents, and Restricted Cash
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
June 30, 2026September 30, 2025
(in thousands)
Cash and cash equivalents$56,953 $222,351 
Restricted cash96,296 38,108 
Cash, cash equivalents, and restricted cash$153,249 $260,459 
Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Nine Months Ended
June 30, 2026June 30, 2025
(in thousands)
Interest payments$64,526 $60,809 
Income tax payments$81,479 $100,891 
21

Accounts Receivable, Net
Table 10.3: Details of Accounts Receivable, Net
June 30, 2026September 30, 2025
(in thousands)
Billed and billable receivables$1,055,494 $720,495 
Unbilled receivables335,329 187,372 
Allowance for credit losses(8,809)(9,772)
Accounts receivable, net$1,382,014 $898,095 
We have a Receivables Purchase Agreement (RPA) with Wells Fargo Bank N.A., under which we may sell certain U.S.-originated accounts receivable balances up to a maximum amount of $350.0 million at any given time. In return for these sales, we receive a cash payment equal to the face value of the receivables less a financing charge.
We account for these transfers as sales. We have no retained interest in the transferred receivables other than administrative responsibilities, and Wells Fargo has no recourse for any credit risk. We estimate that the implicit servicing fees for an arrangement of this size and type would be immaterial.
For the nine months ended June 30, 2026 and 2025, the value of accounts receivables transferred to Wells Fargo and derecognized from our balance sheet was $1.28 billion and $574.2 million, respectively. In exchange for these sales, we received cash of $1.27 billion and $570.7 million for the same periods, respectively. The difference, representing a loss on sale from these transfers, is included within our selling, general, and administrative expenses. We have recorded these transactions within our operating cash flows.

11. COMMITMENTS AND CONTINGENCIES
Litigation
We are subject to audits, investigations, and reviews relating to compliance with the laws and regulations that govern our role as a contractor to agencies and departments of federal, state, local, and foreign governments. Adverse findings could lead to criminal, civil, or administrative proceedings, and we could be faced with penalties, fines, suspension, or debarment. Adverse findings could also have a material adverse effect on us because of our reliance on government contracts. We are subject to periodic audits by federal, state, local, and foreign governments for taxes. We are also involved in various claims, arbitrations, and lawsuits arising in the normal conduct of our business, which include, but are not limited to, bid protests, employment matters, contractual disputes, and charges before administrative agencies. Except for the matters described below for which we cannot predict the outcome, we do not believe the outcome of any existing matter would likely have a material adverse effect on our consolidated financial position, results of operations, or cash flows.
We evaluate developments in our litigation matters and establish or make adjustments to our accruals as appropriate. A liability is accrued if a loss is probable and the amount of such loss can be reasonably estimated. If the risk of loss is probable, but the amount cannot be reasonably estimated, or the risk of loss is only reasonably possible, a potential liability will be disclosed but not accrued, if material. Due to the inherent uncertainty in the outcome of litigation, our estimates and assessments may prove to be incomplete or inaccurate and could be impacted by unanticipated events and circumstances, adverse outcomes, or other future determinations.
MOVEit Cybersecurity Incident Litigation
As previously disclosed, on May 31, 2023, Progress Software Corporation, the developer of MOVEit, a file transfer application used by many organizations to transfer data, announced a critical zero-day vulnerability in the application that allowed unauthorized third parties to access its customers’ MOVEit environments. Maximus uses MOVEit for internal and external file sharing purposes, including to share data with government customers related to Maximus' services in support of certain government programs. Based on our review of the impacted files to date, we have provided notices to individuals whose personal information, including Social Security numbers, protected health information, and/or other personal information, may have been included in the impacted files.
On August 1, 2023, a purported class action was filed against Maximus Federal Services, Inc. (a wholly-owned subsidiary of Maximus, Inc.) in the U.S. District Court for the Eastern District of Virginia arising out of the MOVEit cybersecurity incident – Bishop v. Maximus Federal Services, Case No. 1:23-cv-01019 (U.S. Dist. Ct. E. D. VA). The plaintiff, who
22

purports to represent a nationwide class of individuals, alleges, among other things, that our negligence resulted in the compromise of the plaintiff’s personally identifiable information and protected health information. The plaintiff seeks damages to be proved at trial. Since then, thirteen similar cases have been filed in federal courts across the country (inclusive of one case filed in state court and removed to federal court by us).
On October 4, 2023, the United States Judicial Panel on Multidistrict Litigation granted a Motion to Transfer creating a Multidistrict Litigation (MDL) in the District of Massachusetts for all cases related to the MOVEit cybersecurity incident. Each of the actions pending in federal courts are centralized in the MDL.
On December 12, 2024, the Court granted in part Defendants' omnibus motion to dismiss Plaintiffs’ claims pursuant to Rule 12(b)(1), challenging Plaintiffs’ standing to bring this suit, dismissing claims brought by four of the Plaintiffs in the MOVEit MDL. None of the dismissed claims were asserted against us.
The Court has also named us as a bellwether defendant in the MDL. We and the other bellwether defendants submitted motions to dismiss the pending actions pursuant to Rule 12(b)(6), which the Court granted in part and denied in part on July 31, 2025. Approximately half of the claims asserted against us remain, and we are proceeding to discovery regarding those claims.
Separately, there is currently an individual action pending against us in Florida state court. On September 6, 2023, an individual action related to the MOVEit incident was filed in state court in the Florida Circuit Court for the 7th Judicial Circuit, Volusia County: Taylor v. Maximus Federal Services, Case No. 2023-12349 (Fla. Cir. Ct., 7th Jud. Cir., Volusia Cnty.). The plaintiff alleges, among other things, that our negligence resulted in the compromise of the plaintiff’s personally identifiable information and protected health information. The plaintiff seeks damages to be proved at trial. On April 3, 2024, the Court stayed this action pending further developments in the MOVEit MDL. This case remains stayed.
While we are unable to predict the ultimate outcome of any of the remaining proceedings, we have accrued an amount within a range of possible outcomes expected to be incurred to resolve the matters.
12. SUBSEQUENT EVENT
On July 6, 2026, our Board of Directors declared a quarterly cash dividend of $0.33 for each share of our common stock outstanding. The dividend is payable on August 31, 2026, to shareholders of record on August 14, 2026. Based upon the number of shares outstanding, we anticipate a cash payment of approximately $17.3 million.
23

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with "Risk Factors," "Special Note Regarding Forward-Looking Statements," and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2025 filed with the SEC on November 20, 2025 and elsewhere in this Quarterly Report on Form 10-Q, as applicable.
Business Overview
Maximus is a leading provider of tech-enabled services to government agencies. By moving people, technology, and government forward, Maximus helps improve the delivery of public services for more than 100 million American citizens, as well as citizens in the United Kingdom (U.K.), Canada, and the Middle East, amid complex technological, health, economic, and social challenges. As a trusted and accountable partner to primarily U.S. federal and state customers, we proudly design, develop, and deliver innovative and efficient programs that are designed to improve government’s effectiveness in serving its citizens.
We create value for our customers by translating public policy into operating models that deliver outcomes for governments at scale. Our work covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. These services benefit from an industry with increasing demand, constrained government budgets, and an increased focus on technology as governments prioritize modernization. We also demonstrate the ability to move quickly, ranging from digitally enabled contact center support services for natural disaster response to swift establishments of public health and safety initiatives.

24

Financial Overview
A number of factors have affected our results for the third quarter of fiscal year 2026. More detail on these changes is presented below within our "Results of Operations" section.

Results of Operations
The following table sets forth items from our consolidated statements of operations for the three and nine months ended June 30, 2026, and June 30, 2025.
Table MD&A 1: Consolidated Results of Operations
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands, except per share data)
Revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Cost of revenue930,168 988,887 2,920,247 3,112,970 
Gross profit348,803 359,513 1,009,737 999,891 
Gross profit percentage27.3 %26.7 %25.7 %24.3 %
Selling, general, and administrative expenses167,188 170,831 492,827 525,423 
Selling, general, and administrative expenses as a percentage of revenue13.1 %12.7 %12.5 %12.8 %
Amortization of intangible assets20,187 23,010 60,785 69,041 
Operating income161,428 165,672 456,125 405,427 
Operating margin12.6 %12.3 %11.6 %9.9 %
Interest expense23,878 22,657 66,805 61,648 
Other (income)/expense, net(608)48 (1,639)(603)
Income before income taxes138,158 142,967 390,959 344,382 
Provision for income taxes34,565 36,986 95,360 100,636 
Effective tax rate25.0 %25.9 %24.4 %29.2 %
Net income$103,593 $105,981 $295,599 $243,746 
Earnings per share:
Basic$1.96 $1.87 $5.48 $4.22 
Diluted$1.95 $1.86 $5.45 $4.20 
Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and its associated overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.
Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended June 30, 2026
RevenueCost of RevenueGross Profit
Dollars% ChangeDollars% ChangeDollars% Change
(dollars in thousands)
Three Months Ended June 30, 2025$1,348,400 $988,887 $359,513 
Organic effect(63,043)(4.7) %(53,615)(5.4) %(9,428)(2.6) %
Disposal of businesses(6,963)(0.5)%(5,605)(0.6)%(1,358)(0.4)%
Currency effect compared to the prior period577 —  %501 0.1  %76 —  %
Three Months Ended June 30, 2026$1,278,971 (5.1) %$930,168 (5.9) %$348,803 (3.0) %



25

Table MD&A 3: Changes in Revenue, Cost of Revenue, and Gross Profit for the Nine Months Ended June 30, 2026
RevenueCost of RevenueGross Profit
Dollars% ChangeDollars% ChangeDollars% Change
(dollars in thousands)
Nine Months Ended June 30, 2025$4,112,861 $3,112,970 $999,891 
Organic effect(160,848)(3.9)%(175,451)(5.6)%14,603 1.5 %
Disposal of businesses(34,588)(0.8)%(28,647)(0.9)%(5,941)(0.6)%
Currency effect compared to the prior period12,559 0.3 %11,375 0.4 %1,184 0.1 %
Nine Months Ended June 30, 2026$3,929,984 (4.4)%$2,920,247 (6.2)%$1,009,737 1.0 %
Selling, general, and administrative expenses
Selling, general, and administrative (SG&A) expenses consist of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. We allocate corporate costs to segments on a consistent and rational basis. Fluctuations in our SG&A are primarily driven by changes in our administrative cost base, which are not directly driven by changes in our revenue. As part of our work for the U.S. federal government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards.
Our SG&A expense for the nine months ended June 30, 2026, includes $10.1 million of divestiture-related gain from the sale of our child support business within the United States, which we divested in December 2025. Our SG&A expense for the nine months ended June 30, 2025, includes divestiture-related charges of $39.3 million from our sale of businesses in the Outside the U.S. Segment. These charges included accumulated foreign currency losses incurred over two decades of operations, as well as indemnifications provided to the buyer.
Amortization of intangible assets
Amortization of intangible assets has declined for the three and nine months ended June 30, 2026, as compared to the same periods in fiscal year 2025, since the amortization of technology-based assets acquired in fiscal year 2021 was completed prior to fiscal year 2026.
Our balance sheet includes $367.2 million of intangible assets from a 2021 acquisition. These assets, comprised of customer relationships and a medical provider network, continue to support medical disability examinations (MDE) contracts with the U.S. Department of Veterans Affairs. These assets are being amortized over their remaining useful life of approximately seven years. In the event that our expectations change with respect to these acquired contracts, the value of these assets and the estimated remaining lives of these assets may need to be adjusted.
Interest Expense
During fiscal years 2026 and 2025, we expanded our Term Loan B and Term Loan A Credit Facilities, respectively. This has resulted in an increase to our interest expense in the current year. We continue to mitigate a portion of our interest rate risk through hedging transactions on a portion of our outstanding debt.
Provision for Income Taxes
Our effective income tax rate for the three and nine months ended June 30, 2026, was 25.0% and 24.4%, respectively, compared to 25.9% and 29.2% for the three and nine months ended June 30, 2025, respectively. Our effective tax rate for the nine months ended June 30, 2026 includes approximately $4.5 million of benefit from research and development tax credits identified and claimed in the period. Our tax rate in fiscal year 2025 was affected by the disposal of our businesses in Australia and Korea and other non-recurring items. For fiscal year 2026, we expect an overall effective tax rate between 24% and 24.5%.
26

U.S. Federal Services Segment
Our U.S. Federal Services Segment delivers solutions that help various U.S. federal government agencies better execute their missions, including program operations and management, clinical services, and advanced technology solutions.
Table MD&A 4: U.S. Federal Services Segment - Financial Results
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands)
Revenue$720,991 $761,174 $2,260,735 $2,319,756 
Cost of revenue498,720 535,040 1,598,084 1,718,249 
Gross profit222,271 226,134 662,651 601,507 
Selling, general, and administrative expenses88,231 88,272 266,174 245,563 
Operating income134,040 137,862 396,477 355,944 
Gross profit percentage30.8 %29.7 %29.3 %25.9 %
Operating margin percentage18.6 %18.1 %17.5 %15.3 %
Our revenue and cost of revenue for the three months ended June 30, 2026 and 2025 decreased 5.3% and 6.8%, respectively. Our revenue and cost of revenue for the nine months ended June 30, 2026 and 2025 decreased 2.5%and 7.0%, respectively.
Our results for the three and nine months ended June 30, 2026 have been affected by the following, when compared to the prior year comparative periods.

•Much of the revenue decline relates to year-over-year declines in volumes on our large, transaction-based contracts. During fiscal year 2025 and early fiscal year 2026, these volumes had been running at higher levels.
•Short-term disaster recovery work in fiscal year 2025 did not recur to the same extent in fiscal year 2026.
•Across the remainder of this segment, we received the benefit of growth on profitable contracts, resulting in improvements to margin.

Below is a reconciliation of revenue for the three and nine months ended June 30, 2026 compared to the prior year periods, including the impact of short‑term disaster recovery work and our organic revenue movement excluding this work.

Table MD&A 5: Change in Revenue, Excluding Natural Disaster Recovery Work
Three Months Ended
June 30, 2026
Nine Months Ended
June 30, 2026
Dollars% ChangeDollars% Change
(dollars in thousands)
Revenue for 2025 fiscal period$761,174 $2,319,756 
Decline in short-term disaster recovery work(18,362)(2.4)%(83,289)(3.6)%
Organic revenue movement excluding short-term disaster recovery work(21,821)(2.9)%24,268 1.0 %
Revenue for 2026 fiscal period$720,991 (5.3)%$2,260,735 (2.5)%

In late May 2026, we received notification from a major customer regarding a temporary contractual modification effective July 1, 2026 through December 31, 2026. We anticipate that this modification will reduce our diluted earnings per share by approximately $0.35 per quarter through the remainder of fiscal year 2026 and the first quarter of fiscal year 2027. Accordingly, we anticipate operating margin for the U.S. Federal Services Segment in fiscal year 2026 to range between 16.5% and 17%.
27

U.S. Services Segment
Our U.S. Services Segment provides a variety of services, such as program operations, clinical services, employment services, and advanced technology solutions and related professional services for U.S. state and local government programs. These services support a variety of programs, including those under Medicaid and the Children's Health Insurance Program (CHIP), the Affordable Care Act (ACA) marketplaces, and Temporary Assistance for Needy Families (TANF).
Table MD&A 6: U.S. Services Segment - Financial Results
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands)
Revenue$418,227 $439,818 $1,249,229 $1,334,418 
Cost of revenue311,449 333,886 957,548 1,021,712 
Gross profit106,778 105,932 291,681 312,706 
Selling, general, and administrative expenses61,589 60,975 178,616 173,096 
Operating income45,189 44,957 113,065 139,610 
Gross profit percentage25.5 %24.1 %23.3 %23.4 %
Operating margin percentage10.8 %10.2 %9.1 %10.5 %
Our revenue and cost of revenue for the three months ended June 30, 2026 and 2025 decreased 4.9% and 6.7%, respectively. For the nine months ended June 30, 2026 and 2025, our revenue and cost of revenue decreased 6.4% and 6.3%, respectively.
Table MD&A 7: U.S. Services Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended June 30, 2026
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Three Months Ended June 30, 2025$439,818 $333,886 $105,932 
Organic effect(14,628)(3.3)%(16,832)(5.0)%2,204 2.1 %
Disposal of businesses(6,963)(1.6)%(5,605)(1.7)%(1,358)(1.3)%
Three Months Ended June 30, 2026$418,227 (4.9)%$311,449 (6.7)%$106,778 0.8 %
Table MD&A 8: U.S. Services Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Nine Months Ended June 30, 2026
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Nine Months Ended June 30, 2025$1,334,418 $1,021,712 $312,706 
Organic effect(69,977)(5.2)%(51,937)(5.1)%(18,040)(5.8)%
Disposal of businesses(15,212)(1.1)%(12,227)(1.2)%(2,985)(1.0)%
Nine Months Ended June 30, 2026$1,249,229 (6.4)%$957,548 (6.3)%$291,681 (6.7)%
Our U.S. Services Segment continues to experience lower volumes and demand across a broad range of contracts compared to prior years. We believe the contracts and relationships held by this segment provide it with strong opportunities to assist state customers who will require higher engagement across their federally-funded social programs. As these activities pick up, we anticipate that we will return to organic growth in the fourth quarter of the current fiscal year.
As noted above, we sold our US-based child support business during the first quarter of the current fiscal year.
During the second quarter of fiscal year 2026, we recorded an impairment charge of $6.9 million related to a capitalized software asset following a client decision, which resulted in its carrying value no longer being recoverable.
We anticipate operating margins for the U.S. Services Segment in fiscal year 2026 to range between 9.5% and 10%.
28

Outside the U.S. Segment
Our Outside the U.S. Segment provides business process services and other solutions for international governments. These services include health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally-enabled customer services, and advanced technologies for modernization. We support programs and deliver services in the U.K., including the Functional Assessment Services (FAS) contract and the Restart employment program. We also provide services in Canada and the Middle East.
Table MD&A 9: Outside the U.S. Segment - Financial Results
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands)
Revenue$139,753 $147,408 $420,020 $458,687 
Cost of revenue119,999 119,961 364,615 373,009 
Gross profit19,754 27,447 55,405 85,678 
Selling, general, and administrative expenses18,548 21,507 58,664 66,822 
Operating (loss)/income1,206 5,940 (3,259)18,856 
Gross profit percentage14.1 %18.6 %13.2 %18.7 %
Operating margin percentage0.9 %4.0 %(0.8) %4.1 %
Table MD&A 10: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended June 30, 2026
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Three Months Ended June 30, 2025$147,408 $119,961 $27,447 
Organic effect(8,232)(5.6) %(463)(0.4) %(7,769)(28.3) %
Currency effect compared to the prior period577 0.4 %501 0.4 %76 0.3 %
Three Months Ended June 30, 2026$139,753 (5.2) %$119,999 —  %$19,754 (28.0) %
Table MD&A 11: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Nine Months Ended June 30, 2026
RevenueCost of RevenueGross Profit
Amount% ChangeAmount% ChangeAmount% Change
(dollars in thousands)
Nine Months Ended June 30, 2025$458,687 $373,009 $85,678 
Organic effect(31,850)(6.9)%(3,349)(0.9)%(28,501)(33.3)%
Disposal of businesses(19,376)(4.2)%(16,420)(4.4)%(2,956)(3.5)%
Currency effect compared to the prior period$12,559 2.7 %$11,375 3.0 %1,184 1.4 %
Nine Months Ended June 30, 2026$420,020 (8.4)%$364,615 (2.3)%$55,405 (35.3)%
The organic decline in this segment relates to lower volumes on a number of our contracts.
The divestiture of our businesses in Australia and Korea occurred in December 2024.
The effects of the organic decline and the divestiture were partially offset by the strengthening of the British Pound against the U.S. Dollar.
Following the divestitures in both fiscal years 2024 and 2025, we have taken the opportunity to expand our business development initiatives. We are tracking a number of opportunities, with the aim of driving growth and margin improvement in this segment. For fiscal year 2026, we anticipate a breakeven operating margin.
29

Liquidity and Capital Resources
Our primary sources of liquidity are cash on hand, cash from operations, our $750 million revolving credit facility, and our $350 million Receivables Purchase Agreement (RPA). As of June 30, 2026, we had $57.0 million in cash and cash equivalents. We believe that our current cash position, access to our debt facilities, and cash flow generated from operations should be sufficient for our operating requirements and should enable us to fund required long-term debt repayments, dividends, and any share repurchases we might choose to make. See "Note 7. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.
We have included the following table showing our debt balances as of June 30, 2026, and their effective interest rates.
Table MD&A 12: Debt Balances and Interest Rates as of June 30, 2026
June 30, 2026
Carrying valueEffective cash interest rateInterest rate basis
(dollars in thousands)
Term Loan A - Hedged through September 2027$150,000 4.51 %Fixed rate of 3.14% plus margin. (1)
Term Loan A - Hedged through September 2028200,000 4.84 %Fixed rate of 3.47% plus margin. (1)
Term Loan A - Hedged through May 202950,000 5.42 %Fixed rate of 4.05% plus margin. (1)
Term Loan A - Unhedged419,375 5.02 %Term SOFR reset monthly plus margin. (1)
Term Loan B - Hedged through September 202675,000 5.72 %Fixed rate of 3.72% plus 2% margin.
Term Loan B - Hedged through September 202775,000 5.62 %Fixed rate of 3.62% plus 2% margin.
Term Loan B - Hedged through September 202875,000 6.04 %Fixed rate of 4.04% plus 2% margin.
Term Loan B - Hedged through September 202950,000 6.06 %Fixed rate of 4.06% plus 2% margin.
Term Loan B - Unhedged539,173 5.64 %Term SOFR reset monthly plus margin. (1)
Revolver20,000 5.01 %Term SOFR reset monthly plus margin. (1)
Debt Principal$1,653,548 
(1) The applicable margin for Term Loan A ranges from 1% to 2%, depending on our leverage ratio as determined based on our most recently filed financial statements. As of June 30, 2026, the applicable margin was 1.375%.
Our effective interest rate reflects the drivers of our cash interest payments as of June 30, 2026, which can change based upon the reset of the rates. Including the amortization of the upfront payments, our effective interest rate as of June 30, 2026, was 5.6%.
The table below summarizes our change in cash, cash equivalents, and restricted cash.
Table MD&A 13: Net Change in Cash and Cash Equivalents and Restricted Cash
For the Nine Months Ended
June 30, 2026June 30, 2025
(in thousands)
Operating activities:
Net cash used in operating activities$(179,863)$(220,000)
Net cash used in investing activities(14,410)(57,115)
Net cash provided by financing activities87,507 146,793 
Effect of foreign exchange rates on cash and cash equivalents and restricted cash(444)(65)
Net change in cash and cash equivalents and restricted cash$(107,210)$(130,387)
Net Cash Used in Operating Activities
We reported net cash used in operations of $179.9 million for the first nine months of fiscal year 2026, compared to $220.0 million for the first nine months of fiscal year 2025. We continue to experience administrative delays on payments from one of our large contracts with the U.S. federal government. Subsequent to June 30, 2026, we have received $245 million of cash due from this customer, and we anticipate additional cash collections through the fourth quarter of fiscal year 2026.
30

These short-term delays in collections are reflected in Days Sales Outstanding ("DSO") at June 30, 2026, which were 98 days, compared with 62 days at September 30, 2025. Excluding the effects of the RPA, DSO would have been 123 days and 73 days, respectively.
Net Cash Used in Investing Activities
We reported net cash used in investing activities of $14.4 million for the first nine months of fiscal year 2026, compared to net cash used in investing activities of $57.1 million for the first nine months of fiscal year 2025.
In fiscal year 2025, we made significant investments in our capital base, most notably in updating technology on our Federal MDE contracts. Much of this update was completed in the third quarter of that year.
Our cash flows in fiscal year 2026 include the cash received from the sale of our child support business within the United States, as well as the final installments on our 2023 sale of our commercial practice in the United Kingdom.
Net Cash Provided by Financing Activities
We reported net cash provided by financing activities of $87.5 million for the first nine months of fiscal year 2026, compared to $146.8 million for the first nine months of fiscal year 2025.
During fiscal years 2026 and 2025, we expanded our term loans to provide additional capital for our operations, as well as funds to support share repurchases. We have utilized $204.9 million and $306.4 million in fiscal years 2026 and 2025, respectively, to purchase our common shares.

We have certain contracts where we hold cash on behalf of our customers. We show these funds as restricted cash and include their movement within financing cash flows. During the current fiscal year, the customer under a single large contract has increased their volume of work with us, resulting in significant growth in this balance. The restricted cash asset is offset by a current liability.
Credit Facilities
Our principal debt agreement is with JPMorgan Chase Bank N.A. (the "Credit Agreement"). At June 30, 2026, we owed $1.65 billion under the Credit Agreement, with access to approximately $730.0 million through a revolving credit facility. Mandatory repayments are required under this agreement through May 2031, when the agreement ends, and must be renegotiated or the funds repaid.
The Credit Agreement contains a number of covenants. Failure to meet these requirements would result in a need to renegotiate the agreement, seek a waiver, or a requirement to repay our outstanding debt in full. There are two financial covenants, both defined in the Credit Agreement:
•Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt (as defined by the Credit Agreement), offset by up to $150 million of unrestricted cash (Consolidated Net Total Leverage), against our Consolidated EBITDA (as defined by the Credit Agreement). To comply with our Credit Agreement, this ratio cannot exceed 4.00:1.00 at the end of each quarter, with a step up to 4.50:1.00 under certain circumstances. This ratio also determines both our interest rate and the charge we pay on the unused component of our revolving credit facility, with the charge increasing as the Consolidated Net Total Leverage Ratio increases.
•Our Consolidated Net Interest Coverage Ratio means, for any twelve-month period, the ratio of our Consolidated EBITDA against our Consolidated Net Interest Expense, as defined by the Credit Agreement. To comply with our Credit Agreement, this ratio cannot be less than 3.00:1.00 at the end of each quarter.
Consolidated EBITDA also drives certain permissions within the Credit Agreement, such as the level of investment we are entitled to make without seeking additional approval from our lenders.
Our Credit Agreement defines Consolidated EBITDA, as well as other components of the calculations above. The definition of Consolidated EBITDA requires us to include adjustments not typically included within EBITDA, including unusual, non-recurring expenses, certain non-cash adjustments, the pro forma effects of acquisitions and disposals, and estimated synergies from acquisitions. As a result, Consolidated EBITDA as defined by the Credit Agreement may not be comparable to EBITDA or related or similarly titled measures presented by other companies.
31

We have summarized below the components of our two financial ratio calculations, including the components of Consolidated EBITDA as defined by the Credit Agreement which are included within our financial statements. At June 30, 2026, we were in compliance with all applicable covenants of our Credit Agreement. We do not believe that these covenants represent a significant restriction on our ability to operate our business or to pay our dividends.
Table MD&A 14: Reconciliation of Net Income to Consolidated EBITDA as defined by our Credit Agreement
For the Three Months EndedFor the Trailing Twelve
Months Ended
June 30, 2026June 30, 2026
(in thousands)
Net income$103,593 $370,887 
Adjustments:
Interest expense23,878 89,237 
Other (income)/expense, net(608)(1,676)
Provision for income taxes34,565 120,539 
Amortization of intangibles20,187 83,791 
Stock compensation expense7,356 35,132 
Capitalized software impairment charges— 6,914 
Divestiture-related (gains)/charges, net(1,162)(9,941)
Depreciation and amortization of property, equipment, and capitalized software11,874 51,258 
Pro forma and other adjustments permitted by our Credit Agreement10,715 52,278 
Consolidated EBITDA (as defined by our Credit Agreement)$210,398 $798,419 
Table MD&A 15: Consolidated Net Total Leverage Ratio
For the Trailing Twelve
Months Ended
June 30, 2026
(in thousands, except ratio data)
Funded Debt (as defined by our Credit Agreement)$1,653,548 
Cash and cash equivalents up to $150 million56,953 
Consolidated Net Total Leverage (as defined by our Credit Agreement)$1,596,595 
Consolidated Net Total Leverage Ratio (as defined by our Credit Agreement)2.00 
Table MD&A 16: Consolidated Net Interest Coverage Ratio
For the Trailing Twelve
Months Ended
June 30, 2026
(in thousands, except ratio data)
Consolidated EBITDA (as defined by our Credit Agreement)$798,419 
Interest expense89,237 
Components of other income/expense, net allowed in ratio calculation2,351 
Consolidated Net Interest Expense (as defined by our Credit Agreement)$91,588 
Consolidated Net Interest Coverage Ratio (as defined by our Credit Agreement)8.72 
32

Cash in Foreign Locations
We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.
Free Cash Flow (Non-GAAP)
Table MD&A 17: Free Cash Flow (Non-GAAP)
For the Nine Months Ended
June 30, 2026June 30, 2025
(in thousands)
Net cash used in operating activities$(179,863)(220,000)
Purchases of property and equipment and capitalized software(28,752)(55,686)
Free cash flow (Non-GAAP)$(208,615)$(275,686)
Critical Accounting Policies and Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. Our Annual Report on Form 10-K, filed with the SEC on November 20, 2025, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the nine months ended June 30, 2026.

Non-GAAP and Other Measures
We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, net cash used in operating activities, operating income, net income, or earnings per share as measures of performance or liquidity. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.
For the three months ended June 30, 2026, 11% of our revenue was generated outside the U.S. We believe that users of our financial statements want to understand the performance of our foreign operations using a methodology that excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal year's results for all foreign businesses using the exchange rates in the prior fiscal year.
From time to time, we enter into acquisitions and divestitures. We believe users of our financial statements want to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that have been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal year results, excluding transactions from acquisitions or disposals, to our prior fiscal year results.
Our previous acquisitions have resulted in significant intangible assets, which are amortized over their estimated useful lives. We believe users of our financial statements want to understand the performance of the business by using a methodology that excludes the amortization of our intangible assets. For the nine months ended June 30, 2026 and 2025, we also incurred gains and losses on sales of businesses. We believe that providing supplemental measures that exclude the impact of the items detailed below is useful to investors in evaluating our core operations and results in relation to past periods. Accordingly, we have calculated our net income and diluted earnings per share, excluding the effects of the amortization of intangible assets and divestiture-related gains and charges. Although these measures exclude the amortization of intangible assets acquired as part of our acquisitions, they do include the post-acquisition revenue from
33

the acquired businesses. In addition, Adjusted EBITDA, as calculated by us, is also a useful measure of performance that focuses on the cash generating capacity of the business as it excludes the non-cash expenses of depreciation and amortization of property, equipment, and capitalized software, amortization of intangible assets, capitalized software impairment charges, and divestiture-related activity. We believe that these non-GAAP measures assist investors in making comparisons between the operating performance of companies with different capital structures by excluding interest expense and therefore, the impacts of financing costs. Although Adjusted EBITDA excludes the amortization of intangible assets acquired as part of our acquisitions, it does include the post-acquisition revenue from the acquired businesses. As disclosed above, Adjusted EBITDA is calculated in a different manner from Consolidated EBITDA, as defined by our Credit Agreement.
We have included a table showing our reconciliation of these income measures to their corresponding GAAP measures.
Table MD&A 18: Non-GAAP Adjusted Results - Adjusted EBITDA, Adjusted Net Income, and Adjusted Diluted Earnings per Share
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands, except per share data)
Net income$103,593 $105,981 $295,599 $243,746 
Provision for income taxes34,565 36,986 95,360 100,636 
Interest expense23,878 22,657 66,805 61,648 
Other (income)/expense, net(608)48 (1,639)(603)
Amortization of intangible assets20,187 23,010 60,785 69,041 
Divestiture-related charges/(gains)(1,162)— (10,147)39,343 
Depreciation and amortization of property, equipment, and capitalized software11,874 9,607 37,091 27,502 
Capitalized software impairment charges— — 6,914 — 
Adjusted EBITDA (Non-GAAP)$192,327 $198,289 $550,768 $541,313 
Net income margin (GAAP)*8.1 %7.9 %7.5 %5.9 %
Adjusted EBITDA margin (Non-GAAP)*15.0 %14.7 %14.0 %13.2 %
* Margins are calculated as a percentage of revenue
Net income$103,593 $105,981 $295,599 $243,746 
Add back: Amortization of intangible assets, net of tax14,878 16,958 44,799 50,883 
Add back: Divestiture-related charges/(gains), net of tax(856)— (7,478)39,343 
Adjusted net income excluding amortization of intangible assets and divestiture-related adjustments (Non-GAAP)$117,615 $122,939 $332,920 $333,972 
Diluted earnings per share$1.95 $1.86 $5.45 $4.20 
Add back: Effect of amortization of intangible assets on diluted earnings per share0.28 0.30 0.83 0.88 
Add back: Effect of divestiture-related charges/(gains) on diluted earnings per share(0.01)— (0.14)0.67 
Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture-related adjustments (Non-GAAP)$2.22 $2.16 $6.14 $5.75 
34

In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements want to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology that combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of our operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, repurchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operations to free cash flow in "Liquidity and Capital Resources."
To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements want to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the quarter. Revenue per day for a quarter is determined by dividing total revenue by 91 days.
35

Item 3. Quantitative and Qualitative Disclosures About Market Risk
In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on our Annual Report on Form 10-K, filed with the SEC on November 20, 2025, have not changed materially during the nine month period ended June 30, 2026.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the "Exchange Act")) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that our disclosure controls and procedures are effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified by the SEC's rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

36

PART II - Other Information
Item 1. Legal Proceedings
Refer to our disclosures included in "Note 11. Commitments and Contingencies" included in Part 1, Item 1 of this Quarterly Report on Form 10-Q.
Item 1A. Risk Factors
There were no material changes during the nine months ended June 30, 2026 to the risk factors previously disclosed in our Annual Report on Form 10-K, filed with the SEC on November 20, 2025.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
(a)None.
(b)None.
(c)The following table sets forth the information required regarding repurchases of common stock that we made during the three months ended June 30, 2026.
Common Stock Repurchase Activity During the Three Months Ended June 30, 2026
PeriodTotal Number of Shares PurchasedAverage Price Paid Per Share
Total Number of Shares Purchased as Part of the Publicly Announced Plans or Programs (1)
Maximum Dollar Value that May Yet Be Purchased Under the Plans or Programs (in thousands)
April 1, 2026 - April 30, 2026570,100 $66.51 570,100 $102,282 
May 1, 2026 - May 31, 2026182,600 65.58 182,600 $400,000 
June 1, 2026 - June 30, 2026— — — $400,000 
Total752,700 $66.29 752,700 
(1)In May 2026, the Board of Directors authorized an increase to our existing stock repurchase program whereby we may purchase, at management's discretion, up to $400 million of our common stock. This resolution superseded a similar resolution passed in September 2025.
Item 3. Defaults Upon Senior Securities
(a)None.
(b)None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
(a)None.
(b)None.
(c)During the three months ended June 30, 2026, no director or officer of the Company adopted, modified, or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.
37

Item 6. Exhibits
Exhibit
No.
Description of Exhibit
v
v
Φ
Φ
101.INSvInline XBRL Instance Document.
101.SCHvInline XBRL Taxonomy Extension Schema Document.
101.CALvInline XBRL Taxonomy Calculation Linkbase Document.
101.DEFvInline XBRL Taxonomy Definition Linkbase Document.
101.LABvInline XBRL Taxonomy Label Linkbase Document.
101.PREvInline XBRL Taxonomy Presentation Linkbase Document.
104vCover Page Interactive Data File (formatted as Inline XBRL tags and contained in Exhibit 101).
vFiled herewith.
ΦFurnished herewith.
38

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
Maximus, Inc.
/s/ Bruce L. CaswellAugust 6, 2026
By:Bruce L. Caswell
President and Chief Executive Officer
(Principal Executive Officer)
/s/ David W. MutrynAugust 6, 2026
By:David W. Mutryn
Chief Financial Officer
(Principal Financial Officer)
39
EX-31.1 2 a311-mmsx2026x06x30xxex31x1.htm EX-31.1 Document

EXHIBIT 31.1
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Bruce L. Caswell, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Maximus, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ Bruce L. CaswellAugust 6, 2026
By:Bruce L. Caswell
President and Chief Executive Officer
(Principal Executive Officer)

EX-31.2 3 a312-mmsx2026x06x30xxex31x2.htm EX-31.2 Document

EXHIBIT 31.2
Certification Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, David W. Mutryn, certify that:
1.I have reviewed this Quarterly Report on Form 10-Q of Maximus, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a.Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b.Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c.Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d.Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
a.All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b.Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

/s/ David W. MutrynAugust 6, 2026
By:David W. Mutryn
Chief Financial Officer
(Principal Financial Officer)




EX-32.1 4 a321-mmsx2026x06x30xxex32x1.htm EX-32.1 Document

EXHIBIT 32.1
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Maximus, Inc. (the "Company") on Form 10-Q for the fiscal quarter ended June 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Bruce Caswell, President and Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Bruce L. CaswellAugust 6, 2026
By:Bruce L. Caswell
President and Chief Executive Officer
(Principal Executive Officer)



EX-32.2 5 a322-mmsx2026x06x30xxex32x2.htm EX-32.2 Document

EXHIBIT 32.2
Certification Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
In connection with the Quarterly Report of Maximus, Inc. (the "Company") on Form 10-Q for the fiscal quarter ended June 30, 2026 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, David Mutryn, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1.The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ David W. MutrynAugust 6, 2026
By:David W. Mutryn
Chief Financial Officer
(Principal Financial Officer)



EX-101.SCH 6 mms-20260630.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover Page link:presentationLink link:calculationLink link:definitionLink 9952151 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 9952152 - Statement - Consolidated Statements of Comprehensive Income link:presentationLink link:calculationLink link:definitionLink 9952153 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952154 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 9952155 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 9952156 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 9952157 - Statement - Consolidated Statements of Changes in Shareholders' Equity link:presentationLink link:calculationLink link:definitionLink 9952158 - Disclosure - Organization link:presentationLink link:calculationLink link:definitionLink 9952159 - Disclosure - Significant Accounting Policies link:presentationLink link:calculationLink link:definitionLink 9952160 - Disclosure - Business Segments link:presentationLink link:calculationLink link:definitionLink 9952161 - Disclosure - Revenue Recognition link:presentationLink link:calculationLink link:definitionLink 9952162 - Disclosure - Earnings Per Share link:presentationLink link:calculationLink link:definitionLink 9952163 - Disclosure - Divestitures link:presentationLink link:calculationLink link:definitionLink 9952164 - Disclosure - Debt And Derivatives link:presentationLink link:calculationLink link:definitionLink 9952165 - Disclosure - Fair Value Measurements link:presentationLink link:calculationLink link:definitionLink 9952166 - Disclosure - Equity link:presentationLink link:calculationLink link:definitionLink 9952167 - Disclosure - Other Items link:presentationLink link:calculationLink link:definitionLink 9952168 - Disclosure - Commitments And Contingencies link:presentationLink link:calculationLink link:definitionLink 9952169 - Disclosure - Subsequent Event link:presentationLink link:calculationLink link:definitionLink 9955511 - Disclosure - Significant Accounting Policies (Policies) link:presentationLink link:calculationLink link:definitionLink 9955512 - Disclosure - Business Segments (Tables) link:presentationLink link:calculationLink link:definitionLink 9955513 - Disclosure - Revenue Recognition (Tables) link:presentationLink link:calculationLink link:definitionLink 9955514 - Disclosure - Earnings Per Share (Tables) link:presentationLink link:calculationLink link:definitionLink 9955515 - Disclosure - Debt And Derivatives (Tables) link:presentationLink link:calculationLink link:definitionLink 9955516 - Disclosure - Fair Value Measurements (Tables) link:presentationLink link:calculationLink link:definitionLink 9955517 - Disclosure - Other Items (Tables) link:presentationLink link:calculationLink link:definitionLink 9955518 - Disclosure - Organization - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955519 - Disclosure - Significant Accounting Policies (Details) link:presentationLink link:calculationLink link:definitionLink 9955520 - Disclosure - Business Segments - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955521 - Disclosure - Business Segments - Schedule of Results of Operations by Business Segment (Details) link:presentationLink link:calculationLink link:definitionLink 9955522 - Disclosure - Revenue Recognition - Schedule of Disaggregation of Revenue (Details) link:presentationLink link:calculationLink link:definitionLink 9955523 - Disclosure - Revenue Recognition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955523 - Disclosure - Revenue Recognition - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955524 - Disclosure - Revenue Recognition - Schedule of Effect of Changes in Contract Estimates (Details) link:presentationLink link:calculationLink link:definitionLink 9955525 - Disclosure - Earnings Per Share - Schedule of Weighted Average Number of Shares (Details) link:presentationLink link:calculationLink link:definitionLink 9955526 - Disclosure - Earnings Per Share - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955527 - Disclosure - Divestitures (Details) link:presentationLink link:calculationLink link:definitionLink 9955528 - Disclosure - Debt And Derivatives - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9955528 - Disclosure - Debt And Derivatives - Schedule of Debt (Details) link:presentationLink link:calculationLink link:definitionLink 9955529 - Disclosure - Debt And Derivatives - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955529 - Disclosure - Debt And Derivatives - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955530 - Disclosure - Debt And Derivatives - Schedule of Future Minimum Principal Payments Due (Details) link:presentationLink link:calculationLink link:definitionLink 9955531 - Disclosure - Debt And Derivatives - Schedule of Interest Rate Derivative Instruments (Details) link:presentationLink link:calculationLink link:definitionLink 9955532 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities (Details) link:presentationLink link:calculationLink link:definitionLink 9955533 - Disclosure - Fair Value Measurements - Schedule of Accumulated Other Comprehensive Loss (Details) link:presentationLink link:calculationLink link:definitionLink 9955534 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement using Significant Unobservable Inputs (Level 3) (Details) link:presentationLink link:calculationLink link:definitionLink 9955535 - Disclosure - Equity (Details) link:presentationLink link:calculationLink link:definitionLink 9955536 - Disclosure - Other Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) link:presentationLink link:calculationLink link:definitionLink 9955537 - Disclosure - Other Items - Schedule of Supplemental Cash Flow Information (Details) link:presentationLink link:calculationLink link:definitionLink 9955538 - Disclosure - Other Items - Schedule of Accounts Receivable, Net (Details) link:presentationLink link:calculationLink link:definitionLink 9955539 - Disclosure - Other Items - Narrative (Details) link:presentationLink link:calculationLink link:definitionLink 9955540 - Disclosure - Subsequent Event (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 7 mms-20260630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 8 mms-20260630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 9 mms-20260630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Weighted average shares outstanding: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Trading Arrangement: Trading Arrangement [Axis] Cost of revenue (as a percent) Segment Cost of Revenue as Percent of Segment Revenue Segment Cost of Revenue as Percent of Segment Revenue Maximum Maximum [Member] Range [Domain] Statistical Measurement [Domain] Title of 12(b) Security Title of 12(b) Security Subsequent Event Subsequent Event [Member] Document Fiscal Year Focus Document Fiscal Year Focus Revenue, remaining performance obligation, expected timing of satisfaction, period Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period U.S. Federal Services U.S. Federal Services [Member] U.S. Federal Services [Member] Adjustment to Compensation, Amount Adjustment to Compensation Amount Financial Instrument [Axis] Financial Instrument [Axis] Customer [Axis] Customer [Axis] Segment Reporting [Abstract] Segment Reporting [Abstract] Capitalized software, net Capitalized Cost, Software to be Sold, Leased, or Marketed, after Accumulated Amortization Tax withholding related to RSU vesting Payment, Tax Withholding, Share-Based Payment Arrangement Accrued compensation and benefits Employee-related Liabilities, Current Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis] Revolver Line of Credit [Member] Restatement Determination Date Restatement Determination Date Total debt principal Debt, Long-Term and Short-Term, Combined, Gross Debt, Long-Term and Short-Term, Combined, Gross Derivative Instrument [Axis] Derivative Instrument [Axis] Performance-based Performance Based Contracts [Member] Reflects the percentage that revenues during the period from performance-based contracts are to total revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence. Term Loan A Term Loan A, Due September 2027 [Member] Term Loan A, Due September 2027 U.S. federal government agencies United States Federal Government Agencies [Member] United States Federal Government Agencies [Member] Proceeds from divestitures Proceeds from Divestiture of Businesses Contract with Customer, Basis of Pricing [Domain] Contract with Customer, Basis of Pricing [Domain] Amendment Flag Amendment Flag Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Receivables Billing Status [Domain] Receivables Billing Status [Domain] Total U.S. state government agencies Total United States State Government Agencies [Member] Total United States State Government Agencies [Member] Disposal Group Classification [Axis] Disposal Group Classification [Axis] Other comprehensive (loss)/income, net of tax: Other Comprehensive Income (Loss), Net of Tax [Abstract] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Schedule of Cash and Cash Equivalents Schedule of Cash and Cash Equivalents [Table Text Block] Entity Address, State or Province Entity Address, State or Province Foreign currency translation adjustments Foreign currency translation Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent PEO Total Compensation Amount PEO Total Compensation Amount Notional Amount Derivative, Notional Amount Basic (in shares) Basic weighted average shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Technology Equipment Technology Equipment [Member] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Total current liabilities Liabilities, Current Contract Concentration Risk Contract Concentration Risk [Member] Contract Concentration Risk Depreciation and amortization of property, equipment, and capitalized software Depreciation Of Fixed Assets And Amortization Of Capitalized Software The current period expense charged against earnings for depreciation on property, plant and equipment and amortization of capitalized software. Entity Address, City or Town Entity Address, City or Town Schedule of Supplementary Cash Flow Information Schedule of Cash Flow, Supplemental Disclosures [Table Text Block] Stock-based compensation Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Statement of Financial Position [Abstract] Relationship to Entity [Domain] Title and Position [Domain] Unbilled receivables Unbilled Revenues [Member] Number of reportable segments not disclosed Number Of Reportable Segments Not Disclosed Flag Number Of Reportable Segments Not Disclosed Flag Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Intangible assets, net Intangible Asset, Finite-Lived, after Accumulated Amortization Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Transfer of financial assets, accounted for as sales Transfer of Financial Assets Accounted for as Sales, Amount Derecognized Cash dividends paid to Maximus shareholders Payments of Ordinary Dividends Level 2 Fair Value, Inputs, Level 2 [Member] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Long-term debt, current portion Less: Current portion of long-term debt Long-Term Debt, Current Maturities Revenue Benchmark Revenue Benchmark [Member] Other U.S. state government agencies Other United State Government Agencies [Member] Other United State Government Agencies Subsequent Event Type [Axis] Subsequent Event Type [Axis] Effect of Change in Accounting Estimate, Type [Domain] Effect of Change in Accounting Estimate, Type [Domain] Concentration Risk Type [Axis] Concentration Risk Type [Axis] Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Deferred revenue Increase (Decrease) in Contract with Customer, Liability Schedule of Results of Operations by Business Segment Segment Reporting [Table Text Block] Use of Estimates Use of Estimates, Policy [Policy Text Block] Other comprehensive (loss)/income Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Child Support Business in the United States Child Support Business In The United States [Member] Child Support Business In The United States Document Period End Date Document Period End Date Change in assets and liabilities, net of effects of business combinations and divestitures: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Net cash used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Contingent consideration Disposal Group, Not Discontinued Operation, Contingent Consideration Disposal Group, Not Discontinued Operation, Contingent Consideration Program Operations Program Operations [Member] Program Operations Security Exchange Name Security Exchange Name Annual effective interest rate (as a percent) Debt Instrument, Interest Rate, Effective Percentage Businesses in Australia and Korea Businesses In Australia And Korea [Member] Businesses In Australia And Korea Total liabilities Liabilities, Fair Value Disclosure Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Shell Company Entity Shell Company Consolidation Items [Domain] Consolidation Items [Domain] Operating lease liabilities, current portion Operating Lease, Liability, Current Statement of Comprehensive Income [Abstract] Earnings Per Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Unbilled contracts receivable Unbilled Contracts Receivable Earnings per share: Earnings Per Share [Abstract] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Document Fiscal Period Focus Document Fiscal Period Focus Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Total liabilities Liabilities Trading Symbol Trading Symbol Schedule of Interest Rate Derivative Instruments Schedule of Interest Rate Derivatives [Table Text Block] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Operating lease right-of-use assets and liabilities Increase (Decrease) In Operating Lease Right-Of-Use Assets And Liabilities Increase (Decrease) In Operating Lease Right-Of-Use Assets And Liabilities Income taxes payable Accrued Income Taxes, Current Company Selected Measure Name Company Selected Measure Name Amounts reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Schedule of Restricted Cash and Cash Equivalents Restrictions on Cash and Cash Equivalents [Table Text Block] Segment operating income/(loss) (as a percent) Segment Operating Income (Loss) as Percent of Segment Revenue Represents segment operating income expressed as a percentage of segment revenues. Amortization of debt issuance costs and debt discount Amortization of Debt Issuance Costs and Discounts Fixed Interest Rate Derivative, Fixed Interest Rate Clinical Services Clinical Services [Member] Clinical Services Debt principal Total payments Long-Term Debt, Gross Billed and billable receivables Billed Revenues [Member] Credit Facility [Domain] Credit Facility [Domain] Depreciation and amortization Depreciation, Depletion and Amortization, Nonproduction Cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Term Loan B Term Loan B, Due September 2029 [Member] Term Loan B, Due September 2029 Compensation Amount Outstanding Recovery Compensation Amount Individual: Individual [Axis] Diluted (in shares) Denominator for diluted earnings per share (in shares) Weighted Average Number of Shares Outstanding, Diluted Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Dividends declared per share (in dollars per share) Common Stock, Dividends, Per Share, Cash Paid Entity Emerging Growth Company Entity Emerging Growth Company Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Disposal Group Name [Domain] Disposal Group Name [Domain] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Debt And Derivatives Derivative Instruments and Hedging Activities Disclosure [Text Block] Dividends on RSUs Dividend, Share-Based Payment Arrangement Vesting rights (as a percent) Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Gross profit Gross profit Gross Profit Revenue from Contract with Customer [Abstract] Other assets and liabilities Increase (Decrease) in Other Operating Assets and Liabilities, Net Capitalized software impairment charges Impairment charge Long-Lived Asset, Held and Used, Impairment Loss Award Timing Predetermined Award Timing Predetermined [Flag] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Stock compensation expense APIC, Share-Based Payment Arrangement, Increase for Cost Recognition Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items] Level 1 Fair Value, Inputs, Level 1 [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Notional value, asset Derivative Asset, Notional Amount Dilutive effect of unvested RSUs and PSUs (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements All Executive Categories All Executive Categories [Member] Purchases of Maximus common stock Stock Repurchased and Retired During Period, Value Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract] Operating lease right-of-use assets Operating Lease, Right-of-Use Asset Concentration Risk Type [Domain] Concentration Risk Type [Domain] Schedule of Weighted Average Number of Shares used to Compute Earnings Per Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Fair Value Disclosures [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Business Segments Segment Reporting [Text Block] Minimum Minimum [Member] Expiration Date Trading Arrangement Expiration Date Year ended September 30, 2030 Long-Term Debt, Maturity, Year Four Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Liabilities: Liabilities [Abstract] Effect of exchange rate changes on cash, cash equivalents, and restricted cash Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Restricted cash Restricted Cash and Cash Equivalent Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Disposal Group, Including Discontinued Operations [Line Items] Disposal Group, Including Discontinued Operations [Line Items] Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Exercise Price Award Exercise Price Cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Stock repurchase programs, authorized amount Share Repurchase Program, Authorized, Amount Financial information for each of the Company's business segments Segment Reporting [Line Items] Document Quarterly Report Document Quarterly Report Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Deferred compensation plan assets Asset, Held-in-Trust, Noncurrent Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Segments [Domain] Segments [Domain] Interest Rate Swap Interest Rate Swap [Member] Income taxes Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable Common Stock Common Stock Including Additional Paid in Capital [Member] Debt And Derivatives Debt Disclosure [Text Block] Disposal Group Classification [Domain] Disposal Group Classification [Domain] Less: Unamortized debt-issuance costs and discounts Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Employment & Other Employment and Other [Member] Employment and Other Equity Component [Domain] Equity Component [Domain] PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Term Loan Secured Debt Secured Debt [Member] Accounts receivable, gross Accounts Receivable, before Allowance for Credit Loss, Current Adoption Date Trading Arrangement Adoption Date Disposal group, including discontinued operation, consideration Disposal Group, Including Discontinued Operation, Consideration Cash dividends Payments of dividends Dividends, Common Stock, Cash Total shareholders' equity Beginning balance Ending balance Equity, Attributable to Parent Disposal Group, Disposed of by Sale, Not Discontinued Operations Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member] Assets: Assets [Abstract] Title Trading Arrangement, Individual Title Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Accounting Policies [Abstract] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Insider Trading Policies and Procedures [Line Items] Allowance for credit losses Accounts Receivable, Allowance for Credit Loss, Current Other, including customer escrowed funds Proceeds from (Payment for) Other Financing Activity Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Performance Shares Performance Shares [Member] Fair value of derivative asset Interest Rate Cash Flow Hedge Asset at Fair Value Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward] Deferred income taxes Deferred Income Tax Expense (Benefit) Selling, general, and administrative expenses Selling, General and Administrative Expense Other Items Supplemental Balance Sheet Disclosures [Text Block] Principal payments for debt Repayments of Debt Commitments And Contingencies Commitments and Contingencies Disclosure [Text Block] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Antidilutive securities excluded from computation of earnings per share (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Number of operating segments Number of Operating Segments Restricted Stock Units (RSUs) Restricted Stock Units (RSUs) [Member] Entity Central Index Key Entity Central Index Key Common stock, no par value; 100,000 shares authorized; 52,358 and 54,805 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively Common Stock, Value, Outstanding All Adjustments to Compensation All Adjustments to Compensation [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Net cash used in operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Depreciation and amortization (as a percent) Segment Depreciation and Amortization as Percent of Segment Revenue Segment Depreciation and Amortization as Percent of Segment Revenue Revenue, remaining performance obligation, percentage (as a percent) Revenue, Remaining Performance Obligation, Percentage July 1, 2026 through September 30, 2026 Long-Term Debt, Maturity, Remainder of Fiscal Year Shareholders' equity: Equity, Attributable to Parent [Abstract] Income Statement [Abstract] Income Statement [Abstract] Document Transition Report Document Transition Report Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Deferred income taxes Deferred Income Tax Assets, Net U.S. Services US Services [Member] US Services Term Loan A (TLA) Term Loan A, Due 2029 [Member] Term Loan A, Due 2029 Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Outside the U.S. Outside The United States [Member] Outside The United States [Member] City Area Code City Area Code Accumulated Other Comprehensive Loss Total AOCI Attributable to Parent [Member] All Individuals All Individuals [Member] Subsequent Event Subsequent Events [Text Block] Name Forgone Recovery, Individual Name Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Statement Statement [Line Items] Total assets Assets Operating Segments Operating Segments [Member] Interest expense Interest Expense, Nonoperating Annual revenue Disposal Group, Including Discontinued Operation, Revenue Equity Share-Based Payment Arrangement [Text Block] Other comprehensive income before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent PEO PEO [Member] Year ended September 30, 2028 Long-Term Debt, Maturity, Year Two Total debt Debt, Long-Term and Short-Term, Combined Amount Deferred contract costs Increase (Decrease) in Deferred Charges Purchases of Maximus common stock (in shares) Stock Repurchased and Retired During Period, Shares Other liabilities Other Liabilities, Noncurrent Goodwill Goodwill Technology Solutions Technology Solutions [Member] Technology Solutions [Member] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Other, including local municipalities and commercial customers Other, Including Local Municipalities And Commercial Customers [Member] Other, Including Local Municipalities And Commercial Customers [Member] Deferred revenue, recognized Contract with Customer, Liability, Revenue Recognized Subsequent Event Type [Domain] Subsequent Event Type [Domain] Retained Earnings Retained Earnings [Member] Operating lease liabilities, non-current portion Operating Lease, Liability, Noncurrent Revolver Revolving Credit Facility [Member] Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Increase (Decrease) in Shareholders' Equity Increase (Decrease) in Stockholders' Equity [Roll Forward] Common stock, shares outstanding (in shares) Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding Award Timing Disclosures [Line Items] Foreign currency translation adjustments Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Schedule of Fair Value of Assets and Liabilities Fair Value, by Balance Sheet Grouping [Table Text Block] Diluted (in dollars per share) Increase in diluted earnings per share recognized due to changes in contract estimates (in dollars per share) Earnings Per Share, Diluted Entity Current Reporting Status Entity Current Reporting Status Net cash provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Total Shareholder Return Amount Total Shareholder Return Amount Tax withholding adjustment related to RSU vesting Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Accrued compensation and benefits Increase (Decrease) in Employee Related Liabilities Term Loan A Term Loan A, Due May 2029 [Member] Term Loan A, Due May 2029 Amortization of intangible assets Amortization of intangible assets Amortization of intangible assets Intangible Asset, Finite-Lived, Amortization Expense Adjustments to reconcile net income to cash flows from operations: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Year ended September 30, 2029 Long-Term Debt, Maturity, Year Three Deferred compensation plan liabilities, non-current portion Deferred Compensation Liability, Classified, Noncurrent Share-Based Payment Arrangement [Abstract] Cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Property and equipment, net Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Revenue Total revenue Increase/(decrease) in revenue recognized due to changes in contract estimates Revenue from Contract with Customer, Excluding Assessed Tax Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration] Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration] Financial Instruments [Domain] Financial Instruments [Domain] International government agencies International Government Agencies [Member] International Government Agencies [Member] Common shares repurchased, value Stock Repurchased During Period, Value Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Underlying Securities Award Underlying Securities Amount Revenue Recognition Revenue from Contract with Customer [Text Block] Other Payment for (Proceeds from) Other Investing Activity Segment Reporting [Table] Segment Reporting [Table] Schedule of Future Minimum Principal Payments Due Schedule of Maturities of Long-Term Debt [Table Text Block] Title of Individual [Axis] Title and Position [Axis] Commitments and Contingencies Disclosure [Abstract] All Trading Arrangements All Trading Arrangements [Member] Beginning balance Ending balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Other Performance Measure, Amount Other Performance Measure, Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Operating income Operating income Operating Income (Loss) Revenue, remaining performance obligation, amount Revenue, Remaining Performance Obligation, Amount Current Fiscal Year End Date Current Fiscal Year End Date Gross profit (as a percent) Segment Gross Profit as Percent of Segment Revenue Represents segment gross profit expressed as a percentage of segment revenues. Proceeds from borrowings Proceeds from Issuance of Debt Divestiture-related charges/(gains) Divestiture-related gains/(charges) Gain (Loss) on Disposition of Business Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount RSUs vested (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture Common shares repurchased (in shares) Stock Repurchased During Period, Shares Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Cash dividend declared (in dollars per share) Common Stock, Dividends, Per Share, Declared Entity File Number Entity File Number Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Term Loan B Term Loan B, Due September 2028 [Member] Term Loan B, Due September 2028 Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Common stock, shares issued (in shares) Common Stock, Shares, Issued Measure: Measure [Axis] Contract with Customer, Basis of Pricing [Axis] Contract with Customer, Basis of Pricing [Axis] Equity Components [Axis] Equity Components [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Term Loan A Term Loan A, Due September 2028 [Member] Term Loan A, Due September 2028 Product and Service [Domain] Product and Service [Domain] Income tax payments Income Tax Paid, after Refund Received Deferred contract costs, net Capitalized Contract Cost, Net Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Entity Interactive Data Current Entity Interactive Data Current Term Loan B (TLB) Term Loan B [Member] Term Loan B Deferred income taxes Deferred Income Tax Liabilities, Net Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Accounts payable and accrued liabilities Accounts Payable and Accrued Liabilities, Current Entity Small Reporting Company Entity Small Business Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Termination Date Trading Arrangement Termination Date Property, Plant, and Equipment [Line Items] Property, Plant, and Equipment [Line Items] Number of citizens impacted by service improvements (more than) Number Of Citizens Impacted By Service Improvements Number Of Citizens Impacted By Service Improvements Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table] Subsequent Events [Abstract] Cash payments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements Divestitures Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Other current liabilities Other Liabilities, Current Other assets Other Assets, Noncurrent Document Type Document Type Cost-plus Cost Plus Contracts [Member] Reflects the percentage that revenues during the period from cost-plus contracts are to total revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence. Fixed price Fixed-Price Contract [Member] Fair Value as of Grant Date Award Grant Date Fair Value Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Amount remaining available for future stock repurchases Share Repurchase Program, Remaining Authorized, Amount Arrangement Duration Trading Arrangement Duration Subsequent Event [Line Items] Subsequent Event [Line Items] Statement of Stockholders' Equity [Abstract] Local Phone Number Local Phone Number Indemnification liabilities Guaranty Liabilities Deferred revenue, non-current portion Contract with Customer, Liability, Noncurrent Consolidation Items [Axis] Consolidation Items [Axis] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Registrant Name Entity Registrant Name Income before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Commitments and contingencies (Note 11) Commitments and Contingencies Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Accounts payable and accrued liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Executive Category: Executive Category [Axis] Vesting period Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Liabilities and Shareholders' Equity: Liabilities and Equity [Abstract] Equity Award [Domain] Award Type [Domain] New York state government agencies New York State Government Agencies [Member] New York State Government Agencies Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Other segment items (as a percent) Segment Other Expense as Percent of Segment Revenue Segment Other Expense as Percent of Segment Revenue Fair Value Measurements Fair Value Disclosures [Text Block] Level 3 Fair Value, Inputs, Level 3 [Member] PEO Name PEO Name Billing Status, Type [Axis] Billing Status, Type [Axis] Net unrealized gain on derivatives, net of tax Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Other segment items Segment Reporting, Other Segment Item, Amount Property, Plant and Equipment, Type [Axis] Long-Lived Asset, Class [Axis] Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Entity Tax Identification Number Entity Tax Identification Number Deferred compensation assets - Rabbi Trust Mutual Fund [Member] Cash, cash equivalents, and restricted cash, beginning of period Cash, cash equivalents, and restricted cash, end of period Cash, cash equivalents, and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Non-NEOs Non-NEOs [Member] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Organization Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Debt Instrument [Axis] Debt Instrument [Axis] Subsequent Event [Table] Subsequent Event [Table] Stock compensation expense Share-Based Payment Arrangement, Noncash Expense Years ended thereafter Long Term Debt Maturity, After Year Four Long Term Debt Maturity, After Year Four Disposal Group Name [Axis] Disposal Group Name [Axis] Schedule of Debt Schedule of Debt [Table Text Block] Customer [Domain] Customer [Domain] Year ended September 30, 2027 Long-Term Debt, Maturity, Year One Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Basic (in dollars per share) Earnings Per Share, Basic Purchases of Maximus common stock Payments for Repurchase of Common Stock Deferred revenue, current portion Contract with Customer, Liability, Current Total current assets Assets, Current Range [Axis] Statistical Measurement [Axis] Insider Trading Arrangements [Line Items] Long-term debt, non-current portion Long-term debt Long-Term Debt, Excluding Current Maturities Cost of revenue Cost of Revenue Award Type [Axis] Award Type [Axis] Payments for debt financing costs Payments of Financing Costs Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts receivable, net Accounts receivable, net Accounts Receivable, after Allowance for Credit Loss, Current Retained earnings Retained Earnings (Accumulated Deficit) Product and Service [Axis] Product and Service [Axis] Net gains/(losses) on cash flow hedges, net of tax provision/(benefit) of $28, $(561), $(206), and $(596), respectively Cash flow hedge, net of tax Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Gain on sale of business Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal Effect of Change in Accounting Estimate, Type [Axis] Effect of Change in Accounting Estimate, Type [Axis] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Shares issued (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period Significant Accounting Policies Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Cover [Abstract] Derivative Contract [Domain] Derivative Contract [Domain] Total revenue (as a percent) Concentration Risk, Percentage Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Term Loan B Term Loan B, Due September 2027 [Member] Term Loan B, Due September 2027 Segment operating income/(loss) Segment Operating Income (Loss) Segment Operating Income (Loss) Equity Awards Adjustments Equity Awards Adjustments [Member] Total liabilities and shareholders' equity Liabilities and Equity Employee Stock Option Share-Based Payment Arrangement, Option [Member] Segments [Axis] Segments [Axis] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Schedule of Accounts Receivable, Net Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block] Tabular List, Table Tabular List [Table Text Block] Other (income)/expense, net Other Nonoperating Income (Expense) Other Other Operating Income (Expense), Net Name Awards Close in Time to MNPI Disclosures, Individual Name Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Property, Plant and Equipment, Type [Domain] Long-Lived Asset, Class [Domain] Term Loan B Term Loan B, Due September 2026 [Member] Term Loan B, Due September 2026 Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Table] Adjustment to Compensation: Adjustment to Compensation [Axis] Foreign currency exchange loss Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses) Change in Contract Estimates Change in Accounting Method Accounted for as Change in Estimate [Member] Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Interest payments Interest Paid, Excluding Capitalized Interest, Operating Activity Purchases of property and equipment and capitalized software Payments to Acquire Productive Assets Statement of Cash Flows [Abstract] Fair value of derivative liability Interest Rate Cash Flow Hedge Liability at Fair Value Credit Facility [Axis] Credit Facility [Axis] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Total assets Assets, Fair Value Disclosure Increase in borrowing capacity Line of Credit Facility, Increase (Decrease), Net Excise tax (as a percent) Share Repurchase Program, Excise Tax, Percent Share Repurchase Program, Excise Tax, Percent Discontinued Operations and Disposal Groups [Abstract] Net gains/(losses) on cash flow hedges, tax provision/(benefit) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent Name Measure Name Pay vs Performance Disclosure [Line Items] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Debt Instrument [Line Items] Debt Instrument [Line Items] Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Entity Filer Category Entity Filer Category Member of Board of Directors Director [Member] Name Trading Arrangement, Individual Name Cash and cash equivalents Cash and Cash Equivalent Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Company Selected Measure Amount Company Selected Measure Amount Income taxes receivable Income Taxes Receivable Receivables purchase agreement, maximum sales amount Transfer of Financing Assets, Maximum Amount Authorized for Sale Transfer of Financing Assets, Maximum Amount Authorized for Sale Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Accounts and Financing Receivables [Table] Non-PEO NEO Non-PEO NEO [Member] Entity Address, Address Line One Entity Address, Address Line One Provision for income taxes Income Tax Expense (Benefit) Customer Concentration Risk Customer Concentration Risk [Member] Award Timing Method Award Timing Method [Text Block] Net change in cash, cash equivalents, and restricted cash Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Notional value, liability Derivative Liability, Notional Amount Time and materials Time-and-Materials Contract [Member] Net income Net income Net Income (Loss) Attributable to Parent Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Divestiture related charges Disposal Group, Not Discontinued Operation, Sale Related Expenses Disposal Group, Not Discontinued Operation, Sale Related Expenses Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Balance Sheet Location [Axis] Location, Statement of Financial Position, Balance [Axis] Statement [Table] Statement [Table] Segment Reconciling Items Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member] Restatement Determination Date: Restatement Determination Date [Axis] Schedule of Accumulated Other Comprehensive Loss Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Cash received from transfer of financial assets Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount Foreign currency translation adjustments Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss) Schedule of Fair Value Measurement using Significant Unobservable Inputs (Level 3) Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] Employee Employee [Member] Employee Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] EX-101.PRE 10 mms-20260630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT GRAPHIC 11 mms-20260630_g1.jpg GRAPHIC begin 644 mms-20260630_g1.jpg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htm IDEA: XBRL DOCUMENT v3.26.1
Cover Page - shares
9 Months Ended
Jun. 30, 2026
Aug. 03, 2026
Cover [Abstract]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 30, 2026  
Document Transition Report false  
Entity File Number 1-12997  
Entity Registrant Name Maximus, Inc.  
Entity Incorporation, State or Country Code VA  
Entity Tax Identification Number 54-1000588  
Entity Address, Address Line One 1600 Tysons Boulevard  
Entity Address, City or Town McLean  
Entity Address, State or Province VA  
Entity Address, Postal Zip Code 22102  
City Area Code 703  
Local Phone Number 251-8500  
Title of 12(b) Security Common Stock, no par value  
Trading Symbol MMS  
Security Exchange Name NYSE  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Reporting Company false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding   52,357,763
Entity Central Index Key 0001032220  
Current Fiscal Year End Date --09-30  
Document Fiscal Year Focus 2026  
Document Fiscal Period Focus Q3  
Amendment Flag false  

XML 14 R2.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Income Statement [Abstract]        
Revenue $ 1,278,971 $ 1,348,400 $ 3,929,984 $ 4,112,861
Cost of revenue 930,168 988,887 2,920,247 3,112,970
Gross profit 348,803 359,513 1,009,737 999,891
Selling, general, and administrative expenses 167,188 170,831 492,827 525,423
Amortization of intangible assets 20,187 23,010 60,785 69,041
Operating income 161,428 165,672 456,125 405,427
Interest expense 23,878 22,657 66,805 61,648
Other (income)/expense, net (608) 48 (1,639) (603)
Income before income taxes 138,158 142,967 390,959 344,382
Provision for income taxes 34,565 36,986 95,360 100,636
Net income $ 103,593 $ 105,981 $ 295,599 $ 243,746
Earnings per share:        
Basic (in dollars per share) $ 1.96 $ 1.87 $ 5.48 $ 4.22
Diluted (in dollars per share) $ 1.95 $ 1.86 $ 5.45 $ 4.20
Weighted average shares outstanding:        
Basic (in shares) 52,854 56,683 53,974 57,776
Diluted (in shares) 53,057 56,984 54,243 58,100
Dividends declared per share (in dollars per share) $ 0.33 $ 0.30 $ 0.96 $ 0.90
XML 15 R3.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Comprehensive Income - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Statement of Comprehensive Income [Abstract]        
Net income $ 103,593 $ 105,981 $ 295,599 $ 243,746
Other comprehensive (loss)/income, net of tax:        
Foreign currency translation adjustments 255 7,320 (2,276) 21,503
Net gains/(losses) on cash flow hedges, net of tax provision/(benefit) of $28, $(561), $(206), and $(596), respectively 79 (1,574) (578) (1,672)
Other comprehensive (loss)/income 334 5,746 (2,854) 19,831
Comprehensive income $ 103,927 $ 111,727 $ 292,745 $ 263,577
XML 16 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Comprehensive Income (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Statement of Comprehensive Income [Abstract]        
Net gains/(losses) on cash flow hedges, tax provision/(benefit) $ 28 $ (561) $ (206) $ (596)
XML 17 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Jun. 30, 2026
Sep. 30, 2025
Assets:    
Cash and cash equivalents $ 56,953 $ 222,351
Accounts receivable, net 1,382,014 898,095
Income taxes receivable 31,019 3,904
Prepaid expenses and other current assets 171,377 128,574
Total current assets 1,641,363 1,252,924
Property and equipment, net 28,485 30,972
Capitalized software, net 201,373 214,260
Operating lease right-of-use assets 88,302 100,514
Goodwill 1,780,543 1,782,095
Intangible assets, net 477,031 538,266
Deferred contract costs, net 60,205 63,332
Deferred compensation plan assets 67,877 63,272
Deferred income taxes 8,047 11,491
Other assets 13,553 12,513
Total assets 4,366,779 4,069,639
Liabilities:    
Accounts payable and accrued liabilities 263,220 296,888
Accrued compensation and benefits 146,064 236,948
Deferred revenue, current portion 36,626 53,784
Income taxes payable 1,138 17,321
Long-term debt, current portion 71,599 52,680
Operating lease liabilities, current portion 38,280 38,605
Other current liabilities 121,142 68,937
Total current liabilities 678,069 765,163
Deferred revenue, non-current portion 35,863 43,757
Deferred income taxes 199,887 149,020
Long-term debt, non-current portion 1,565,336 1,281,593
Deferred compensation plan liabilities, non-current portion 66,468 62,145
Operating lease liabilities, non-current portion 56,603 71,289
Other liabilities 24,002 22,637
Total liabilities 2,626,228 2,395,604
Commitments and contingencies (Note 11)
Shareholders' equity:    
Common stock, no par value; 100,000 shares authorized; 52,358 and 54,805 shares issued and outstanding as of June 30, 2026 and September 30, 2025, respectively 647,138 628,118
Accumulated other comprehensive loss (20,721) (17,867)
Retained earnings 1,114,134 1,063,784
Total shareholders' equity 1,740,551 1,674,035
Total liabilities and shareholders' equity $ 4,366,779 $ 4,069,639
XML 18 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Balance Sheets (Parenthetical) - shares
shares in Thousands
Jun. 30, 2026
Sep. 30, 2025
Statement of Financial Position [Abstract]    
Common stock, shares authorized (in shares) 100,000 100,000
Common stock, shares issued (in shares) 52,358 54,805
Common stock, shares outstanding (in shares) 52,358 54,805
XML 19 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 295,599 $ 243,746
Adjustments to reconcile net income to cash flows from operations:    
Depreciation and amortization of property, equipment, and capitalized software 37,091 27,502
Capitalized software impairment charges 6,914 0
Amortization of intangible assets 60,785 69,041
Amortization of debt issuance costs and debt discount 2,314 2,046
Deferred income taxes 54,416 (5,829)
Stock compensation expense 24,274 30,324
Divestiture-related charges/(gains) (10,147) 39,343
Change in assets and liabilities, net of effects of business combinations and divestitures:    
Accounts receivable (489,403) (553,297)
Prepaid expenses and other current assets 13,152 9,341
Deferred contract costs 2,748 (856)
Accounts payable and accrued liabilities (33,345) (21,808)
Accrued compensation and benefits (79,734) (50,369)
Deferred revenue (24,658) (8,675)
Income taxes (40,504) 5,625
Operating lease right-of-use assets and liabilities (2,814) (3,508)
Other assets and liabilities 3,449 (2,626)
Net cash used in operating activities (179,863) (220,000)
Cash flows from investing activities:    
Purchases of property and equipment and capitalized software (28,752) (55,686)
Proceeds from divestitures 16,842 736
Other (2,500) (2,165)
Net cash used in investing activities (14,410) (57,115)
Cash flows from financing activities:    
Cash dividends paid to Maximus shareholders (51,437) (51,865)
Purchases of Maximus common stock (204,919) (306,443)
Tax withholding related to RSU vesting (17,325) (16,451)
Payments for debt financing costs (2,393) (1,658)
Proceeds from borrowings 1,368,675 1,335,208
Principal payments for debt (1,065,935) (810,174)
Other, including customer escrowed funds 60,841 (1,824)
Net cash provided by financing activities 87,507 146,793
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (444) (65)
Net change in cash, cash equivalents, and restricted cash (107,210) (130,387)
Cash, cash equivalents, and restricted cash, beginning of period 260,459 235,763
Cash, cash equivalents, and restricted cash, end of period $ 153,249 $ 105,376
XML 20 R8.htm IDEA: XBRL DOCUMENT v3.26.1
Consolidated Statements of Changes in Shareholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Accumulated Other Comprehensive Loss
Retained Earnings
Beginning balance (in shares) at Sep. 30, 2024   60,352    
Beginning balance at Sep. 30, 2024 $ 1,842,815 $ 598,304 $ (32,460) $ 1,276,971
Increase (Decrease) in Shareholders' Equity        
Net income 41,196     41,196
Foreign currency translation 10,452   10,452  
Cash flow hedge, net of tax 2,454   2,454  
Cash dividends (18,060)     (18,060)
Dividends on RSUs 0 $ 301   (301)
Purchases of Maximus common stock (in shares)   (3,113)    
Purchases of Maximus common stock (236,655)     (236,655)
Stock compensation expense 6,952 $ 6,952    
Tax withholding adjustment related to RSU vesting (2,305) $ (2,305)    
RSUs vested (in shares)   47    
Ending balance (in shares) at Dec. 31, 2024   57,286    
Ending balance at Dec. 31, 2024 1,646,849 $ 603,252 (19,554) 1,063,151
Beginning balance (in shares) at Sep. 30, 2024   60,352    
Beginning balance at Sep. 30, 2024 1,842,815 $ 598,304 (32,460) 1,276,971
Increase (Decrease) in Shareholders' Equity        
Net income 243,746      
Foreign currency translation 21,503      
Cash flow hedge, net of tax (1,672)      
Ending balance (in shares) at Jun. 30, 2025   56,350    
Ending balance at Jun. 30, 2025 1,773,036 $ 627,496 (12,629) 1,158,169
Beginning balance (in shares) at Dec. 31, 2024   57,286    
Beginning balance at Dec. 31, 2024 1,646,849 $ 603,252 (19,554) 1,063,151
Increase (Decrease) in Shareholders' Equity        
Net income 96,569     96,569
Foreign currency translation 3,731   3,731  
Cash flow hedge, net of tax (2,552)   (2,552)  
Cash dividends (16,901)     (16,901)
Dividends on RSUs 0 $ 440   (440)
Purchases of Maximus common stock (in shares)   (947)    
Purchases of Maximus common stock (72,845)     (72,845)
Stock compensation expense 12,623 $ 12,623    
RSUs vested (in shares)   10    
Ending balance (in shares) at Mar. 31, 2025   56,349    
Ending balance at Mar. 31, 2025 1,667,474 $ 616,315 (18,375) 1,069,534
Increase (Decrease) in Shareholders' Equity        
Net income 105,981     105,981
Foreign currency translation 7,320   7,320  
Cash flow hedge, net of tax (1,574)   (1,574)  
Cash dividends (16,904)     (16,904)
Dividends on RSUs 0 442   (442)
Stock compensation expense 10,749 10,749    
Tax withholding adjustment related to RSU vesting (10) $ (10)    
RSUs vested (in shares)   1    
Ending balance (in shares) at Jun. 30, 2025   56,350    
Ending balance at Jun. 30, 2025 $ 1,773,036 $ 627,496 (12,629) 1,158,169
Beginning balance (in shares) at Sep. 30, 2025 54,805 54,805    
Beginning balance at Sep. 30, 2025 $ 1,674,035 $ 628,118 (17,867) 1,063,784
Increase (Decrease) in Shareholders' Equity        
Net income 93,943     93,943
Foreign currency translation 248   248  
Cash flow hedge, net of tax (1,407)   (1,407)  
Cash dividends (16,338)     (16,338)
Dividends on RSUs 0 $ 363   (363)
Purchases of Maximus common stock (in shares)   (353)    
Purchases of Maximus common stock (31,055)     (31,055)
Stock compensation expense 7,019 $ 7,019    
Tax withholding adjustment related to RSU vesting (6,633) $ (6,633)    
RSUs vested (in shares)   97    
Ending balance (in shares) at Dec. 31, 2025   54,549    
Ending balance at Dec. 31, 2025 $ 1,719,812 $ 628,867 (19,026) 1,109,971
Beginning balance (in shares) at Sep. 30, 2025 54,805 54,805    
Beginning balance at Sep. 30, 2025 $ 1,674,035 $ 628,118 (17,867) 1,063,784
Increase (Decrease) in Shareholders' Equity        
Net income 295,599      
Foreign currency translation (2,276)      
Cash flow hedge, net of tax $ (578)      
Ending balance (in shares) at Jun. 30, 2026 52,358 52,358    
Ending balance at Jun. 30, 2026 $ 1,740,551 $ 647,138 (20,721) 1,114,134
Beginning balance (in shares) at Dec. 31, 2025   54,549    
Beginning balance at Dec. 31, 2025 1,719,812 $ 628,867 (19,026) 1,109,971
Increase (Decrease) in Shareholders' Equity        
Net income 98,063     98,063
Foreign currency translation (2,779)   (2,779)  
Cash flow hedge, net of tax 750   750  
Cash dividends (17,821)     (17,821)
Dividends on RSUs 0 $ 503   (503)
Purchases of Maximus common stock (in shares)   (1,445)    
Purchases of Maximus common stock (110,963)     (110,963)
Stock compensation expense 9,899 $ 9,899    
RSUs vested (in shares)   6    
Ending balance (in shares) at Mar. 31, 2026   53,110    
Ending balance at Mar. 31, 2026 1,696,961 $ 639,269 (21,055) 1,078,747
Increase (Decrease) in Shareholders' Equity        
Net income 103,593     103,593
Foreign currency translation 255   255  
Cash flow hedge, net of tax 79   79  
Cash dividends (17,278)     (17,278)
Dividends on RSUs 0 $ 513   (513)
Purchases of Maximus common stock (in shares)   (752)    
Purchases of Maximus common stock (50,415)     (50,415)
Stock compensation expense $ 7,356 $ 7,356    
Ending balance (in shares) at Jun. 30, 2026 52,358 52,358    
Ending balance at Jun. 30, 2026 $ 1,740,551 $ 647,138 $ (20,721) $ 1,114,134
XML 21 R9.htm IDEA: XBRL DOCUMENT v3.26.1
Organization
9 Months Ended
Jun. 30, 2026
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization ORGANIZATIONMaximus, a Virginia corporation, is a leading provider of tech-enabled services to government agencies. By moving people, technology, and government forward, Maximus helps improve the delivery of public services for more than 100 million American citizens amid complex technological, health, economic, and social challenges. As a trusted and accountable partner to primarily U.S. federal and state customers, we proudly design, develop, and deliver innovative and efficient programs that are designed to improve government’s effectiveness in serving its citizens.
XML 22 R10.htm IDEA: XBRL DOCUMENT v3.26.1
Significant Accounting Policies
9 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Significant Accounting Policies SIGNIFICANT ACCOUNTING POLICIES
Basis of Presentation
The accompanying consolidated financial statements, including the notes, include our accounts and those of our subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP, and the rules and regulations of the Securities and Exchange Commission (SEC). All intercompany balances and transactions have been eliminated in consolidation.
Basis of Presentation for Interim Periods
Certain information and disclosures normally included for the annual financial statements to be prepared in accordance with U.S. GAAP have been condensed or omitted for the interim periods presented. We believe that the unaudited interim financial statements include all adjustments (which are normal and recurring in nature) necessary to present fairly our financial position and the results of operations and cash flows for the periods presented.
The results of operations for the interim periods presented are not necessarily indicative of results that may be expected for the year or future periods. The financial statements should be read in conjunction with our audited consolidated financial statements and the accompanying notes contained in our Annual Report on Form 10-K for the fiscal year ended September 30, 2025. We have continued to follow the accounting policies set forth in those financial statements.
Use of Estimates
The preparation of these financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. At each reporting period end, we make estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of long-lived assets, and amounts related to income taxes, certain accrued liabilities, and contingencies and litigation.
At June 30, 2026, our capitalized software balance includes $32.3 million related to technology for new services within our U.S. Services Segment. During the second quarter of fiscal year 2026, we recorded an impairment charge of $6.9 million to an asset following a client decision that resulted in its carrying value no longer being recoverable. At this time, we believe that the remaining balance of these assets is recoverable. We continue to monitor these assets, and if circumstances change, we may be required to further adjust the value or useful life of the remaining assets.
XML 23 R11.htm IDEA: XBRL DOCUMENT v3.26.1
Business Segments
9 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Business Segments BUSINESS SEGMENTS
We conduct our operations through three business segments: U.S. Federal Services, U.S. Services, and Outside the U.S. Our operating segments represent the manner in which our Chief Executive Officer (CEO), who is our Chief Operating Decision Maker (CODM), reviews our financial results. The CODM reviews segment-level revenue, gross profit, and segment operating income/(loss) on a regular basis to assess performance and manage the business. Revenue is used to evaluate growth trends and performance relative to budget, while gross profit and segment operating income/(loss) are used to assess overall profitability, business efficiency, and the effectiveness of cost-reduction initiatives. These measures also inform the CODM’s decisions regarding the allocation of resources across segments, including allocations of management bonus as well as investments in technology, personnel, and strategic transactions, such as mergers and acquisitions.
Our CODM does not evaluate operating segments using asset or liability information.
U.S. Federal Services
Our U.S. Federal Services Segment delivers solutions that help various U.S. federal government agencies better execute their missions, including program operations and management, clinical services, and advanced technology solutions.
U.S. Services
Our U.S. Services Segment provides a variety of services, such as program operations, clinical services, employment services, and advanced technology solutions and related professional services for U.S. state and local government programs. These services support a variety of programs, including those under Medicaid and the Children's Health Insurance Program (CHIP), the Affordable Care Act (ACA) marketplaces, and Temporary Assistance for Needy Families (TANF).
Outside the U.S.
Our Outside the U.S. Segment provides business process services and other solutions for international governments. These services include health and disability assessments, program administration for employment services, wellbeing solutions and other job seeker-related services, digitally-enabled customer services, and advanced technologies for modernization. We support programs and deliver services in the United Kingdom, including the Functional Assessment Services (FAS) contract and the Restart employment program. We also provide services in Canada and the Middle East.
Table 3.1: Results of Operations by Business Segment for the Three Months Ended
For the Three Months Ended June 30, 2026
(dollars in thousands)U.S. Federal Services% (1 )U.S. Services% (1 )Outside the U.S.% (1 )Total
Revenue$720,991 $418,227 $139,753 $1,278,971 
Cost of revenue498,720 69.2 %311,449 74.5 %119,999 85.9 %930,168 
Gross profit222,271 30.8 %106,778 25.5 %19,754 14.1 %348,803 
Other segment items (2)88,231 12.2 %61,589 14.7 %18,548 13.3 %168,368 
Segment operating income$134,040 18.6 %$45,189 10.8 %$1,206 0.9 %180,435 
Divestiture-related gains/(charges) (3)1,162 
Other (4)18 
Amortization of intangible assets(20,187)
Operating income$161,428 
Depreciation and amortization$7,223 1.0 %$3,997 1.0 %$654 0.5 %$11,874 
For the Three Months Ended June 30, 2025
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$761,174 $439,818 $147,408 $1,348,400 
Cost of revenue535,040 70.3 %333,886 75.9 %119,961 81.4 %988,887 
Gross profit226,134 29.7 %105,932 24.1 %27,447 18.6 %359,513 
Other segment items (2)88,272 11.6 %60,975 13.9 %21,507 14.6 %170,754 
Segment operating income$137,862 18.1 %$44,957 10.2 %$5,940 4.0 %188,759 
Other (4)(77)
Amortization of intangible assets(23,010)
Operating income$165,672 
Depreciation and amortization$3,125 0.4 %$4,631 1.1 %$1,851 1.3 %$9,607 
Table 3.2: Results of Operations by Business Segment for the Nine Months Ended
For the Nine Months Ended June 30, 2026
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$2,260,735 $1,249,229 $420,020 $3,929,984 
Cost of revenue1,598,084 70.7 %957,548 76.7 %364,615 86.8 %2,920,247 
Gross profit662,651 29.3 %291,681 23.3 %55,405 13.2 %1,009,737 
Other segment items (2)266,174 11.8 %178,616 14.3 %58,664 14.0 %503,454 
Segment operating income/(loss)$396,477 17.5 %$113,065 9.1 %$(3,259)(0.8)%506,283 
Divestiture-related gains/(charges) (3)10,147 
Other (4)480 
Amortization of intangible assets(60,785)
Operating income$456,125 
Depreciation and amortization$21,637 1.0 %$12,381 1.0 %$3,073 0.7 %$37,091 
For the Nine Months Ended June 30, 2025
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$2,319,756 $1,334,418 $458,687 $4,112,861 
Cost of revenue1,718,249 74.1 %1,021,712 76.6 %373,009 81.3 %3,112,970 
Gross profit601,507 25.9 %312,706 23.4 %85,678 18.7 %999,891 
Other segment items (2)245,563 10.6 %173,096 13.0 %66,822 14.6 %485,481 
Segment operating income$355,944 15.3 %$139,610 10.5 %$18,856 4.1 %514,410 
Divestiture-related gains/(charges) (3)(39,343)
Other (4)(599)
Amortization of intangible assets(69,041)
Operating income$405,427 
Depreciation and amortization$9,653 0.4 %$12,603 0.9 %$5,246 1.1 %$27,502 
(1)Percentage of respective revenue, as applicable.
(2)Other segment items are principally selling, general, and administrative expenses allocated to segments.
(3)During fiscal years 2026 and 2025, we divested businesses from our U.S. Services and Outside the U.S. Segments, respectively. See "Note 6. Divestitures" for additional information.
(4)Other expenses include credits and costs that are not allocated to a particular segment.
XML 24 R12.htm IDEA: XBRL DOCUMENT v3.26.1
Revenue Recognition
9 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Revenue Recognition REVENUE RECOGNITION
We recognize revenue as, or when, we satisfy performance obligations under a contract. The majority of our contracts have performance obligations that are satisfied over time. In most cases, we view our performance obligations as promises to transfer a series of distinct services to our customers that are substantially the same and which have the same pattern of service. We recognize revenue over the performance period as a customer receives the benefits of our services.
Disaggregation of Revenue
In addition to our segment reporting, we disaggregate our revenues by service type, contract type, and customer type.
Table 4.1: Revenue by Service Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands)
Program Operations$602,807 47.1 %$626,981 46.5 %$1,924,106 49.0 %$2,045,720 49.7 %
Clinical Services553,075 43.2 %560,360 41.6 %1,607,602 40.9 %1,535,849 37.3 %
Employment & Other55,852 4.4 %81,906 6.1 %186,025 4.7 %274,513 6.7 %
Technology Solutions67,237 5.3 %79,153 5.9 %212,251 5.4 %256,779 6.2 %
Total revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Table 4.2: Revenue by Contract Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands)
Performance-based$755,826 59.1 %$761,428 56.5 %$2,209,585 56.2 %$2,193,605 53.3 %
Cost-plus303,486 23.7 %301,385 22.4 %1,033,798 26.3 %1,020,311 24.8 %
Fixed price155,200 12.1 %180,390 13.4 %489,327 12.5 %540,078 13.1 %
Time and materials64,459 5.0 %105,197 7.8 %197,274 5.0 %358,867 8.7 %
Total revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Table 4.3: Revenue by Customer Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands)
New York state government agencies$148,067 11.6 %$148,408 11.0 %$445,548 11.3 %$466,053 11.3 %
Other U.S. state government agencies275,793 21.6 %291,312 21.6 %817,052 20.8 %869,561 21.1 %
Total U.S. state government agencies423,860 439,720 1,262,600 1,335,614 
U.S. federal government agencies701,932 54.9 %743,058 55.1 %2,204,623 56.1 %2,267,078 55.1 %
International government agencies137,462 10.7 %146,018 10.8 %413,321 10.5 %451,608 11.0 %
Other, including local municipalities and commercial customers15,717 1.2 %19,604 1.5 %49,440 1.3 %58,561 1.4 %
Total revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Contract balances
Differences in timing between revenue recognition and cash collection result in contract assets and contract liabilities. We classify these assets as accounts receivable — billed and billable and unbilled receivables; the liabilities are classified as deferred revenue.
In many contracts, we bill our customers on a monthly basis shortly after the month end for work performed in that month, and such balances are considered collectible and are included within accounts receivable, net.
Exceptions to this pattern will arise for various reasons, including those listed below.
•Under cost-plus contracts, we are typically required to estimate a contract's share of our general and administrative expenses. This share is based upon estimates of total costs, which may vary over time. We typically invoice our customers at an agreed provisional billing rate, which may differ from actual rates incurred. If our actual rates are higher than the provisional billing rates, an asset is recorded for this variance; if the provisional billing rates are higher than our actual rates, we record a liability.
•Certain contracts include retainage balances, whereby revenue is earned, but some portion of cash payments are held back by the customer for a period of time, typically to allow the customer to confirm the objective criteria laid out by the contract have been met. This balance is classified as accounts receivable-unbilled, until restrictions on billing are lifted. As of June 30, 2026, and September 30, 2025, $27.4 million and $24.1 million, respectively, of our unbilled receivables related to amounts pursuant to contractual retainage provisions.
•In certain contracts, we may receive funds from our customers prior to performing operations. These funds are typically referred to as "set-up costs" and reflect the need for us to make investments in infrastructure prior to providing a service. This investment in infrastructure is not a performance obligation that is distinct from the service that is subsequently provided, and, as a result, revenue is not recognized based upon the establishment of this infrastructure, but rather over the course of the contractual relationship. The funds are initially recorded as deferred revenue and recognized over the term of the contract. Other contracts may not include set-up fees but will provide higher fees in earlier periods of the contract. The premium on these fees is deferred.
•Some of our contracts, notably our employment services contracts in the Outside the U.S. Segment, include payments for specific milestones, such as job placement and job retention, and these outcome payments occur over several months. We are required to estimate these outcome fees ahead of their realization and recognize this estimated fee over the period of delivery.
During the three and nine months ended June 30, 2026, we recognized revenue of $2.0 million and $45.2 million, respectively, included in our deferred revenue balances at September 30, 2025. During the three and nine months ended June 30, 2025, we recognized revenue of $13.8 million and $87.0 million, respectively, included in our deferred revenue balances at September 30, 2024.
Contract estimates
We are required to use estimates in recognizing revenue from some of our contracts.
Certain performance-based contracts include variable consideration in the form of penalties and incentives, based upon our performance under the terms of the contract. The calculation of these penalties and incentives requires the evaluation of both objective and subjective criteria, which may require the use of estimates.
Within our employment services business in our Outside the U.S. Segment, some of our performance-based contract revenue is recognized based upon future milestones defined in each contract, which requires us to make estimates about the attainment of those milestones.
We estimate the total variable consideration we will receive using the expected value method. We recognize the revenue over the expected period of performance. At each reporting period, we update our estimates of the variable fees to represent the circumstances present at the end of the reporting period. We include variable consideration in our estimates to the extent it is probable that a subsequent change in the estimate will not result in a significant reversal of cumulative revenue when the uncertainty is resolved. We do not have a history of significant constraints on these contracts.
Table 4.4: Effect of Changes in Contract Estimates
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands, except per share data)
Increase/(decrease) in revenue recognized due to changes in contract estimates$(1,291)$607 $5,628 $11,181 
Increase/(decrease) in diluted earnings per share recognized due to changes in contract estimates$(0.02)$0.01 $0.08 $0.14 
Remaining performance obligations
As of June 30, 2026, we had approximately $230 million of remaining performance obligations. We anticipate that we will recognize revenue on approximately 57% of this balance within the next 12 months. This balance excludes contracts with an original duration of twelve months or less, including contracts with a penalty-free termination for convenience clause, and any variable consideration that is allocated entirely to future performance obligations, including variable transaction fees or fees tied directly to costs incurred.
XML 25 R13.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share
9 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Earnings Per Share EARNINGS PER SHARE
Table 5: Weighted Average Number of Shares - Earnings Per Share
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands)
Basic weighted average shares outstanding52,854 56,683 53,974 57,776 
Dilutive effect of unvested RSUs and PSUs203 301 269 324 
Denominator for diluted earnings per share53,057 56,984 54,243 58,100 
The diluted earnings per share calculations for the three and nine months ended June 30, 2026 exclude approximately 571,000 and 567,000 unvested anti-dilutive restricted stock units, respectively. The diluted earnings per share calculations for the three and nine months ended June 30, 2025 exclude approximately 140,000 and 142,000 unvested anti-dilutive restricted stock units, respectively.
XML 26 R14.htm IDEA: XBRL DOCUMENT v3.26.1
Divestitures
9 Months Ended
Jun. 30, 2026
Discontinued Operations and Disposal Groups [Abstract]  
Divestitures DIVESTITURES
U.S. Services Segment
In December 2025, we sold our child support business within the United States for approximately $15.0 million. This business had been reporting approximately $25.0 million of annual revenue. We recorded a gain on sale of $10.1 million.
Outside the U.S. Segment
In December 2024, we sold our businesses in Australia and Korea for a nominal sum. The sale agreement includes up to $5.0 million of contingent consideration based upon future performance. As of June 30, 2026, we have not recorded any potential contingent consideration. Our total divestiture-related charges of $39.5 million included approximately $21.3 million of previously unrealized foreign exchange losses, which we had recorded through other comprehensive income. We also provided an indemnification to the buyer that has been recorded at fair value in our consolidated balance sheets. No tax benefit is anticipated from this transaction.
XML 27 R15.htm IDEA: XBRL DOCUMENT v3.26.1
Debt And Derivatives
9 Months Ended
Jun. 30, 2026
Debt Disclosure [Abstract]  
Debt And Derivatives DEBT AND DERIVATIVES
Table 7.1: Details of Debt
June 30, 2026September 30, 2025
(in thousands)
Term Loan A (TLA)$819,375 $853,125 
Term Loan B (TLB)814,173 493,750 
Revolver20,000 — 
Total debt principal1,653,548 1,346,875 
Less: Unamortized debt-issuance costs and discounts(16,613)(12,602)
Total debt1,636,935 1,334,273 
Less: Current portion of long-term debt(71,599)(52,680)
Long-term debt$1,565,336 $1,281,593 
On May 27, 2026, we amended our existing credit agreement (the "Amendment") with J.P. Morgan Chase Bank, N.A. The Amendment increased our TLB by $325 million.
Our credit agreements require us to comply with a number of covenants, including leverage and interest coverage ratios. At June 30, 2026, we are in compliance with all covenants. We do not believe that the covenants represent a significant restriction on our ability to successfully operate the business or to pay dividends.
The following table sets forth future minimum principal payments due under our debt obligations as of June 30, 2026 for the remainder of fiscal year 2026 through fiscal year 2031:
Table 7.2: Details of Future Minimum Principal Payments Due
Amount Due
(in thousands)
July 1, 2026 through September 30, 2026$18,952 
Year ended September 30, 202775,809 
Year ended September 30, 202881,434 
Year ended September 30, 2029690,184 
Year ended September 30, 20308,309 
Years ended thereafter778,860 
Total payments$1,653,548 
Interest Rate Derivative Instruments
Both our TLA and TLB interest payments are comprised of an applicable margin rate and a floating rate, the latter being based on SOFR. We utilize interest rate swaps that are designed to reduce our risk from changes in floating rates, which we have designated as cash flow hedges. Effective June 1, 2026, we entered into new interest rate swap agreements to reduce interest rate risks in both our TLA and TLB. The following table presents our active interest rate swaps:
Table 7.3: Interest Rate Derivative Instruments
As of June 30, 2026
Debt Principal HedgedNotional AmountFixed Interest RateExpiry
(in thousands)
Term Loan B$75,000 3.72 %September 2026
Term Loan B$75,000 3.62 %September 2027
Term Loan A$150,000 3.14 %September 2027
Term Loan A$200,000 3.47 %September 2028
Term Loan B$75,000 4.04 %September 2028
Term Loan A$50,000 4.05 %May 2029
Term Loan B$50,000 4.06 %September 2029
The fixed interest rate on the table above identifies the payment rate to our counterparties in lieu of the floating rate.
The balance of the debt pays interest based upon the Secured Overnight Financing Rate (SOFR). At June 30, 2026, our effective interest rate, including the original issuance costs and discount rate, was 5.6%.
At June 30, 2026, we recorded an asset of $3.9 million and a liability of $0.8 million to reflect the fair value of our interest rate swap agreements, compared to an asset of $5.5 million and a liability of $1.7 million at September 30, 2025. The assets and liabilities are recorded as "other assets" and "other liabilities," respectively, within our consolidated balance sheets. As these instruments are effective cash flow hedges, gains and losses based upon interest rate fluctuations are recorded within "accumulated other comprehensive loss" on our consolidated financial statements.
Debt And Derivatives DEBT AND DERIVATIVES
Table 7.1: Details of Debt
June 30, 2026September 30, 2025
(in thousands)
Term Loan A (TLA)$819,375 $853,125 
Term Loan B (TLB)814,173 493,750 
Revolver20,000 — 
Total debt principal1,653,548 1,346,875 
Less: Unamortized debt-issuance costs and discounts(16,613)(12,602)
Total debt1,636,935 1,334,273 
Less: Current portion of long-term debt(71,599)(52,680)
Long-term debt$1,565,336 $1,281,593 
On May 27, 2026, we amended our existing credit agreement (the "Amendment") with J.P. Morgan Chase Bank, N.A. The Amendment increased our TLB by $325 million.
Our credit agreements require us to comply with a number of covenants, including leverage and interest coverage ratios. At June 30, 2026, we are in compliance with all covenants. We do not believe that the covenants represent a significant restriction on our ability to successfully operate the business or to pay dividends.
The following table sets forth future minimum principal payments due under our debt obligations as of June 30, 2026 for the remainder of fiscal year 2026 through fiscal year 2031:
Table 7.2: Details of Future Minimum Principal Payments Due
Amount Due
(in thousands)
July 1, 2026 through September 30, 2026$18,952 
Year ended September 30, 202775,809 
Year ended September 30, 202881,434 
Year ended September 30, 2029690,184 
Year ended September 30, 20308,309 
Years ended thereafter778,860 
Total payments$1,653,548 
Interest Rate Derivative Instruments
Both our TLA and TLB interest payments are comprised of an applicable margin rate and a floating rate, the latter being based on SOFR. We utilize interest rate swaps that are designed to reduce our risk from changes in floating rates, which we have designated as cash flow hedges. Effective June 1, 2026, we entered into new interest rate swap agreements to reduce interest rate risks in both our TLA and TLB. The following table presents our active interest rate swaps:
Table 7.3: Interest Rate Derivative Instruments
As of June 30, 2026
Debt Principal HedgedNotional AmountFixed Interest RateExpiry
(in thousands)
Term Loan B$75,000 3.72 %September 2026
Term Loan B$75,000 3.62 %September 2027
Term Loan A$150,000 3.14 %September 2027
Term Loan A$200,000 3.47 %September 2028
Term Loan B$75,000 4.04 %September 2028
Term Loan A$50,000 4.05 %May 2029
Term Loan B$50,000 4.06 %September 2029
The fixed interest rate on the table above identifies the payment rate to our counterparties in lieu of the floating rate.
The balance of the debt pays interest based upon the Secured Overnight Financing Rate (SOFR). At June 30, 2026, our effective interest rate, including the original issuance costs and discount rate, was 5.6%.
At June 30, 2026, we recorded an asset of $3.9 million and a liability of $0.8 million to reflect the fair value of our interest rate swap agreements, compared to an asset of $5.5 million and a liability of $1.7 million at September 30, 2025. The assets and liabilities are recorded as "other assets" and "other liabilities," respectively, within our consolidated balance sheets. As these instruments are effective cash flow hedges, gains and losses based upon interest rate fluctuations are recorded within "accumulated other comprehensive loss" on our consolidated financial statements.
XML 28 R16.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value Measurements
9 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Fair Value Measurements FAIR VALUE MEASUREMENTS
We record the following assets and liabilities at fair value on a recurring basis.
•We hold mutual fund assets within a Rabbi Trust to cover liabilities in our deferred compensation plan. These assets have prices quoted within active markets and, accordingly, are classified as level 1 within the fair value hierarchy.
•We have interest rate swap agreements that are designed to manage our interest rate exposure. These agreements can be valued using observable data and, accordingly, are classified as level 2 within the fair value hierarchy.
•In connection with the businesses sold in Australia and Korea, we indemnified the buyer related to certain potential losses, which are recorded at fair value, based on an assessment of probability-weighted outcomes. Accordingly, these inputs are not observable and are classified as level 3 within the fair value hierarchy. Changes in the fair value of the indemnification liability are recorded in the consolidated statements of operations.
The table below presents assets and liabilities measured and recorded at fair value in our consolidated balance sheets on a recurring basis, along with their corresponding level within the fair value hierarchy. No transfers between Level 1, Level 2, and Level 3 fair value measurements occurred for the nine months ended June 30, 2026.
Table 8.1: Fair Value Measurements
As of June 30, 2026
Level 1Level 2Level 3Balance
(in thousands)
Assets:
Deferred compensation assets - Rabbi Trust$46,375 $— $— $46,375 
Interest rate swap - $450 million notional value
— 3,898 — 3,898 
Total assets$46,375 $3,898 $— $50,273 
Liabilities:
Interest rate swap - $225 million notional value
$— $829 $— $829 
Indemnification liabilities— — 8,767 8,767 
Total liabilities$— $829 $8,767 $9,596 
The fair values of receivables, prepaid assets, other assets, accounts payable, accrued costs, and other current liabilities approximate the carrying values as a result of the short-term nature of these instruments. The carrying value of our debt is consistent with the fair value, as the stated interest rates in the agreements are consistent with the current market rates used in notes with similar terms in the markets (Level 2 inputs).
Accumulated Other Comprehensive Loss
All amounts recorded in accumulated other comprehensive loss are related to our foreign currency translations and interest rate swaps, net of tax. The following table shows changes in accumulated other comprehensive loss. Amounts reclassified from other comprehensive income were recorded within our selling, general, and administrative expenses (for foreign currency translation adjustments) and within interest expense (for gains on derivatives).
Table 8.2: Details of Changes in Accumulated Other Comprehensive Loss by Category
Foreign currency translation adjustmentsNet unrealized gain on derivatives, net of taxTotal
(in thousands)
Balance as of September 30, 2025$(20,706)$2,839 $(17,867)
Other comprehensive income before reclassifications(2,276)3,223 947 
Amounts reclassified from accumulated other comprehensive loss— (3,801)(3,801)
Net current period other comprehensive income/(loss)(2,276)(578)(2,854)
Balance as of June 30, 2026$(22,982)$2,261 $(20,721)
Indemnification Liability
The fair value of our indemnification liability is recorded at fair value as of the disposal date, based on an assessment of probability-weighted outcomes. This liability is reviewed on a quarterly basis. Changes in estimates are recorded to selling and general administrative expenses and foreign currency translation adjustments are recorded in other income/expenses on our Consolidated Statement of Operations.
Movement in our indemnification liability balance is as follows:
Table 8.3: Fair Value Measurement Using Significant Unobservable Inputs (Level 3)
Indemnification Liability
(in thousands)
Opening indemnification liability as of September 30, 2025$11,342 
Cash payments(2,264)
Foreign currency translation adjustments(311)
Closing indemnification liability as of June 30, 2026$8,767 
XML 29 R17.htm IDEA: XBRL DOCUMENT v3.26.1
Equity
9 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Equity EQUITY
Stock Compensation
We grant restricted stock units (RSUs) and performance stock units (PSUs) to eligible participants under our 2021 Omnibus Incentive Plan, which was approved by our Board of Directors and stockholders. The RSUs granted to employees vest ratably over three to four years, with a small number that cliff vest after three years. The RSUs granted to directors cliff vest one year from the grant date. PSU vesting is subject to the achievement of certain performance and market conditions, and the number of PSUs earned could vary from 0% to 200% of the number of PSUs awarded. The PSUs will vest at the end of a three-year performance period if the performance conditions are met. We issue new shares to satisfy our obligations under these plans. The fair value of each RSU and PSU is calculated at the date of the grant.
During the nine months ended June 30, 2026, we issued approximately 341,000 RSUs, which will vest ratably over one to four years, and approximately 146,000 PSUs, which will vest after three years if the performance conditions are met.
Stock Repurchase Programs
In May 2026, our Board of Directors authorized an increase to our existing stock repurchase program that allows us to repurchase, at management's discretion, up to $400 million of our common stock; this resolution superseded a similar resolution authorized in September 2025.
During the nine months ended June 30, 2026, we purchased approximately 2.6 million common shares at a cost of $192.4 million, which includes an additional charge from the 1% excise tax on share repurchases. During the nine months ended June 30, 2025, we repurchased approximately 4.1 million common shares at a cost of $309.5 million under a similar program.
At June 30, 2026, approximately $400.0 million remained available for future stock repurchases.
XML 30 R18.htm IDEA: XBRL DOCUMENT v3.26.1
Other Items
9 Months Ended
Jun. 30, 2026
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]  
Other Items OTHER ITEMS
Cash, Cash Equivalents, and Restricted Cash
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
June 30, 2026September 30, 2025
(in thousands)
Cash and cash equivalents$56,953 $222,351 
Restricted cash96,296 38,108 
Cash, cash equivalents, and restricted cash$153,249 $260,459 
Restricted cash is recorded within "Prepaid expenses and other current assets" on the Consolidated Balance Sheets.
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Nine Months Ended
June 30, 2026June 30, 2025
(in thousands)
Interest payments$64,526 $60,809 
Income tax payments$81,479 $100,891 
Accounts Receivable, Net
Table 10.3: Details of Accounts Receivable, Net
June 30, 2026September 30, 2025
(in thousands)
Billed and billable receivables$1,055,494 $720,495 
Unbilled receivables335,329 187,372 
Allowance for credit losses(8,809)(9,772)
Accounts receivable, net$1,382,014 $898,095 
We have a Receivables Purchase Agreement (RPA) with Wells Fargo Bank N.A., under which we may sell certain U.S.-originated accounts receivable balances up to a maximum amount of $350.0 million at any given time. In return for these sales, we receive a cash payment equal to the face value of the receivables less a financing charge.
We account for these transfers as sales. We have no retained interest in the transferred receivables other than administrative responsibilities, and Wells Fargo has no recourse for any credit risk. We estimate that the implicit servicing fees for an arrangement of this size and type would be immaterial.
For the nine months ended June 30, 2026 and 2025, the value of accounts receivables transferred to Wells Fargo and derecognized from our balance sheet was $1.28 billion and $574.2 million, respectively. In exchange for these sales, we received cash of $1.27 billion and $570.7 million for the same periods, respectively. The difference, representing a loss on sale from these transfers, is included within our selling, general, and administrative expenses. We have recorded these transactions within our operating cash flows.
XML 31 R19.htm IDEA: XBRL DOCUMENT v3.26.1
Commitments And Contingencies
9 Months Ended
Jun. 30, 2026
Commitments and Contingencies Disclosure [Abstract]  
Commitments And Contingencies COMMITMENTS AND CONTINGENCIES
Litigation
We are subject to audits, investigations, and reviews relating to compliance with the laws and regulations that govern our role as a contractor to agencies and departments of federal, state, local, and foreign governments. Adverse findings could lead to criminal, civil, or administrative proceedings, and we could be faced with penalties, fines, suspension, or debarment. Adverse findings could also have a material adverse effect on us because of our reliance on government contracts. We are subject to periodic audits by federal, state, local, and foreign governments for taxes. We are also involved in various claims, arbitrations, and lawsuits arising in the normal conduct of our business, which include, but are not limited to, bid protests, employment matters, contractual disputes, and charges before administrative agencies. Except for the matters described below for which we cannot predict the outcome, we do not believe the outcome of any existing matter would likely have a material adverse effect on our consolidated financial position, results of operations, or cash flows.
We evaluate developments in our litigation matters and establish or make adjustments to our accruals as appropriate. A liability is accrued if a loss is probable and the amount of such loss can be reasonably estimated. If the risk of loss is probable, but the amount cannot be reasonably estimated, or the risk of loss is only reasonably possible, a potential liability will be disclosed but not accrued, if material. Due to the inherent uncertainty in the outcome of litigation, our estimates and assessments may prove to be incomplete or inaccurate and could be impacted by unanticipated events and circumstances, adverse outcomes, or other future determinations.
MOVEit Cybersecurity Incident Litigation
As previously disclosed, on May 31, 2023, Progress Software Corporation, the developer of MOVEit, a file transfer application used by many organizations to transfer data, announced a critical zero-day vulnerability in the application that allowed unauthorized third parties to access its customers’ MOVEit environments. Maximus uses MOVEit for internal and external file sharing purposes, including to share data with government customers related to Maximus' services in support of certain government programs. Based on our review of the impacted files to date, we have provided notices to individuals whose personal information, including Social Security numbers, protected health information, and/or other personal information, may have been included in the impacted files.
On August 1, 2023, a purported class action was filed against Maximus Federal Services, Inc. (a wholly-owned subsidiary of Maximus, Inc.) in the U.S. District Court for the Eastern District of Virginia arising out of the MOVEit cybersecurity incident – Bishop v. Maximus Federal Services, Case No. 1:23-cv-01019 (U.S. Dist. Ct. E. D. VA). The plaintiff, who
purports to represent a nationwide class of individuals, alleges, among other things, that our negligence resulted in the compromise of the plaintiff’s personally identifiable information and protected health information. The plaintiff seeks damages to be proved at trial. Since then, thirteen similar cases have been filed in federal courts across the country (inclusive of one case filed in state court and removed to federal court by us).
On October 4, 2023, the United States Judicial Panel on Multidistrict Litigation granted a Motion to Transfer creating a Multidistrict Litigation (MDL) in the District of Massachusetts for all cases related to the MOVEit cybersecurity incident. Each of the actions pending in federal courts are centralized in the MDL.
On December 12, 2024, the Court granted in part Defendants' omnibus motion to dismiss Plaintiffs’ claims pursuant to Rule 12(b)(1), challenging Plaintiffs’ standing to bring this suit, dismissing claims brought by four of the Plaintiffs in the MOVEit MDL. None of the dismissed claims were asserted against us.
The Court has also named us as a bellwether defendant in the MDL. We and the other bellwether defendants submitted motions to dismiss the pending actions pursuant to Rule 12(b)(6), which the Court granted in part and denied in part on July 31, 2025. Approximately half of the claims asserted against us remain, and we are proceeding to discovery regarding those claims.
Separately, there is currently an individual action pending against us in Florida state court. On September 6, 2023, an individual action related to the MOVEit incident was filed in state court in the Florida Circuit Court for the 7th Judicial Circuit, Volusia County: Taylor v. Maximus Federal Services, Case No. 2023-12349 (Fla. Cir. Ct., 7th Jud. Cir., Volusia Cnty.). The plaintiff alleges, among other things, that our negligence resulted in the compromise of the plaintiff’s personally identifiable information and protected health information. The plaintiff seeks damages to be proved at trial. On April 3, 2024, the Court stayed this action pending further developments in the MOVEit MDL. This case remains stayed.
While we are unable to predict the ultimate outcome of any of the remaining proceedings, we have accrued an amount within a range of possible outcomes expected to be incurred to resolve the matters.
XML 32 R20.htm IDEA: XBRL DOCUMENT v3.26.1
Subsequent Event
9 Months Ended
Jun. 30, 2026
Subsequent Events [Abstract]  
Subsequent Event SUBSEQUENT EVENT
On July 6, 2026, our Board of Directors declared a quarterly cash dividend of $0.33 for each share of our common stock outstanding. The dividend is payable on August 31, 2026, to shareholders of record on August 14, 2026. Based upon the number of shares outstanding, we anticipate a cash payment of approximately $17.3 million.
XML 33 R21.htm IDEA: XBRL DOCUMENT v3.26.1
Insider Trading Arrangements
3 Months Ended
Jun. 30, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
XML 34 R22.htm IDEA: XBRL DOCUMENT v3.26.1
Significant Accounting Policies (Policies)
9 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Basis of Presentation
Basis of Presentation
The accompanying consolidated financial statements, including the notes, include our accounts and those of our subsidiaries and have been prepared in accordance with accounting principles generally accepted in the United States, or U.S. GAAP, and the rules and regulations of the Securities and Exchange Commission (SEC). All intercompany balances and transactions have been eliminated in consolidation.
Use of Estimates
Use of Estimates
The preparation of these financial statements, in conformity with U.S. GAAP, requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent liabilities, and the reported amounts of revenue and expenses. At each reporting period end, we make estimates, including those related to revenue recognition and cost estimation on certain contracts, the realizability of long-lived assets, and amounts related to income taxes, certain accrued liabilities, and contingencies and litigation.
At June 30, 2026, our capitalized software balance includes $32.3 million related to technology for new services within our U.S. Services Segment. During the second quarter of fiscal year 2026, we recorded an impairment charge of $6.9 million to an asset following a client decision that resulted in its carrying value no longer being recoverable. At this time, we believe that the remaining balance of these assets is recoverable. We continue to monitor these assets, and if circumstances change, we may be required to further adjust the value or useful life of the remaining assets.
XML 35 R23.htm IDEA: XBRL DOCUMENT v3.26.1
Business Segments (Tables)
9 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Results of Operations by Business Segment
Table 3.1: Results of Operations by Business Segment for the Three Months Ended
For the Three Months Ended June 30, 2026
(dollars in thousands)U.S. Federal Services% (1 )U.S. Services% (1 )Outside the U.S.% (1 )Total
Revenue$720,991 $418,227 $139,753 $1,278,971 
Cost of revenue498,720 69.2 %311,449 74.5 %119,999 85.9 %930,168 
Gross profit222,271 30.8 %106,778 25.5 %19,754 14.1 %348,803 
Other segment items (2)88,231 12.2 %61,589 14.7 %18,548 13.3 %168,368 
Segment operating income$134,040 18.6 %$45,189 10.8 %$1,206 0.9 %180,435 
Divestiture-related gains/(charges) (3)1,162 
Other (4)18 
Amortization of intangible assets(20,187)
Operating income$161,428 
Depreciation and amortization$7,223 1.0 %$3,997 1.0 %$654 0.5 %$11,874 
For the Three Months Ended June 30, 2025
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$761,174 $439,818 $147,408 $1,348,400 
Cost of revenue535,040 70.3 %333,886 75.9 %119,961 81.4 %988,887 
Gross profit226,134 29.7 %105,932 24.1 %27,447 18.6 %359,513 
Other segment items (2)88,272 11.6 %60,975 13.9 %21,507 14.6 %170,754 
Segment operating income$137,862 18.1 %$44,957 10.2 %$5,940 4.0 %188,759 
Other (4)(77)
Amortization of intangible assets(23,010)
Operating income$165,672 
Depreciation and amortization$3,125 0.4 %$4,631 1.1 %$1,851 1.3 %$9,607 
Table 3.2: Results of Operations by Business Segment for the Nine Months Ended
For the Nine Months Ended June 30, 2026
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$2,260,735 $1,249,229 $420,020 $3,929,984 
Cost of revenue1,598,084 70.7 %957,548 76.7 %364,615 86.8 %2,920,247 
Gross profit662,651 29.3 %291,681 23.3 %55,405 13.2 %1,009,737 
Other segment items (2)266,174 11.8 %178,616 14.3 %58,664 14.0 %503,454 
Segment operating income/(loss)$396,477 17.5 %$113,065 9.1 %$(3,259)(0.8)%506,283 
Divestiture-related gains/(charges) (3)10,147 
Other (4)480 
Amortization of intangible assets(60,785)
Operating income$456,125 
Depreciation and amortization$21,637 1.0 %$12,381 1.0 %$3,073 0.7 %$37,091 
For the Nine Months Ended June 30, 2025
(dollars in thousands)U.S. Federal Services% (1)U.S. Services% (1)Outside the U.S.% (1)Total
Revenue$2,319,756 $1,334,418 $458,687 $4,112,861 
Cost of revenue1,718,249 74.1 %1,021,712 76.6 %373,009 81.3 %3,112,970 
Gross profit601,507 25.9 %312,706 23.4 %85,678 18.7 %999,891 
Other segment items (2)245,563 10.6 %173,096 13.0 %66,822 14.6 %485,481 
Segment operating income$355,944 15.3 %$139,610 10.5 %$18,856 4.1 %514,410 
Divestiture-related gains/(charges) (3)(39,343)
Other (4)(599)
Amortization of intangible assets(69,041)
Operating income$405,427 
Depreciation and amortization$9,653 0.4 %$12,603 0.9 %$5,246 1.1 %$27,502 
(1)Percentage of respective revenue, as applicable.
(2)Other segment items are principally selling, general, and administrative expenses allocated to segments.
(3)During fiscal years 2026 and 2025, we divested businesses from our U.S. Services and Outside the U.S. Segments, respectively. See "Note 6. Divestitures" for additional information.
(4)Other expenses include credits and costs that are not allocated to a particular segment.
XML 36 R24.htm IDEA: XBRL DOCUMENT v3.26.1
Revenue Recognition (Tables)
9 Months Ended
Jun. 30, 2026
Revenue from Contract with Customer [Abstract]  
Schedule of Disaggregation of Revenue
Table 4.1: Revenue by Service Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands)
Program Operations$602,807 47.1 %$626,981 46.5 %$1,924,106 49.0 %$2,045,720 49.7 %
Clinical Services553,075 43.2 %560,360 41.6 %1,607,602 40.9 %1,535,849 37.3 %
Employment & Other55,852 4.4 %81,906 6.1 %186,025 4.7 %274,513 6.7 %
Technology Solutions67,237 5.3 %79,153 5.9 %212,251 5.4 %256,779 6.2 %
Total revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Table 4.2: Revenue by Contract Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands)
Performance-based$755,826 59.1 %$761,428 56.5 %$2,209,585 56.2 %$2,193,605 53.3 %
Cost-plus303,486 23.7 %301,385 22.4 %1,033,798 26.3 %1,020,311 24.8 %
Fixed price155,200 12.1 %180,390 13.4 %489,327 12.5 %540,078 13.1 %
Time and materials64,459 5.0 %105,197 7.8 %197,274 5.0 %358,867 8.7 %
Total revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Table 4.3: Revenue by Customer Type
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(dollars in thousands)
New York state government agencies$148,067 11.6 %$148,408 11.0 %$445,548 11.3 %$466,053 11.3 %
Other U.S. state government agencies275,793 21.6 %291,312 21.6 %817,052 20.8 %869,561 21.1 %
Total U.S. state government agencies423,860 439,720 1,262,600 1,335,614 
U.S. federal government agencies701,932 54.9 %743,058 55.1 %2,204,623 56.1 %2,267,078 55.1 %
International government agencies137,462 10.7 %146,018 10.8 %413,321 10.5 %451,608 11.0 %
Other, including local municipalities and commercial customers15,717 1.2 %19,604 1.5 %49,440 1.3 %58,561 1.4 %
Total revenue$1,278,971 $1,348,400 $3,929,984 $4,112,861 
Table 4.4: Effect of Changes in Contract Estimates
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands, except per share data)
Increase/(decrease) in revenue recognized due to changes in contract estimates$(1,291)$607 $5,628 $11,181 
Increase/(decrease) in diluted earnings per share recognized due to changes in contract estimates$(0.02)$0.01 $0.08 $0.14 
XML 37 R25.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share (Tables)
9 Months Ended
Jun. 30, 2026
Earnings Per Share [Abstract]  
Schedule of Weighted Average Number of Shares used to Compute Earnings Per Share
Table 5: Weighted Average Number of Shares - Earnings Per Share
For the Three Months EndedFor the Nine Months Ended
June 30, 2026June 30, 2025June 30, 2026June 30, 2025
(in thousands)
Basic weighted average shares outstanding52,854 56,683 53,974 57,776 
Dilutive effect of unvested RSUs and PSUs203 301 269 324 
Denominator for diluted earnings per share53,057 56,984 54,243 58,100 
XML 38 R26.htm IDEA: XBRL DOCUMENT v3.26.1
Debt And Derivatives (Tables)
9 Months Ended
Jun. 30, 2026
Debt Disclosure [Abstract]  
Schedule of Debt
Table 7.1: Details of Debt
June 30, 2026September 30, 2025
(in thousands)
Term Loan A (TLA)$819,375 $853,125 
Term Loan B (TLB)814,173 493,750 
Revolver20,000 — 
Total debt principal1,653,548 1,346,875 
Less: Unamortized debt-issuance costs and discounts(16,613)(12,602)
Total debt1,636,935 1,334,273 
Less: Current portion of long-term debt(71,599)(52,680)
Long-term debt$1,565,336 $1,281,593 
Schedule of Future Minimum Principal Payments Due
The following table sets forth future minimum principal payments due under our debt obligations as of June 30, 2026 for the remainder of fiscal year 2026 through fiscal year 2031:
Table 7.2: Details of Future Minimum Principal Payments Due
Amount Due
(in thousands)
July 1, 2026 through September 30, 2026$18,952 
Year ended September 30, 202775,809 
Year ended September 30, 202881,434 
Year ended September 30, 2029690,184 
Year ended September 30, 20308,309 
Years ended thereafter778,860 
Total payments$1,653,548 
Schedule of Interest Rate Derivative Instruments The following table presents our active interest rate swaps:
Table 7.3: Interest Rate Derivative Instruments
As of June 30, 2026
Debt Principal HedgedNotional AmountFixed Interest RateExpiry
(in thousands)
Term Loan B$75,000 3.72 %September 2026
Term Loan B$75,000 3.62 %September 2027
Term Loan A$150,000 3.14 %September 2027
Term Loan A$200,000 3.47 %September 2028
Term Loan B$75,000 4.04 %September 2028
Term Loan A$50,000 4.05 %May 2029
Term Loan B$50,000 4.06 %September 2029
XML 39 R27.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value Measurements (Tables)
9 Months Ended
Jun. 30, 2026
Fair Value Disclosures [Abstract]  
Schedule of Fair Value of Assets and Liabilities
The table below presents assets and liabilities measured and recorded at fair value in our consolidated balance sheets on a recurring basis, along with their corresponding level within the fair value hierarchy. No transfers between Level 1, Level 2, and Level 3 fair value measurements occurred for the nine months ended June 30, 2026.
Table 8.1: Fair Value Measurements
As of June 30, 2026
Level 1Level 2Level 3Balance
(in thousands)
Assets:
Deferred compensation assets - Rabbi Trust$46,375 $— $— $46,375 
Interest rate swap - $450 million notional value
— 3,898 — 3,898 
Total assets$46,375 $3,898 $— $50,273 
Liabilities:
Interest rate swap - $225 million notional value
$— $829 $— $829 
Indemnification liabilities— — 8,767 8,767 
Total liabilities$— $829 $8,767 $9,596 
Schedule of Accumulated Other Comprehensive Loss The following table shows changes in accumulated other comprehensive loss. Amounts reclassified from other comprehensive income were recorded within our selling, general, and administrative expenses (for foreign currency translation adjustments) and within interest expense (for gains on derivatives).
Table 8.2: Details of Changes in Accumulated Other Comprehensive Loss by Category
Foreign currency translation adjustmentsNet unrealized gain on derivatives, net of taxTotal
(in thousands)
Balance as of September 30, 2025$(20,706)$2,839 $(17,867)
Other comprehensive income before reclassifications(2,276)3,223 947 
Amounts reclassified from accumulated other comprehensive loss— (3,801)(3,801)
Net current period other comprehensive income/(loss)(2,276)(578)(2,854)
Balance as of June 30, 2026$(22,982)$2,261 $(20,721)
Schedule of Fair Value Measurement using Significant Unobservable Inputs (Level 3)
Movement in our indemnification liability balance is as follows:
Table 8.3: Fair Value Measurement Using Significant Unobservable Inputs (Level 3)
Indemnification Liability
(in thousands)
Opening indemnification liability as of September 30, 2025$11,342 
Cash payments(2,264)
Foreign currency translation adjustments(311)
Closing indemnification liability as of June 30, 2026$8,767 
XML 40 R28.htm IDEA: XBRL DOCUMENT v3.26.1
Other Items (Tables)
9 Months Ended
Jun. 30, 2026
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]  
Schedule of Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
June 30, 2026September 30, 2025
(in thousands)
Cash and cash equivalents$56,953 $222,351 
Restricted cash96,296 38,108 
Cash, cash equivalents, and restricted cash$153,249 $260,459 
Schedule of Restricted Cash and Cash Equivalents
Table 10.1: Details of Cash and Cash Equivalents and Restricted Cash
June 30, 2026September 30, 2025
(in thousands)
Cash and cash equivalents$56,953 $222,351 
Restricted cash96,296 38,108 
Cash, cash equivalents, and restricted cash$153,249 $260,459 
Schedule of Supplementary Cash Flow Information
Table 10.2: Supplemental Disclosures of Cash Flow Information
For the Nine Months Ended
June 30, 2026June 30, 2025
(in thousands)
Interest payments$64,526 $60,809 
Income tax payments$81,479 $100,891 
Schedule of Accounts Receivable, Net
Table 10.3: Details of Accounts Receivable, Net
June 30, 2026September 30, 2025
(in thousands)
Billed and billable receivables$1,055,494 $720,495 
Unbilled receivables335,329 187,372 
Allowance for credit losses(8,809)(9,772)
Accounts receivable, net$1,382,014 $898,095 
XML 41 R29.htm IDEA: XBRL DOCUMENT v3.26.1
Organization - Narrative (Details)
Jun. 30, 2026
citizen
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Number of citizens impacted by service improvements (more than) 100,000,000
XML 42 R30.htm IDEA: XBRL DOCUMENT v3.26.1
Significant Accounting Policies (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Mar. 31, 2026
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
Property, Plant, and Equipment [Line Items]        
Capitalized software, net   $ 201,373   $ 214,260
Impairment charge   6,914 $ 0  
U.S. Services        
Property, Plant, and Equipment [Line Items]        
Capitalized software, net   $ 32,300    
Technology Equipment        
Property, Plant, and Equipment [Line Items]        
Impairment charge $ 6,900      
XML 43 R31.htm IDEA: XBRL DOCUMENT v3.26.1
Business Segments - Narrative (Details)
9 Months Ended
Jun. 30, 2026
segment
Segment Reporting [Abstract]  
Number of operating segments 3
Number of reportable segments not disclosed business segments
XML 44 R32.htm IDEA: XBRL DOCUMENT v3.26.1
Business Segments - Schedule of Results of Operations by Business Segment (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Financial information for each of the Company's business segments        
Revenue $ 1,278,971 $ 1,348,400 $ 3,929,984 $ 4,112,861
Cost of revenue 930,168 988,887 2,920,247 3,112,970
Gross profit 348,803 359,513 1,009,737 999,891
Other segment items 168,368 170,754 503,454 485,481
Segment operating income/(loss) 180,435 188,759 506,283 514,410
Divestiture-related gains/(charges)     10,147 (39,343)
Amortization of intangible assets (20,187) (23,010) (60,785) (69,041)
Operating income 161,428 165,672 456,125 405,427
Depreciation and amortization 11,874 9,607 37,091 27,502
Operating Segments | U.S. Federal Services        
Financial information for each of the Company's business segments        
Revenue 720,991 761,174 2,260,735 2,319,756
Cost of revenue $ 498,720 $ 535,040 $ 1,598,084 $ 1,718,249
Cost of revenue (as a percent) 69.20% 70.30% 70.70% 74.10%
Gross profit $ 222,271 $ 226,134 $ 662,651 $ 601,507
Gross profit (as a percent) 30.80% 29.70% 29.30% 25.90%
Other segment items $ 88,231 $ 88,272 $ 266,174 $ 245,563
Other segment items (as a percent) 12.20% 11.60% 11.80% 10.60%
Segment operating income/(loss) $ 134,040 $ 137,862 $ 396,477 $ 355,944
Segment operating income/(loss) (as a percent) 18.60% 18.10% 17.50% 15.30%
Depreciation and amortization $ 7,223 $ 3,125 $ 21,637 $ 9,653
Depreciation and amortization (as a percent) 1.00% 0.40% 1.00% 0.40%
Operating Segments | U.S. Services        
Financial information for each of the Company's business segments        
Revenue $ 418,227 $ 439,818 $ 1,249,229 $ 1,334,418
Cost of revenue $ 311,449 $ 333,886 $ 957,548 $ 1,021,712
Cost of revenue (as a percent) 74.50% 75.90% 76.70% 76.60%
Gross profit $ 106,778 $ 105,932 $ 291,681 $ 312,706
Gross profit (as a percent) 25.50% 24.10% 23.30% 23.40%
Other segment items $ 61,589 $ 60,975 $ 178,616 $ 173,096
Other segment items (as a percent) 14.70% 13.90% 14.30% 13.00%
Segment operating income/(loss) $ 45,189 $ 44,957 $ 113,065 $ 139,610
Segment operating income/(loss) (as a percent) 10.80% 10.20% 9.10% 10.50%
Depreciation and amortization $ 3,997 $ 4,631 $ 12,381 $ 12,603
Depreciation and amortization (as a percent) 1.00% 1.10% 1.00% 0.90%
Operating Segments | Outside the U.S.        
Financial information for each of the Company's business segments        
Revenue $ 139,753 $ 147,408 $ 420,020 $ 458,687
Cost of revenue $ 119,999 $ 119,961 $ 364,615 $ 373,009
Cost of revenue (as a percent) 85.90% 81.40% 86.80% 81.30%
Gross profit $ 19,754 $ 27,447 $ 55,405 $ 85,678
Gross profit (as a percent) 14.10% 18.60% 13.20% 18.70%
Other segment items $ 18,548 $ 21,507 $ 58,664 $ 66,822
Other segment items (as a percent) 13.30% 14.60% 14.00% 14.60%
Segment operating income/(loss) $ 1,206 $ 5,940 $ (3,259) $ 18,856
Segment operating income/(loss) (as a percent) 0.90% 4.00% (0.80%) 4.10%
Depreciation and amortization $ 654 $ 1,851 $ 3,073 $ 5,246
Depreciation and amortization (as a percent) 0.50% 1.30% 0.70% 1.10%
Segment Reconciling Items        
Financial information for each of the Company's business segments        
Divestiture-related gains/(charges) $ 1,162   $ 10,147 $ (39,343)
Other 18 $ (77) 480 (599)
Amortization of intangible assets $ (20,187) $ (23,010) $ (60,785) $ (69,041)
XML 45 R33.htm IDEA: XBRL DOCUMENT v3.26.1
Revenue Recognition - Schedule of Disaggregation of Revenue (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue [Line Items]        
Total revenue $ 1,278,971 $ 1,348,400 $ 3,929,984 $ 4,112,861
New York state government agencies        
Disaggregation of Revenue [Line Items]        
Total revenue $ 148,067 $ 148,408 $ 445,548 $ 466,053
New York state government agencies | Revenue Benchmark | Customer Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 11.60% 11.00% 11.30% 11.30%
Other U.S. state government agencies        
Disaggregation of Revenue [Line Items]        
Total revenue $ 275,793 $ 291,312 $ 817,052 $ 869,561
Other U.S. state government agencies | Revenue Benchmark | Customer Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 21.60% 21.60% 20.80% 21.10%
Total U.S. state government agencies        
Disaggregation of Revenue [Line Items]        
Total revenue $ 423,860 $ 439,720 $ 1,262,600 $ 1,335,614
U.S. federal government agencies        
Disaggregation of Revenue [Line Items]        
Total revenue $ 701,932 $ 743,058 $ 2,204,623 $ 2,267,078
U.S. federal government agencies | Revenue Benchmark | Customer Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 54.90% 55.10% 56.10% 55.10%
International government agencies        
Disaggregation of Revenue [Line Items]        
Total revenue $ 137,462 $ 146,018 $ 413,321 $ 451,608
International government agencies | Revenue Benchmark | Customer Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 10.70% 10.80% 10.50% 11.00%
Other, including local municipalities and commercial customers        
Disaggregation of Revenue [Line Items]        
Total revenue $ 15,717 $ 19,604 $ 49,440 $ 58,561
Other, including local municipalities and commercial customers | Revenue Benchmark | Customer Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 1.20% 1.50% 1.30% 1.40%
Performance-based        
Disaggregation of Revenue [Line Items]        
Total revenue $ 755,826 $ 761,428 $ 2,209,585 $ 2,193,605
Performance-based | Revenue Benchmark | Contract Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 59.10% 56.50% 56.20% 53.30%
Cost-plus        
Disaggregation of Revenue [Line Items]        
Total revenue $ 303,486 $ 301,385 $ 1,033,798 $ 1,020,311
Cost-plus | Revenue Benchmark | Contract Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 23.70% 22.40% 26.30% 24.80%
Fixed price        
Disaggregation of Revenue [Line Items]        
Total revenue $ 155,200 $ 180,390 $ 489,327 $ 540,078
Fixed price | Revenue Benchmark | Contract Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 12.10% 13.40% 12.50% 13.10%
Time and materials        
Disaggregation of Revenue [Line Items]        
Total revenue $ 64,459 $ 105,197 $ 197,274 $ 358,867
Time and materials | Revenue Benchmark | Contract Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 5.00% 7.80% 5.00% 8.70%
Program Operations        
Disaggregation of Revenue [Line Items]        
Total revenue $ 602,807 $ 626,981 $ 1,924,106 $ 2,045,720
Program Operations | Revenue Benchmark | Contract Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 47.10% 46.50% 49.00% 49.70%
Clinical Services        
Disaggregation of Revenue [Line Items]        
Total revenue $ 553,075 $ 560,360 $ 1,607,602 $ 1,535,849
Clinical Services | Revenue Benchmark | Contract Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 43.20% 41.60% 40.90% 37.30%
Employment & Other        
Disaggregation of Revenue [Line Items]        
Total revenue $ 55,852 $ 81,906 $ 186,025 $ 274,513
Employment & Other | Revenue Benchmark | Contract Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 4.40% 6.10% 4.70% 6.70%
Technology Solutions        
Disaggregation of Revenue [Line Items]        
Total revenue $ 67,237 $ 79,153 $ 212,251 $ 256,779
Technology Solutions | Revenue Benchmark | Contract Concentration Risk        
Disaggregation of Revenue [Line Items]        
Total revenue (as a percent) 5.30% 5.90% 5.40% 6.20%
XML 46 R34.htm IDEA: XBRL DOCUMENT v3.26.1
Revenue Recognition - Narrative (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Sep. 30, 2025
Disaggregation of Revenue [Line Items]          
Deferred revenue, recognized $ 2.0 $ 13.8 $ 45.2 $ 87.0  
Revenue, remaining performance obligation, amount $ 230.0   $ 230.0    
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2026-07-01          
Disaggregation of Revenue [Line Items]          
Revenue, remaining performance obligation, percentage (as a percent) 57.00%   57.00%    
Revenue, remaining performance obligation, expected timing of satisfaction, period 12 months   12 months    
Unbilled receivables          
Disaggregation of Revenue [Line Items]          
Unbilled contracts receivable $ 27.4   $ 27.4   $ 24.1
XML 47 R35.htm IDEA: XBRL DOCUMENT v3.26.1
Revenue Recognition - Schedule of Effect of Changes in Contract Estimates (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Disaggregation of Revenue [Line Items]        
Increase/(decrease) in revenue recognized due to changes in contract estimates $ 1,278,971 $ 1,348,400 $ 3,929,984 $ 4,112,861
Increase in diluted earnings per share recognized due to changes in contract estimates (in dollars per share) $ 1.95 $ 1.86 $ 5.45 $ 4.20
Change in Contract Estimates        
Disaggregation of Revenue [Line Items]        
Increase/(decrease) in revenue recognized due to changes in contract estimates $ (1,291) $ 607 $ 5,628 $ 11,181
Increase in diluted earnings per share recognized due to changes in contract estimates (in dollars per share) $ (0.02) $ 0.01 $ 0.08 $ 0.14
XML 48 R36.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share - Schedule of Weighted Average Number of Shares (Details) - shares
shares in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Earnings Per Share [Abstract]        
Basic weighted average shares outstanding (in shares) 52,854 56,683 53,974 57,776
Dilutive effect of unvested RSUs and PSUs (in shares) 203 301 269 324
Denominator for diluted earnings per share (in shares) 53,057 56,984 54,243 58,100
XML 49 R37.htm IDEA: XBRL DOCUMENT v3.26.1
Earnings Per Share - Narrative (Details) - shares
shares in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Earnings Per Share [Abstract]        
Antidilutive securities excluded from computation of earnings per share (in shares) 571 140 567 142
XML 50 R38.htm IDEA: XBRL DOCUMENT v3.26.1
Divestitures (Details) - Disposal Group, Disposed of by Sale, Not Discontinued Operations - USD ($)
$ in Millions
1 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Child Support Business in the United States    
Disposal Group, Including Discontinued Operations [Line Items]    
Disposal group, including discontinued operation, consideration $ 15.0  
Annual revenue 25.0  
Gain on sale of business $ 10.1  
Businesses in Australia and Korea    
Disposal Group, Including Discontinued Operations [Line Items]    
Contingent consideration   $ 5.0
Divestiture related charges   39.5
Foreign currency exchange loss   $ 21.3
XML 51 R39.htm IDEA: XBRL DOCUMENT v3.26.1
Debt And Derivatives - Schedule of Debt (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Sep. 30, 2025
Debt Instrument [Line Items]    
Debt principal $ 1,653,548  
Total debt principal 1,653,548 $ 1,346,875
Less: Unamortized debt-issuance costs and discounts (16,613) (12,602)
Total debt 1,636,935 1,334,273
Less: Current portion of long-term debt (71,599) (52,680)
Long-term debt 1,565,336 1,281,593
Term Loan | Term Loan A (TLA)    
Debt Instrument [Line Items]    
Debt principal 819,375 853,125
Term Loan | Term Loan B (TLB)    
Debt Instrument [Line Items]    
Debt principal 814,173 493,750
Revolver | Revolver    
Debt Instrument [Line Items]    
Debt principal $ 20,000 $ 0
XML 52 R40.htm IDEA: XBRL DOCUMENT v3.26.1
Debt And Derivatives - Narrative (Details) - USD ($)
$ in Millions
May 27, 2026
Jun. 30, 2026
Sep. 30, 2025
Debt Instrument [Line Items]      
Annual effective interest rate (as a percent)   5.60%  
Balance Sheet Location [Axis]: us-gaap:OtherAssetsNoncurrent      
Debt Instrument [Line Items]      
Fair value of derivative asset   $ 3.9 $ 5.5
Balance Sheet Location [Axis]: us-gaap:OtherLiabilitiesNoncurrent      
Debt Instrument [Line Items]      
Fair value of derivative liability   $ 0.8 $ 1.7
Secured Debt | Term Loan B (TLB)      
Debt Instrument [Line Items]      
Increase in borrowing capacity $ 325.0    
XML 53 R41.htm IDEA: XBRL DOCUMENT v3.26.1
Debt And Derivatives - Schedule of Future Minimum Principal Payments Due (Details)
$ in Thousands
Jun. 30, 2026
USD ($)
Debt Disclosure [Abstract]  
July 1, 2026 through September 30, 2026 $ 18,952
Year ended September 30, 2027 75,809
Year ended September 30, 2028 81,434
Year ended September 30, 2029 690,184
Year ended September 30, 2030 8,309
Years ended thereafter 778,860
Total payments $ 1,653,548
XML 54 R42.htm IDEA: XBRL DOCUMENT v3.26.1
Debt And Derivatives - Schedule of Interest Rate Derivative Instruments (Details) - Interest Rate Swap - Term Loan
$ in Thousands
Jun. 30, 2026
USD ($)
Term Loan B  
Debt Instrument [Line Items]  
Notional Amount $ 75,000
Fixed Interest Rate 3.72%
Term Loan B  
Debt Instrument [Line Items]  
Notional Amount $ 75,000
Fixed Interest Rate 3.62%
Term Loan A  
Debt Instrument [Line Items]  
Notional Amount $ 150,000
Fixed Interest Rate 3.14%
Term Loan A  
Debt Instrument [Line Items]  
Notional Amount $ 200,000
Fixed Interest Rate 3.47%
Term Loan B  
Debt Instrument [Line Items]  
Notional Amount $ 75,000
Fixed Interest Rate 4.04%
Term Loan A  
Debt Instrument [Line Items]  
Notional Amount $ 50,000
Fixed Interest Rate 4.05%
Term Loan B  
Debt Instrument [Line Items]  
Notional Amount $ 50,000
Fixed Interest Rate 4.06%
XML 55 R43.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities (Details)
$ in Thousands
Jun. 30, 2026
USD ($)
Financial information for each of the Company's business segments  
Total assets $ 50,273
Total liabilities 9,596
Indemnification liabilities 8,767
Interest Rate Swap  
Financial information for each of the Company's business segments  
Total assets 3,898
Notional value, asset 450,000
Total liabilities 829
Notional value, liability 225,000
Deferred compensation assets - Rabbi Trust  
Financial information for each of the Company's business segments  
Total assets 46,375
Level 1  
Financial information for each of the Company's business segments  
Total assets 46,375
Total liabilities 0
Indemnification liabilities 0
Level 1 | Interest Rate Swap  
Financial information for each of the Company's business segments  
Total assets 0
Total liabilities 0
Level 1 | Deferred compensation assets - Rabbi Trust  
Financial information for each of the Company's business segments  
Total assets 46,375
Level 2  
Financial information for each of the Company's business segments  
Total assets 3,898
Total liabilities 829
Indemnification liabilities 0
Level 2 | Interest Rate Swap  
Financial information for each of the Company's business segments  
Total assets 3,898
Total liabilities 829
Level 2 | Deferred compensation assets - Rabbi Trust  
Financial information for each of the Company's business segments  
Total assets 0
Level 3  
Financial information for each of the Company's business segments  
Total assets 0
Total liabilities 8,767
Indemnification liabilities 8,767
Level 3 | Interest Rate Swap  
Financial information for each of the Company's business segments  
Total assets 0
Total liabilities 0
Level 3 | Deferred compensation assets - Rabbi Trust  
Financial information for each of the Company's business segments  
Total assets $ 0
XML 56 R44.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value Measurements - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Increase (Decrease) in Shareholders' Equity        
Beginning balance $ 1,696,961 $ 1,667,474 $ 1,674,035 $ 1,842,815
Other comprehensive income before reclassifications     947  
Amounts reclassified from accumulated other comprehensive loss     (3,801)  
Other comprehensive (loss)/income 334 5,746 (2,854) 19,831
Ending balance 1,740,551 1,773,036 1,740,551 1,773,036
Foreign currency translation adjustments        
Increase (Decrease) in Shareholders' Equity        
Beginning balance     (20,706)  
Other comprehensive income before reclassifications     (2,276)  
Amounts reclassified from accumulated other comprehensive loss     0  
Other comprehensive (loss)/income     (2,276)  
Ending balance (22,982)   (22,982)  
Net unrealized gain on derivatives, net of tax        
Increase (Decrease) in Shareholders' Equity        
Beginning balance     2,839  
Other comprehensive income before reclassifications     3,223  
Amounts reclassified from accumulated other comprehensive loss     (3,801)  
Other comprehensive (loss)/income     (578)  
Ending balance 2,261   2,261  
Total        
Increase (Decrease) in Shareholders' Equity        
Beginning balance (21,055) (18,375) (17,867) (32,460)
Ending balance $ (20,721) $ (12,629) $ (20,721) $ (12,629)
XML 57 R45.htm IDEA: XBRL DOCUMENT v3.26.1
Fair Value Measurements - Schedule of Fair Value Measurement using Significant Unobservable Inputs (Level 3) (Details)
$ in Thousands
9 Months Ended
Jun. 30, 2026
USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]  
Beginning balance $ 11,342
Cash payments (2,264)
Foreign currency translation adjustments $ (311)
Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration] Foreign currency translation adjustments
Ending balance $ 8,767
XML 58 R46.htm IDEA: XBRL DOCUMENT v3.26.1
Equity (Details) - USD ($)
shares in Thousands, $ in Millions
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
May 31, 2026
Stock-based compensation      
Stock repurchase programs, authorized amount     $ 400.0
Common shares repurchased (in shares) 2,600 4,100  
Common shares repurchased, value $ 192.4 $ 309.5  
Excise tax (as a percent) 1.00%    
Amount remaining available for future stock repurchases $ 400.0    
Restricted Stock Units (RSUs)      
Stock-based compensation      
Shares issued (in shares) 341    
Restricted Stock Units (RSUs) | Employee      
Stock-based compensation      
Vesting period 3 years    
Restricted Stock Units (RSUs) | Member of Board of Directors      
Stock-based compensation      
Vesting period 1 year    
Restricted Stock Units (RSUs) | Minimum      
Stock-based compensation      
Vesting period 1 year    
Restricted Stock Units (RSUs) | Minimum | Employee      
Stock-based compensation      
Vesting period 3 years    
Restricted Stock Units (RSUs) | Maximum      
Stock-based compensation      
Vesting period 4 years    
Restricted Stock Units (RSUs) | Maximum | Employee      
Stock-based compensation      
Vesting period 4 years    
Performance Shares      
Stock-based compensation      
Vesting period 3 years    
Shares issued (in shares) 146    
Performance Shares | Minimum      
Stock-based compensation      
Vesting rights (as a percent) 0.00%    
Performance Shares | Maximum      
Stock-based compensation      
Vesting rights (as a percent) 200.00%    
XML 59 R47.htm IDEA: XBRL DOCUMENT v3.26.1
Other Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Sep. 30, 2025
Jun. 30, 2025
Sep. 30, 2024
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]        
Cash and cash equivalents $ 56,953 $ 222,351    
Restricted cash 96,296 38,108    
Cash, cash equivalents, and restricted cash $ 153,249 $ 260,459 $ 105,376 $ 235,763
XML 60 R48.htm IDEA: XBRL DOCUMENT v3.26.1
Other Items - Schedule of Supplemental Cash Flow Information (Details) - USD ($)
$ in Thousands
9 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]    
Interest payments $ 64,526 $ 60,809
Income tax payments $ 81,479 $ 100,891
XML 61 R49.htm IDEA: XBRL DOCUMENT v3.26.1
Other Items - Schedule of Accounts Receivable, Net (Details) - USD ($)
$ in Thousands
Jun. 30, 2026
Sep. 30, 2025
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Allowance for credit losses $ (8,809) $ (9,772)
Accounts receivable, net 1,382,014 898,095
Billed and billable receivables    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Accounts receivable, gross 1,055,494 720,495
Unbilled receivables    
Accounts, Notes, Loans and Financing Receivable [Line Items]    
Accounts receivable, gross $ 335,329 $ 187,372
XML 62 R50.htm IDEA: XBRL DOCUMENT v3.26.1
Other Items - Narrative (Details) - USD ($)
$ in Millions
Jun. 30, 2026
Jun. 30, 2025
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]    
Receivables purchase agreement, maximum sales amount $ 350.0  
Transfer of financial assets, accounted for as sales 1,280.0 $ 574.2
Cash received from transfer of financial assets $ 1,270.0 $ 570.7
XML 63 R51.htm IDEA: XBRL DOCUMENT v3.26.1
Subsequent Event (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Jul. 06, 2026
Jun. 30, 2026
Mar. 31, 2026
Dec. 31, 2025
Jun. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Subsequent Event [Line Items]              
Payments of dividends   $ 17,278 $ 17,821 $ 16,338 $ 16,904 $ 16,901 $ 18,060
Subsequent Event              
Subsequent Event [Line Items]              
Cash dividend declared (in dollars per share) $ 0.33            
Payments of dividends $ 17,300            
XML 64 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ .report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } .report table.authRefData a { display: block; font-weight: bold; } .report table.authRefData p { margin-top: 0px; } .report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } .report table.authRefData .hide a:hover { background-color: #2F4497; } .report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } .report table.authRefData table{ font-size: 1em; } /* Report Styles */ .pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ .report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } .report hr { border: 1px solid #acf; } /* Top labels */ .report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } .report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } .report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } .report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } .report td.pl div.a { width: 200px; } .report td.pl a:hover { background-color: #ffc; } /* Header rows... */ .report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ .report .rc { background-color: #f0f0f0; } /* Even rows... */ .report .re, .report .reu { background-color: #def; } .report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ .report .ro, .report .rou { background-color: white; } .report .rou td { border-bottom: 1px solid black; } .report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ .report .fn { white-space: nowrap; } /* styles for numeric types */ .report .num, .report .nump { text-align: right; white-space: nowrap; } .report .nump { padding-left: 2em; } .report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ .report .text { text-align: left; white-space: normal; } .report .text .big { margin-bottom: 1em; width: 17em; } .report .text .more { display: none; } .report .text .note { font-style: italic; font-weight: bold; } .report .text .small { width: 10em; } .report sup { font-style: italic; } .report .outerFootnotes { font-size: 1em; } XML 65 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 67 FilingSummary.xml IDEA: XBRL DOCUMENT 3.26.1 html 244 229 1 false 60 0 false 6 false false R1.htm 0000001 - Document - Cover Page Sheet http://www.maximus.com/role/CoverPage Cover Page Cover 1 false false R2.htm 9952151 - Statement - Consolidated Statements of Operations Sheet http://www.maximus.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 2 false false R3.htm 9952152 - Statement - Consolidated Statements of Comprehensive Income Sheet http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome Consolidated Statements of Comprehensive Income Statements 3 false false R4.htm 9952153 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical) Sheet http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical Consolidated Statements of Comprehensive Income (Parenthetical) Statements 4 false false R5.htm 9952154 - Statement - Consolidated Balance Sheets Sheet http://www.maximus.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 5 false false R6.htm 9952155 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.maximus.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 6 false false R7.htm 9952156 - Statement - Consolidated Statements of Cash Flows Sheet http://www.maximus.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 7 false false R8.htm 9952157 - Statement - Consolidated Statements of Changes in Shareholders' Equity Sheet http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity Consolidated Statements of Changes in Shareholders' Equity Statements 8 false false R9.htm 9952158 - Disclosure - Organization Sheet http://www.maximus.com/role/Organization Organization Notes 9 false false R10.htm 9952159 - Disclosure - Significant Accounting Policies Sheet http://www.maximus.com/role/SignificantAccountingPolicies Significant Accounting Policies Notes 10 false false R11.htm 9952160 - Disclosure - Business Segments Sheet http://www.maximus.com/role/BusinessSegments Business Segments Notes 11 false false R12.htm 9952161 - Disclosure - Revenue Recognition Sheet http://www.maximus.com/role/RevenueRecognition Revenue Recognition Notes 12 false false R13.htm 9952162 - Disclosure - Earnings Per Share Sheet http://www.maximus.com/role/EarningsPerShare Earnings Per Share Notes 13 false false R14.htm 9952163 - Disclosure - Divestitures Sheet http://www.maximus.com/role/Divestitures Divestitures Notes 14 false false R15.htm 9952164 - Disclosure - Debt And Derivatives Sheet http://www.maximus.com/role/DebtAndDerivatives Debt And Derivatives Notes 15 false false R16.htm 9952165 - Disclosure - Fair Value Measurements Sheet http://www.maximus.com/role/FairValueMeasurements Fair Value Measurements Notes 16 false false R17.htm 9952166 - Disclosure - Equity Sheet http://www.maximus.com/role/Equity Equity Notes 17 false false R18.htm 9952167 - Disclosure - Other Items Sheet http://www.maximus.com/role/OtherItems Other Items Notes 18 false false R19.htm 9952168 - Disclosure - Commitments And Contingencies Sheet http://www.maximus.com/role/CommitmentsAndContingencies Commitments And Contingencies Notes 19 false false R20.htm 9952169 - Disclosure - Subsequent Event Sheet http://www.maximus.com/role/SubsequentEvent Subsequent Event Notes 20 false false R21.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 21 false false R22.htm 9955511 - Disclosure - Significant Accounting Policies (Policies) Sheet http://www.maximus.com/role/SignificantAccountingPoliciesPolicies Significant Accounting Policies (Policies) Policies http://www.maximus.com/role/SignificantAccountingPolicies 22 false false R23.htm 9955512 - Disclosure - Business Segments (Tables) Sheet http://www.maximus.com/role/BusinessSegmentsTables Business Segments (Tables) Tables http://www.maximus.com/role/BusinessSegments 23 false false R24.htm 9955513 - Disclosure - Revenue Recognition (Tables) Sheet http://www.maximus.com/role/RevenueRecognitionTables Revenue Recognition (Tables) Tables http://www.maximus.com/role/RevenueRecognition 24 false false R25.htm 9955514 - Disclosure - Earnings Per Share (Tables) Sheet http://www.maximus.com/role/EarningsPerShareTables Earnings Per Share (Tables) Tables http://www.maximus.com/role/EarningsPerShare 25 false false R26.htm 9955515 - Disclosure - Debt And Derivatives (Tables) Sheet http://www.maximus.com/role/DebtAndDerivativesTables Debt And Derivatives (Tables) Tables http://www.maximus.com/role/DebtAndDerivatives 26 false false R27.htm 9955516 - Disclosure - Fair Value Measurements (Tables) Sheet http://www.maximus.com/role/FairValueMeasurementsTables Fair Value Measurements (Tables) Tables http://www.maximus.com/role/FairValueMeasurements 27 false false R28.htm 9955517 - Disclosure - Other Items (Tables) Sheet http://www.maximus.com/role/OtherItemsTables Other Items (Tables) Tables http://www.maximus.com/role/OtherItems 28 false false R29.htm 9955518 - Disclosure - Organization - Narrative (Details) Sheet http://www.maximus.com/role/OrganizationNarrativeDetails Organization - Narrative (Details) Details 29 false false R30.htm 9955519 - Disclosure - Significant Accounting Policies (Details) Sheet http://www.maximus.com/role/SignificantAccountingPoliciesDetails Significant Accounting Policies (Details) Details http://www.maximus.com/role/SignificantAccountingPoliciesPolicies 30 false false R31.htm 9955520 - Disclosure - Business Segments - Narrative (Details) Sheet http://www.maximus.com/role/BusinessSegmentsNarrativeDetails Business Segments - Narrative (Details) Details 31 false false R32.htm 9955521 - Disclosure - Business Segments - Schedule of Results of Operations by Business Segment (Details) Sheet http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails Business Segments - Schedule of Results of Operations by Business Segment (Details) Details 32 false false R33.htm 9955522 - Disclosure - Revenue Recognition - Schedule of Disaggregation of Revenue (Details) Sheet http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails Revenue Recognition - Schedule of Disaggregation of Revenue (Details) Details 33 false false R34.htm 9955523 - Disclosure - Revenue Recognition - Narrative (Details) Sheet http://www.maximus.com/role/RevenueRecognitionNarrativeDetails Revenue Recognition - Narrative (Details) Details 34 false false R35.htm 9955524 - Disclosure - Revenue Recognition - Schedule of Effect of Changes in Contract Estimates (Details) Sheet http://www.maximus.com/role/RevenueRecognitionScheduleofEffectofChangesinContractEstimatesDetails Revenue Recognition - Schedule of Effect of Changes in Contract Estimates (Details) Details 35 false false R36.htm 9955525 - Disclosure - Earnings Per Share - Schedule of Weighted Average Number of Shares (Details) Sheet http://www.maximus.com/role/EarningsPerShareScheduleofWeightedAverageNumberofSharesDetails Earnings Per Share - Schedule of Weighted Average Number of Shares (Details) Details 36 false false R37.htm 9955526 - Disclosure - Earnings Per Share - Narrative (Details) Sheet http://www.maximus.com/role/EarningsPerShareNarrativeDetails Earnings Per Share - Narrative (Details) Details 37 false false R38.htm 9955527 - Disclosure - Divestitures (Details) Sheet http://www.maximus.com/role/DivestituresDetails Divestitures (Details) Details http://www.maximus.com/role/Divestitures 38 false false R39.htm 9955528 - Disclosure - Debt And Derivatives - Schedule of Debt (Details) Sheet http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails Debt And Derivatives - Schedule of Debt (Details) Details 39 false false R40.htm 9955529 - Disclosure - Debt And Derivatives - Narrative (Details) Sheet http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails Debt And Derivatives - Narrative (Details) Details 40 false false R41.htm 9955530 - Disclosure - Debt And Derivatives - Schedule of Future Minimum Principal Payments Due (Details) Sheet http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails Debt And Derivatives - Schedule of Future Minimum Principal Payments Due (Details) Details 41 false false R42.htm 9955531 - Disclosure - Debt And Derivatives - Schedule of Interest Rate Derivative Instruments (Details) Sheet http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails Debt And Derivatives - Schedule of Interest Rate Derivative Instruments (Details) Details 42 false false R43.htm 9955532 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities (Details) Sheet http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities (Details) Details 43 false false R44.htm 9955533 - Disclosure - Fair Value Measurements - Schedule of Accumulated Other Comprehensive Loss (Details) Sheet http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails Fair Value Measurements - Schedule of Accumulated Other Comprehensive Loss (Details) Details 44 false false R45.htm 9955534 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement using Significant Unobservable Inputs (Level 3) (Details) Sheet http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueMeasurementusingSignificantUnobservableInputsLevel3Details Fair Value Measurements - Schedule of Fair Value Measurement using Significant Unobservable Inputs (Level 3) (Details) Details 45 false false R46.htm 9955535 - Disclosure - Equity (Details) Sheet http://www.maximus.com/role/EquityDetails Equity (Details) Details http://www.maximus.com/role/Equity 46 false false R47.htm 9955536 - Disclosure - Other Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) Sheet http://www.maximus.com/role/OtherItemsScheduleofCashCashEquivalentsandRestrictedCashDetails Other Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details) Details 47 false false R48.htm 9955537 - Disclosure - Other Items - Schedule of Supplemental Cash Flow Information (Details) Sheet http://www.maximus.com/role/OtherItemsScheduleofSupplementalCashFlowInformationDetails Other Items - Schedule of Supplemental Cash Flow Information (Details) Details 48 false false R49.htm 9955538 - Disclosure - Other Items - Schedule of Accounts Receivable, Net (Details) Sheet http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails Other Items - Schedule of Accounts Receivable, Net (Details) Details 49 false false R50.htm 9955539 - Disclosure - Other Items - Narrative (Details) Sheet http://www.maximus.com/role/OtherItemsNarrativeDetails Other Items - Narrative (Details) Details 50 false false R51.htm 9955540 - Disclosure - Subsequent Event (Details) Sheet http://www.maximus.com/role/SubsequentEventDetails Subsequent Event (Details) Details http://www.maximus.com/role/SubsequentEvent 51 false false All Reports Book All Reports mms-20260630.htm mms-20260630.xsd mms-20260630_cal.xml mms-20260630_def.xml mms-20260630_lab.xml mms-20260630_pre.xml mms-20260630_g1.jpg http://fasb.org/srt/2026 http://fasb.org/us-gaap/2026 http://xbrl.sec.gov/dei/2026 http://xbrl.sec.gov/ecd/2026 true true JSON 70 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "mms-20260630.htm": { "nsprefix": "mms", "nsuri": "http://www.maximus.com/20260630", "dts": { "inline": { "local": [ "mms-20260630.htm" ] }, "schema": { "local": [ "mms-20260630.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/2023/calculation-1.1.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2024-01-31/types.xsd", "https://xbrl.fasb.org/srt/2026/elts/srt-2026.xsd", "https://xbrl.fasb.org/srt/2026/elts/srt-roles-2026.xsd", "https://xbrl.fasb.org/srt/2026/elts/srt-types-2026.xsd", "https://xbrl.fasb.org/us-gaap/2026/elts/us-gaap-2026.xsd", "https://xbrl.fasb.org/us-gaap/2026/elts/us-roles-2026.xsd", "https://xbrl.fasb.org/us-gaap/2026/elts/us-types-2026.xsd", "https://xbrl.sec.gov/country/2026/country-2026.xsd", "https://xbrl.sec.gov/dei/2026/dei-2026.xsd", "https://xbrl.sec.gov/ecd/2026/ecd-2026.xsd", "https://xbrl.sec.gov/stpr/2026/stpr-2026.xsd" ] }, "calculationLink": { "local": [ "mms-20260630_cal.xml" ] }, "definitionLink": { "local": [ "mms-20260630_def.xml" ] }, "labelLink": { "local": [ "mms-20260630_lab.xml" ] }, "presentationLink": { "local": [ "mms-20260630_pre.xml" ] } }, "keyStandard": 213, "keyCustom": 16, "axisStandard": 25, "axisCustom": 0, "memberStandard": 31, "memberCustom": 28, "hidden": { "total": 8, "http://fasb.org/us-gaap/2026": 3, "http://xbrl.sec.gov/dei/2026": 5 }, "contextCount": 244, "entityCount": 1, "segmentCount": 60, "elementCount": 488, "unitCount": 6, "baseTaxonomies": { "http://fasb.org/us-gaap/2026": 784, "http://xbrl.sec.gov/dei/2026": 29, "http://xbrl.sec.gov/ecd/2026": 4, "http://fasb.org/srt/2026": 1 }, "report": { "R1": { "role": "http://www.maximus.com/role/CoverPage", "longName": "0000001 - Document - Cover Page", "shortName": "Cover Page", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R2": { "role": "http://www.maximus.com/role/ConsolidatedStatementsofOperations", "longName": "9952151 - Statement - Consolidated Statements of Operations", "shortName": "Consolidated Statements of Operations", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "2", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:SellingGeneralAndAdministrativeExpense", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R3": { "role": "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome", "longName": "9952152 - Statement - Consolidated Statements of Comprehensive Income", "shortName": "Consolidated Statements of Comprehensive Income", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "3", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:ComprehensiveIncomeNetOfTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R4": { "role": "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical", "longName": "9952153 - Statement - Consolidated Statements of Comprehensive Income (Parenthetical)", "shortName": "Consolidated Statements of Comprehensive Income (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "4", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R5": { "role": "http://www.maximus.com/role/ConsolidatedBalanceSheets", "longName": "9952154 - Statement - Consolidated Balance Sheets", "shortName": "Consolidated Balance Sheets", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "5", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:IncomeTaxReceivable", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R6": { "role": "http://www.maximus.com/role/ConsolidatedBalanceSheetsParenthetical", "longName": "9952155 - Statement - Consolidated Balance Sheets (Parenthetical)", "shortName": "Consolidated Balance Sheets (Parenthetical)", "isDefault": "false", "groupType": "statement", "subGroupType": "parenthetical", "menuCat": "Statements", "order": "6", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:CommonStockSharesAuthorized", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "us-gaap:CommonStockSharesAuthorized", "span", "div", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R7": { "role": "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows", "longName": "9952156 - Statement - Consolidated Statements of Cash Flows", "shortName": "Consolidated Statements of Cash Flows", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "7", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "mms:DepreciationOfFixedAssetsAndAmortizationOfCapitalizedSoftware", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R8": { "role": "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "longName": "9952157 - Statement - Consolidated Statements of Changes in Shareholders' Equity", "shortName": "Consolidated Statements of Changes in Shareholders' Equity", "isDefault": "false", "groupType": "statement", "subGroupType": "", "menuCat": "Statements", "order": "8", "firstAnchor": { "contextRef": "c-35", "name": "us-gaap:CommonStockSharesOutstanding", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-39", "name": "us-gaap:NetIncomeLoss", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R9": { "role": "http://www.maximus.com/role/Organization", "longName": "9952158 - Disclosure - Organization", "shortName": "Organization", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "9", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R10": { "role": "http://www.maximus.com/role/SignificantAccountingPolicies", "longName": "9952159 - Disclosure - Significant Accounting Policies", "shortName": "Significant Accounting Policies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "10", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R11": { "role": "http://www.maximus.com/role/BusinessSegments", "longName": "9952160 - Disclosure - Business Segments", "shortName": "Business Segments", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "11", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SegmentReportingDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R12": { "role": "http://www.maximus.com/role/RevenueRecognition", "longName": "9952161 - Disclosure - Revenue Recognition", "shortName": "Revenue Recognition", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "12", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:RevenueFromContractWithCustomerTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R13": { "role": "http://www.maximus.com/role/EarningsPerShare", "longName": "9952162 - Disclosure - Earnings Per Share", "shortName": "Earnings Per Share", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "13", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:EarningsPerShareTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R14": { "role": "http://www.maximus.com/role/Divestitures", "longName": "9952163 - Disclosure - Divestitures", "shortName": "Divestitures", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "14", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R15": { "role": "http://www.maximus.com/role/DebtAndDerivatives", "longName": "9952164 - Disclosure - Debt And Derivatives", "shortName": "Debt And Derivatives", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "15", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DebtDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "us-gaap:DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R16": { "role": "http://www.maximus.com/role/FairValueMeasurements", "longName": "9952165 - Disclosure - Fair Value Measurements", "shortName": "Fair Value Measurements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "16", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R17": { "role": "http://www.maximus.com/role/Equity", "longName": "9952166 - Disclosure - Equity", "shortName": "Equity", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "17", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R18": { "role": "http://www.maximus.com/role/OtherItems", "longName": "9952167 - Disclosure - Other Items", "shortName": "Other Items", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "18", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R19": { "role": "http://www.maximus.com/role/CommitmentsAndContingencies", "longName": "9952168 - Disclosure - Commitments And Contingencies", "shortName": "Commitments And Contingencies", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "19", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R20": { "role": "http://www.maximus.com/role/SubsequentEvent", "longName": "9952169 - Disclosure - Subsequent Event", "shortName": "Subsequent Event", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "20", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:SubsequentEventsTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R21": { "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "longName": "995445 - Disclosure - Insider Trading Arrangements", "shortName": "Insider Trading Arrangements", "isDefault": "false", "groupType": "disclosure", "subGroupType": "", "menuCat": "Notes", "order": "21", "firstAnchor": { "contextRef": "c-3", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "ecd:Rule10b51ArrAdoptedFlag", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ecd:NonRule10b51ArrAdoptedFlag", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R22": { "role": "http://www.maximus.com/role/SignificantAccountingPoliciesPolicies", "longName": "9955511 - Disclosure - Significant Accounting Policies (Policies)", "shortName": "Significant Accounting Policies (Policies)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "policies", "menuCat": "Policies", "order": "22", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R23": { "role": "http://www.maximus.com/role/BusinessSegmentsTables", "longName": "9955512 - Disclosure - Business Segments (Tables)", "shortName": "Business Segments (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "23", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R24": { "role": "http://www.maximus.com/role/RevenueRecognitionTables", "longName": "9955513 - Disclosure - Revenue Recognition (Tables)", "shortName": "Revenue Recognition (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "24", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R25": { "role": "http://www.maximus.com/role/EarningsPerShareTables", "longName": "9955514 - Disclosure - Earnings Per Share (Tables)", "shortName": "Earnings Per Share (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "25", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R26": { "role": "http://www.maximus.com/role/DebtAndDerivativesTables", "longName": "9955515 - Disclosure - Debt And Derivatives (Tables)", "shortName": "Debt And Derivatives (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "26", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfDebtTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R27": { "role": "http://www.maximus.com/role/FairValueMeasurementsTables", "longName": "9955516 - Disclosure - Fair Value Measurements (Tables)", "shortName": "Fair Value Measurements (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "27", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R28": { "role": "http://www.maximus.com/role/OtherItemsTables", "longName": "9955517 - Disclosure - Other Items (Tables)", "shortName": "Other Items (Tables)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "tables", "menuCat": "Tables", "order": "28", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R29": { "role": "http://www.maximus.com/role/OrganizationNarrativeDetails", "longName": "9955518 - Disclosure - Organization - Narrative (Details)", "shortName": "Organization - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "29", "firstAnchor": { "contextRef": "c-6", "name": "mms:NumberOfCitizensImpactedByServiceImprovements", "unitRef": "citizen", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "mms:NumberOfCitizensImpactedByServiceImprovements", "unitRef": "citizen", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "ix:continuation", "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R30": { "role": "http://www.maximus.com/role/SignificantAccountingPoliciesDetails", "longName": "9955519 - Disclosure - Significant Accounting Policies (Details)", "shortName": "Significant Accounting Policies (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "30", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CapitalizedComputerSoftwareNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-60", "name": "us-gaap:CapitalizedComputerSoftwareNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "us-gaap:UseOfEstimates", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R31": { "role": "http://www.maximus.com/role/BusinessSegmentsNarrativeDetails", "longName": "9955520 - Disclosure - Business Segments - Narrative (Details)", "shortName": "Business Segments - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "31", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:NumberOfOperatingSegments", "unitRef": "segment", "xsiNil": "false", "lang": "en-US", "decimals": "INF", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R32": { "role": "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "longName": "9955521 - Disclosure - Business Segments - Schedule of Results of Operations by Business Segment (Details)", "shortName": "Business Segments - Schedule of Results of Operations by Business Segment (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "32", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:SegmentReportingOtherItemAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "us-gaap:ScheduleOfSegmentReportingInformationBySegmentTextBlock", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R33": { "role": "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails", "longName": "9955522 - Disclosure - Revenue Recognition - Schedule of Disaggregation of Revenue (Details)", "shortName": "Revenue Recognition - Schedule of Disaggregation of Revenue (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "33", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-142", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R34": { "role": "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails", "longName": "9955523 - Disclosure - Revenue Recognition - Narrative (Details)", "shortName": "Revenue Recognition - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "34", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:ContractWithCustomerLiabilityRevenueRecognized", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R35": { "role": "http://www.maximus.com/role/RevenueRecognitionScheduleofEffectofChangesinContractEstimatesDetails", "longName": "9955524 - Disclosure - Revenue Recognition - Schedule of Effect of Changes in Contract Estimates (Details)", "shortName": "Revenue Recognition - Schedule of Effect of Changes in Contract Estimates (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "35", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:DisaggregationOfRevenueTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-188", "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R36": { "role": "http://www.maximus.com/role/EarningsPerShareScheduleofWeightedAverageNumberofSharesDetails", "longName": "9955525 - Disclosure - Earnings Per Share - Schedule of Weighted Average Number of Shares (Details)", "shortName": "Earnings Per Share - Schedule of Weighted Average Number of Shares (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "36", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:WeightedAverageNumberOfSharesOutstandingBasic", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R37": { "role": "http://www.maximus.com/role/EarningsPerShareNarrativeDetails", "longName": "9955526 - Disclosure - Earnings Per Share - Narrative (Details)", "shortName": "Earnings Per Share - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "37", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-3", "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "unitRef": "shares", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R38": { "role": "http://www.maximus.com/role/DivestituresDetails", "longName": "9955527 - Disclosure - Divestitures (Details)", "shortName": "Divestitures (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "38", "firstAnchor": { "contextRef": "c-193", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-193", "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationConsideration", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R39": { "role": "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails", "longName": "9955528 - Disclosure - Debt And Derivatives - Schedule of Debt (Details)", "shortName": "Debt And Derivatives - Schedule of Debt (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "39", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtInstrumentCarryingAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "mms:DebtLongTermAndShortTermCombinedGross", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfDebtTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R40": { "role": "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails", "longName": "9955529 - Disclosure - Debt And Derivatives - Narrative (Details)", "shortName": "Debt And Derivatives - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "40", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:DebtInstrumentInterestRateEffectivePercentage", "unitRef": "number", "xsiNil": "false", "lang": "en-US", "decimals": "3", "ancestors": [ "span", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R41": { "role": "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails", "longName": "9955530 - Disclosure - Debt And Derivatives - Schedule of Future Minimum Principal Payments Due (Details)", "shortName": "Debt And Derivatives - Schedule of Future Minimum Principal Payments Due (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "41", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R42": { "role": "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails", "longName": "9955531 - Disclosure - Debt And Derivatives - Schedule of Interest Rate Derivative Instruments (Details)", "shortName": "Debt And Derivatives - Schedule of Interest Rate Derivative Instruments (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "42", "firstAnchor": { "contextRef": "c-203", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-203", "name": "us-gaap:DerivativeNotionalAmount", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R43": { "role": "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails", "longName": "9955532 - Disclosure - Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities (Details)", "shortName": "Fair Value Measurements - Schedule of Fair Value of Assets and Liabilities (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "43", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AssetsFairValueDisclosure", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueByBalanceSheetGroupingTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R44": { "role": "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails", "longName": "9955533 - Disclosure - Fair Value Measurements - Schedule of Accumulated Other Comprehensive Loss (Details)", "shortName": "Fair Value Measurements - Schedule of Accumulated Other Comprehensive Loss (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "44", "firstAnchor": { "contextRef": "c-28", "name": "us-gaap:StockholdersEquity", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:OciBeforeReclassificationsNetOfTaxAttributableToParent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "ix:continuation", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R45": { "role": "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueMeasurementusingSignificantUnobservableInputsLevel3Details", "longName": "9955534 - Disclosure - Fair Value Measurements - Schedule of Fair Value Measurement using Significant Unobservable Inputs (Level 3) (Details)", "shortName": "Fair Value Measurements - Schedule of Fair Value Measurement using Significant Unobservable Inputs (Level 3) (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "45", "firstAnchor": { "contextRef": "c-7", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-7", "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R46": { "role": "http://www.maximus.com/role/EquityDetails", "longName": "9955535 - Disclosure - Equity (Details)", "shortName": "Equity (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "46", "firstAnchor": { "contextRef": "c-241", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-241", "name": "srt:StockRepurchaseProgramAuthorizedAmount1", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-6", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R47": { "role": "http://www.maximus.com/role/OtherItemsScheduleofCashCashEquivalentsandRestrictedCashDetails", "longName": "9955536 - Disclosure - Other Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)", "shortName": "Other Items - Schedule of Cash, Cash Equivalents and Restricted Cash (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "47", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:RestrictedCashAndCashEquivalents", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "us-gaap:ScheduleOfCashAndCashEquivalentsTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } }, "R48": { "role": "http://www.maximus.com/role/OtherItemsScheduleofSupplementalCashFlowInformationDetails", "longName": "9955537 - Disclosure - Other Items - Schedule of Supplemental Cash Flow Information (Details)", "shortName": "Other Items - Schedule of Supplemental Cash Flow Information (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "48", "firstAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "us-gaap:InterestPaidNet", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R49": { "role": "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails", "longName": "9955538 - Disclosure - Other Items - Schedule of Accounts Receivable, Net (Details)", "shortName": "Other Items - Schedule of Accounts Receivable, Net (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "49", "firstAnchor": { "contextRef": "c-6", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "us-gaap:ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R50": { "role": "http://www.maximus.com/role/OtherItemsNarrativeDetails", "longName": "9955539 - Disclosure - Other Items - Narrative (Details)", "shortName": "Other Items - Narrative (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "50", "firstAnchor": { "contextRef": "c-6", "name": "mms:TransferOfFinancingAssetsMaximumAmountAuthorizedForSale", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-6", "name": "mms:TransferOfFinancingAssetsMaximumAmountAuthorizedForSale", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-5", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true, "unique": true } }, "R51": { "role": "http://www.maximus.com/role/SubsequentEventDetails", "longName": "9955540 - Disclosure - Subsequent Event (Details)", "shortName": "Subsequent Event (Details)", "isDefault": "false", "groupType": "disclosure", "subGroupType": "details", "menuCat": "Details", "order": "51", "firstAnchor": { "contextRef": "c-3", "name": "us-gaap:DividendsCommonStockCash", "unitRef": "usd", "xsiNil": "false", "lang": "en-US", "decimals": "-3", "ancestors": [ "span", "td", "tr", "table", "div", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "first": true }, "uniqueAnchor": { "contextRef": "c-244", "name": "us-gaap:CommonStockDividendsPerShareDeclared", "unitRef": "usdPerShare", "xsiNil": "false", "lang": "en-US", "decimals": "2", "ancestors": [ "span", "div", "ix:continuation", "body", "html" ], "reportCount": 1, "baseRef": "mms-20260630.htm", "unique": true } } }, "tag": { "us-gaap_AccountingPoliciesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountingPoliciesAbstract", "lang": { "en-us": { "role": { "label": "Accounting Policies [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AccountsNotesAndLoansReceivableLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsNotesAndLoansReceivableLineItems", "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "label": "Accounts, Notes, Loans and Financing Receivable [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r252", "r1089", "r1194", "r1195" ] }, "us-gaap_AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsNotesLoansAndFinancingReceivablesByBillingStatusTypeAxis", "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails", "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Billing Status, Type [Axis]", "label": "Billing Status, Type [Axis]", "documentation": "Information by billing status of receivables." } } }, "auth_ref": [ "r1089" ] }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Accounts Payable and Accrued Liabilities, Current", "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r1092" ] }, "us-gaap_AccountsReceivableGrossCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsReceivableGrossCurrent", "crdr": "debit", "calculation": { "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, gross", "label": "Accounts Receivable, before Allowance for Credit Loss, Current", "documentation": "Amount, before allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r111", "r140", "r252", "r863" ] }, "us-gaap_AccountsReceivableNetCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccountsReceivableNetCurrent", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 2.0 }, "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets", "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts receivable, net", "totalLabel": "Accounts receivable, net", "label": "Accounts Receivable, after Allowance for Credit Loss, Current", "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current." } } }, "auth_ref": [ "r1193" ] }, "us-gaap_AccruedIncomeTaxesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccruedIncomeTaxesCurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes payable", "label": "Accrued Income Taxes, Current", "documentation": "Carrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations." } } }, "auth_ref": [ "r1082" ] }, "us-gaap_AccumulatedGainLossNetCashFlowHedgeParentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccumulatedGainLossNetCashFlowHedgeParentMember", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Net unrealized gain on derivatives, net of tax", "label": "Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) from gain (loss) of derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r149", "r156", "r157", "r513", "r583", "r584", "r585", "r586", "r872", "r1102" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated other comprehensive loss", "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax", "documentation": "Amount, after tax, of accumulated increase (decrease) in equity from transaction and other event and circumstance from nonowner source." } } }, "auth_ref": [ "r9", "r10", "r21", "r142", "r412", "r684", "r685", "r696", "r731", "r767", "r768", "r1302" ] }, "us-gaap_AccumulatedOtherComprehensiveIncomeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccumulatedOtherComprehensiveIncomeMember", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Accumulated Other Comprehensive Loss", "verboseLabel": "Total", "label": "AOCI Attributable to Parent [Member]", "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r1", "r7", "r10", "r574", "r578", "r581", "r634", "r763", "r764", "r1102", "r1103", "r1104", "r1166", "r1167", "r1168", "r1170", "r1238", "r1239" ] }, "us-gaap_AccumulatedTranslationAdjustmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AccumulatedTranslationAdjustmentMember", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "label": "Accumulated Foreign Currency Adjustment Attributable to Parent [Member]", "documentation": "Accumulated other comprehensive income (loss) resulting from foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to the parent." } } }, "auth_ref": [ "r2", "r7", "r10", "r19", "r20", "r156", "r157", "r621", "r622", "r623", "r624", "r625", "r1102" ] }, "ecd_Additional402vDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "Additional402vDisclosureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Additional 402(v) Disclosure", "label": "Additional 402(v) Disclosure [Text Block]" } } }, "auth_ref": [ "r1007" ] }, "ecd_AdjToCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AdjToCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation, Amount", "label": "Adjustment to Compensation Amount" } } }, "auth_ref": [ "r1020" ] }, "ecd_AdjToCompAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AdjToCompAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Compensation:", "label": "Adjustment to Compensation [Axis]" } } }, "auth_ref": [ "r1020" ] }, "ecd_AdjToNonPeoNeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AdjToNonPeoNeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote", "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]" } } }, "auth_ref": [ "r1020" ] }, "ecd_AdjToPeoCompFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AdjToPeoCompFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustment To PEO Compensation, Footnote", "label": "Adjustment To PEO Compensation, Footnote [Text Block]" } } }, "auth_ref": [ "r1020" ] }, "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Tax withholding adjustment related to RSU vesting", "label": "Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation", "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r1270" ] }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Stock compensation expense", "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition", "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement." } } }, "auth_ref": [ "r457" ] }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Adjustments to reconcile net income to cash flows from operations:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract]" } } }, "auth_ref": [] }, "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table", "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1053" ] }, "ecd_AggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Amount", "label": "Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r979", "r989", "r999", "r1031" ] }, "ecd_AggtErrCompNotYetDeterminedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AggtErrCompNotYetDeterminedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined", "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]" } } }, "auth_ref": [ "r982", "r992", "r1002", "r1034" ] }, "ecd_AggtPnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AggtPnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Pension Adjustments Service Cost", "label": "Aggregate Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r1054" ] }, "ecd_AllAdjToCompMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AllAdjToCompMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Adjustments to Compensation", "label": "All Adjustments to Compensation [Member]" } } }, "auth_ref": [ "r1020" ] }, "ecd_AllExecutiveCategoriesMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AllExecutiveCategoriesMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Executive Categories", "label": "All Executive Categories [Member]" } } }, "auth_ref": [ "r1027" ] }, "ecd_AllIndividualsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AllIndividualsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "All Individuals", "label": "All Individuals [Member]" } } }, "auth_ref": [ "r983", "r993", "r1003", "r1027", "r1035", "r1039", "r1047" ] }, "ecd_AllTradingArrangementsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AllTradingArrangementsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "All Trading Arrangements", "label": "All Trading Arrangements [Member]" } } }, "auth_ref": [ "r1045" ] }, "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AllowanceForDoubtfulAccountsReceivableCurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails": { "parentTag": "us-gaap_AccountsReceivableNetCurrent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Allowance for credit losses", "label": "Accounts Receivable, Allowance for Credit Loss, Current", "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current." } } }, "auth_ref": [ "r145", "r253", "r287" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "AmendmentFlag", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AmortizationOfFinancingCostsAndDiscounts", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of debt issuance costs and debt discount", "label": "Amortization of Debt Issuance Costs and Discounts", "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r382", "r903", "r904", "r1155", "r1325" ] }, "us-gaap_AmortizationOfIntangibleAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AmortizationOfIntangibleAssets", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 3.0 }, "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows", "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Amortization of intangible assets", "verboseLabel": "Amortization of intangible assets", "negatedTerseLabel": "Amortization of intangible assets", "label": "Intangible Asset, Finite-Lived, Amortization Expense", "documentation": "Amount of amortization expense for finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r5", "r163", "r315", "r316", "r855", "r873", "r874", "r876", "r878", "r1205" ] }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "presentation": [ "http://www.maximus.com/role/EarningsPerShareNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount", "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented." } } }, "auth_ref": [ "r206" ] }, "us-gaap_Assets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Assets", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total assets", "label": "Assets", "documentation": "Amount of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r97", "r103", "r119", "r172", "r175", "r176", "r211", "r222", "r240", "r244", "r284", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r415", "r511", "r515", "r617", "r684", "r685", "r687", "r701", "r702", "r727", "r803", "r888", "r889", "r905", "r950", "r960", "r961", "r970", "r1231", "r1232", "r1328" ] }, "us-gaap_AssetsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Assets:", "label": "Assets [Abstract]" } } }, "auth_ref": [] }, "us-gaap_AssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsCurrent", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current assets", "label": "Assets, Current", "documentation": "Amount of asset recognized for present right to economic benefit, classified as current." } } }, "auth_ref": [ "r97", "r103", "r146", "r172", "r175", "r176", "r284", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r415", "r511", "r515", "r617", "r950", "r1078", "r1231", "r1232", "r1328" ] }, "us-gaap_AssetsFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsFairValueDisclosure", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total assets", "label": "Assets, Fair Value Disclosure", "documentation": "Fair value portion of asset recognized for present right to economic benefit." } } }, "auth_ref": [ "r592", "r593", "r936" ] }, "us-gaap_AssetsHeldInTrustNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AssetsHeldInTrustNoncurrent", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 8.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation plan assets", "label": "Asset, Held-in-Trust, Noncurrent", "documentation": "The amount of cash, securities, or other assets held by a third-party trustee pursuant to the terms of an agreement which assets are available to be used by beneficiaries to that agreement only within the specific terms thereof and which agreement is expected to terminate more than one year from the balance sheet date (or operating cycle, if longer) at which time the assets held-in-trust will be released or forfeited." } } }, "auth_ref": [ "r1158", "r1160", "r1331" ] }, "ecd_AwardExrcPrice": { "xbrltype": "perShareItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardExrcPrice", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Exercise Price", "label": "Award Exercise Price" } } }, "auth_ref": [ "r1042" ] }, "ecd_AwardGrantDateFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardGrantDateFairValue", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value as of Grant Date", "label": "Award Grant Date Fair Value" } } }, "auth_ref": [ "r1043" ] }, "ecd_AwardTmgDiscLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgDiscLineItems", "lang": { "en-us": { "role": { "label": "Award Timing Disclosures [Line Items]" } } }, "auth_ref": [ "r1038" ] }, "ecd_AwardTmgHowMnpiCnsdrdTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgHowMnpiCnsdrdTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing, How MNPI Considered", "label": "Award Timing, How MNPI Considered [Text Block]" } } }, "auth_ref": [ "r1038" ] }, "ecd_AwardTmgMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Method", "label": "Award Timing Method [Text Block]" } } }, "auth_ref": [ "r1038" ] }, "ecd_AwardTmgMnpiCnsdrdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgMnpiCnsdrdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Considered", "label": "Award Timing MNPI Considered [Flag]" } } }, "auth_ref": [ "r1038" ] }, "ecd_AwardTmgMnpiDiscTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgMnpiDiscTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing MNPI Disclosure", "label": "Award Timing MNPI Disclosure [Text Block]" } } }, "auth_ref": [ "r1038" ] }, "ecd_AwardTmgPredtrmndFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardTmgPredtrmndFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Timing Predetermined", "label": "Award Timing Predetermined [Flag]" } } }, "auth_ref": [ "r1038" ] }, "us-gaap_AwardTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "AwardTypeAxis", "presentation": [ "http://www.maximus.com/role/EquityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Award Type [Axis]", "label": "Award Type [Axis]", "documentation": "Information by type of award under share-based payment arrangement." } } }, "auth_ref": [ "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r487" ] }, "ecd_AwardUndrlygSecuritiesAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardUndrlygSecuritiesAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Securities", "label": "Award Underlying Securities Amount" } } }, "auth_ref": [ "r1041" ] }, "ecd_AwardsCloseToMnpiDiscIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardsCloseToMnpiDiscIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Awards Close in Time to MNPI Disclosures, Individual Name" } } }, "auth_ref": [ "r1040" ] }, "ecd_AwardsCloseToMnpiDiscTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardsCloseToMnpiDiscTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures", "label": "Awards Close in Time to MNPI Disclosures [Table]" } } }, "auth_ref": [ "r1039" ] }, "ecd_AwardsCloseToMnpiDiscTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "AwardsCloseToMnpiDiscTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Awards Close in Time to MNPI Disclosures, Table", "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]" } } }, "auth_ref": [ "r1039" ] }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BasisOfAccountingPolicyPolicyTextBlock", "presentation": [ "http://www.maximus.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Basis of Presentation", "label": "Basis of Accounting, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS)." } } }, "auth_ref": [ "r1157" ] }, "us-gaap_BilledRevenuesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "BilledRevenuesMember", "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Billed and billable receivables", "label": "Billed Revenues [Member]", "documentation": "Billed amounts due for services rendered or products shipped. This element is distinct from Billed contracts receivables because this is based on noncontract transactions." } } }, "auth_ref": [ "r1089" ] }, "mms_BusinessesInAustraliaAndKoreaMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "BusinessesInAustraliaAndKoreaMember", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Businesses in Australia and Korea", "label": "Businesses In Australia And Korea [Member]", "documentation": "Businesses In Australia And Korea" } } }, "auth_ref": [] }, "us-gaap_CapitalizedComputerSoftwareNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CapitalizedComputerSoftwareNet", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets", "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized software, net", "label": "Capitalized Cost, Software to be Sold, Leased, or Marketed, after Accumulated Amortization", "documentation": "Amount, after accumulated amortization, of capitalized cost for software to be sold, leased, or marketed. Excludes capitalized cost for internal-use software." } } }, "auth_ref": [ "r853" ] }, "us-gaap_CapitalizedContractCostNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CapitalizedContractCostNet", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred contract costs, net", "label": "Capitalized Contract Cost, Net", "documentation": "Amount, after accumulated amortization and accumulated impairment loss, of asset recognized from cost incurred to obtain or fulfill contract with customer." } } }, "auth_ref": [ "r304" ] }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashAndCashEquivalentsAtCarryingValue", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 1.0 }, "http://www.maximus.com/role/OtherItemsScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets", "http://www.maximus.com/role/OtherItemsScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash and cash equivalents", "label": "Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r116", "r168", "r171", "r862", "r1330" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.maximus.com/role/OtherItemsScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows", "http://www.maximus.com/role/OtherItemsScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "periodStartLabel": "Cash, cash equivalents, and restricted cash, beginning of period", "periodEndLabel": "Cash, cash equivalents, and restricted cash, end of period", "totalLabel": "Cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r29", "r168", "r171" ] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract", "lang": { "en-us": { "role": { "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net change in cash, cash equivalents, and restricted cash", "label": "Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation", "documentation": "Amount of increase (decrease) in cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; including effect from exchange rate change and including, but not limited to, discontinued operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r0", "r29" ] }, "us-gaap_ChangeInAccountingEstimateByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ChangeInAccountingEstimateByTypeAxis", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofEffectofChangesinContractEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of Change in Accounting Estimate, Type [Axis]", "label": "Effect of Change in Accounting Estimate, Type [Axis]", "documentation": "Information by type of effect from change in accounting estimate." } } }, "auth_ref": [ "r14", "r189", "r701", "r703" ] }, "us-gaap_ChangeInAccountingEstimateTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ChangeInAccountingEstimateTypeDomain", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofEffectofChangesinContractEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of Change in Accounting Estimate, Type [Domain]", "label": "Effect of Change in Accounting Estimate, Type [Domain]", "documentation": "Type of effect from change in accounting estimate." } } }, "auth_ref": [ "r14", "r189", "r701", "r703" ] }, "us-gaap_ChangeInAccountingMethodAccountedForAsChangeInEstimateMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ChangeInAccountingMethodAccountedForAsChangeInEstimateMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofEffectofChangesinContractEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Contract Estimates", "label": "Change in Accounting Method Accounted for as Change in Estimate [Member]", "documentation": "A change from one acceptable accounting method to another based upon a revision in estimated future benefits or obligations." } } }, "auth_ref": [ "r1169" ] }, "ecd_ChangedPeerGroupFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ChangedPeerGroupFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Changed Peer Group, Footnote", "label": "Changed Peer Group, Footnote [Text Block]" } } }, "auth_ref": [ "r1018" ] }, "mms_ChildSupportBusinessInTheUnitedStatesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "ChildSupportBusinessInTheUnitedStatesMember", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Child Support Business in the United States", "label": "Child Support Business In The United States [Member]", "documentation": "Child Support Business In The United States" } } }, "auth_ref": [] }, "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year", "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]" } } }, "auth_ref": [ "r1015" ] }, "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested", "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r1013" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "CityAreaCode", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "mms_ClinicalServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "ClinicalServicesMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Clinical Services", "label": "Clinical Services [Member]", "documentation": "Clinical Services" } } }, "auth_ref": [] }, "ecd_CoSelectedMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CoSelectedMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Amount", "label": "Company Selected Measure Amount" } } }, "auth_ref": [ "r1019" ] }, "ecd_CoSelectedMeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CoSelectedMeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Company Selected Measure Name", "label": "Company Selected Measure Name" } } }, "auth_ref": [ "r1019" ] }, "us-gaap_CommitmentsAndContingencies": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommitmentsAndContingencies", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments and contingencies (Note 11)", "label": "Commitments and Contingencies", "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur." } } }, "auth_ref": [ "r134", "r684", "r685", "r692", "r729", "r790" ] }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommitmentsAndContingenciesDisclosureAbstract", "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "presentation": [ "http://www.maximus.com/role/CommitmentsAndContingencies" ], "lang": { "en-us": { "role": { "terseLabel": "Commitments And Contingencies", "label": "Commitments and Contingencies Disclosure [Text Block]", "documentation": "The entire disclosure for commitments and contingencies." } } }, "auth_ref": [ "r341", "r342", "r850", "r1220", "r1225", "r1226" ] }, "us-gaap_CommonStockDividendsPerShareCashPaid": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockDividendsPerShareCashPaid", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends declared per share (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Cash Paid", "documentation": "Aggregate dividends paid during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r1238", "r1239" ] }, "us-gaap_CommonStockDividendsPerShareDeclared": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockDividendsPerShareDeclared", "presentation": [ "http://www.maximus.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash dividend declared (in dollars per share)", "label": "Common Stock, Dividends, Per Share, Declared", "documentation": "Aggregate dividends declared during the period for each share of common stock outstanding." } } }, "auth_ref": [ "r414", "r416" ] }, "us-gaap_CommonStockIncludingAdditionalPaidInCapitalMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockIncludingAdditionalPaidInCapitalMember", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common Stock", "label": "Common Stock Including Additional Paid in Capital [Member]", "documentation": "Common stock held by shareholders with par value plus amounts in excess of par value or issuance value (in cases of no-par value stock)." } } }, "auth_ref": [] }, "us-gaap_CommonStockSharesAuthorized": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockSharesAuthorized", "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares authorized (in shares)", "label": "Common Stock, Shares Authorized", "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws." } } }, "auth_ref": [ "r139", "r411", "r684", "r685", "r695", "r791" ] }, "us-gaap_CommonStockSharesIssued": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockSharesIssued", "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheetsParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares issued (in shares)", "label": "Common Stock, Shares, Issued", "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury." } } }, "auth_ref": [ "r139", "r411", "r684", "r685", "r695" ] }, "us-gaap_CommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockSharesOutstanding", "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheetsParenthetical", "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Common stock, shares outstanding (in shares)", "periodStartLabel": "Beginning balance (in shares)", "periodEndLabel": "Ending balance (in shares)", "label": "Common Stock, Shares, Outstanding", "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation." } } }, "auth_ref": [ "r139", "r411", "r684", "r685", "r695", "r791", "r809", "r1235", "r1385", "r1386" ] }, "us-gaap_CommonStockValueOutstanding": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CommonStockValueOutstanding", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "verboseLabel": "Common stock, no par value; 100,000 shares authorized; 52,358 and 54,805 shares issued and outstanding as of June\u00a030, 2026 and September\u00a030, 2025, respectively", "label": "Common Stock, Value, Outstanding", "documentation": "Value of common shares held by shareholders. Excludes common shares repurchased and held as treasury shares." } } }, "auth_ref": [ "r139", "r411", "r684", "r685", "r695", "r791" ] }, "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Company Selected Measure", "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]" } } }, "auth_ref": [ "r1024" ] }, "ecd_CompActuallyPaidVsNetIncomeTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CompActuallyPaidVsNetIncomeTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Net Income", "label": "Compensation Actually Paid vs. Net Income [Text Block]" } } }, "auth_ref": [ "r1023" ] }, "ecd_CompActuallyPaidVsOtherMeasureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CompActuallyPaidVsOtherMeasureTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Other Measure", "label": "Compensation Actually Paid vs. Other Measure [Text Block]" } } }, "auth_ref": [ "r1025" ] }, "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return", "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]" } } }, "auth_ref": [ "r1022" ] }, "us-gaap_ComprehensiveIncomeNetOfTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ComprehensiveIncomeNetOfTax", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "totalLabel": "Comprehensive income", "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent", "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners." } } }, "auth_ref": [ "r11", "r152", "r154", "r158", "r699", "r739", "r740" ] }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskBenchmarkDomain", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Domain]", "label": "Concentration Risk Benchmark [Domain]", "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "auth_ref": [ "r214", "r250", "r770", "r771", "r849", "r1173", "r1174", "r1175", "r1176", "r1177" ] }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskByBenchmarkAxis", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Benchmark [Axis]", "label": "Concentration Risk Benchmark [Axis]", "documentation": "Information by benchmark of concentration risk." } } }, "auth_ref": [ "r214", "r250", "r770", "r771", "r849", "r1173", "r1174", "r1175", "r1176", "r1177" ] }, "us-gaap_ConcentrationRiskByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskByTypeAxis", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Axis]", "label": "Concentration Risk Type [Axis]", "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender." } } }, "auth_ref": [ "r214", "r250", "r770", "r771", "r849", "r1173", "r1174", "r1175", "r1176", "r1177" ] }, "us-gaap_ConcentrationRiskPercentage1": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskPercentage1", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Total revenue (as a percent)", "label": "Concentration Risk, Percentage", "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division." } } }, "auth_ref": [ "r214", "r250", "r1173", "r1174", "r1175", "r1176", "r1177" ] }, "us-gaap_ConcentrationRiskTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ConcentrationRiskTypeDomain", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Concentration Risk Type [Domain]", "label": "Concentration Risk Type [Domain]", "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "auth_ref": [ "r214", "r250", "r770", "r771", "r849", "r1173", "r1174", "r1175", "r1176", "r1177" ] }, "srt_ConsolidationItemsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ConsolidationItemsAxis", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Axis]", "label": "Consolidation Items [Axis]", "documentation": "Information by components, eliminations, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r50", "r65", "r66", "r67", "r68", "r69", "r70", "r71", "r72", "r73", "r172", "r173", "r177", "r178", "r211", "r224", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r349", "r350", "r351", "r352", "r354", "r355", "r356", "r357", "r358", "r415", "r704", "r888", "r889", "r1068", "r1069", "r1231", "r1232" ] }, "srt_ConsolidationItemsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ConsolidationItemsDomain", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Consolidation Items [Domain]", "label": "Consolidation Items [Domain]", "documentation": "Components, elimination, non-segment corporate-level activity and reconciling items used in consolidating a parent entity and its subsidiaries or its operating segments." } } }, "auth_ref": [ "r50", "r65", "r66", "r67", "r68", "r69", "r70", "r71", "r72", "r73", "r172", "r173", "r177", "r178", "r211", "r224", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r349", "r350", "r351", "r352", "r354", "r355", "r356", "r357", "r358", "r415", "r704", "r888", "r889", "r1068", "r1069", "r1231", "r1232" ] }, "mms_ContractConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "ContractConcentrationRiskMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract Concentration Risk", "label": "Contract Concentration Risk [Member]", "documentation": "Contract Concentration Risk" } } }, "auth_ref": [] }, "us-gaap_ContractWithCustomerBasisOfPricingAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ContractWithCustomerBasisOfPricingAxis", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with Customer, Basis of Pricing [Axis]", "label": "Contract with Customer, Basis of Pricing [Axis]", "documentation": "Information by basis of pricing for contract representing right to consideration in exchange for good or service transferred to customer." } } }, "auth_ref": [ "r906", "r910" ] }, "us-gaap_ContractWithCustomerBasisOfPricingDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ContractWithCustomerBasisOfPricingDomain", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contract with Customer, Basis of Pricing [Domain]", "label": "Contract with Customer, Basis of Pricing [Domain]", "documentation": "Basis of pricing for contract with customer. Includes, but is not limited to, fixed-price and time-and-materials contracts." } } }, "auth_ref": [ "r906", "r910" ] }, "us-gaap_ContractWithCustomerLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ContractWithCustomerLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, current portion", "label": "Contract with Customer, Liability, Current", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current." } } }, "auth_ref": [ "r421", "r422", "r424", "r436", "r865" ] }, "us-gaap_ContractWithCustomerLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ContractWithCustomerLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, non-current portion", "label": "Contract with Customer, Liability, Noncurrent", "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent." } } }, "auth_ref": [ "r421", "r422", "r424", "r436" ] }, "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ContractWithCustomerLiabilityRevenueRecognized", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue, recognized", "label": "Contract with Customer, Liability, Revenue Recognized", "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due." } } }, "auth_ref": [ "r437" ] }, "us-gaap_CostOfRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CostOfRevenue", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue", "label": "Cost of Revenue", "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period." } } }, "auth_ref": [ "r24", "r172", "r175", "r176", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r415", "r617", "r888", "r1075", "r1076", "r1200", "r1231" ] }, "mms_CostPlusContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "CostPlusContractsMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost-plus", "label": "Cost Plus Contracts [Member]", "documentation": "Reflects the percentage that revenues during the period from cost-plus contracts are to total revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "us-gaap_CreditFacilityAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CreditFacilityAxis", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Axis]", "label": "Credit Facility [Axis]", "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r114", "r121", "r348", "r684", "r685", "r688", "r1230" ] }, "us-gaap_CreditFacilityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CreditFacilityDomain", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Credit Facility [Domain]", "label": "Credit Facility [Domain]", "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "auth_ref": [ "r114", "r121", "r348", "r684", "r685", "r688", "r1230" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Current Fiscal Year End Date", "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "us-gaap_CustomerConcentrationRiskMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "CustomerConcentrationRiskMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer Concentration Risk", "label": "Customer Concentration Risk [Member]", "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer." } } }, "auth_ref": [ "r250", "r1174" ] }, "us-gaap_DebtDisclosureAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtDisclosureAbstract", "lang": { "en-us": { "role": { "terseLabel": "Debt Disclosure [Abstract]", "label": "Debt Disclosure [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DebtDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtDisclosureTextBlock", "presentation": [ "http://www.maximus.com/role/DebtAndDerivatives" ], "lang": { "en-us": { "role": { "terseLabel": "Debt And Derivatives", "label": "Debt Disclosure [Text Block]", "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants." } } }, "auth_ref": [ "r33", "r114", "r115", "r121", "r122", "r125", "r127", "r128", "r130", "r131", "r172", "r174", "r333", "r334", "r335", "r336", "r337", "r347", "r348", "r360", "r366", "r367", "r368", "r369", "r370", "r371", "r376", "r383", "r384", "r386", "r572", "r628", "r684", "r685", "r691" ] }, "us-gaap_DebtInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentAxis", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Axis]", "label": "Debt Instrument [Axis]", "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities." } } }, "auth_ref": [ "r114", "r115", "r121", "r125", "r126", "r127", "r128", "r129", "r131", "r361", "r362", "r363", "r364", "r365", "r367", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r405", "r684", "r685", "r691", "r900", "r901", "r902", "r903", "r904", "r949", "r1158", "r1159", "r1161", "r1165", "r1221", "r1222", "r1223", "r1324", "r1326", "r1339" ] }, "us-gaap_DebtInstrumentCarryingAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentCarryingAmount", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt principal", "totalLabel": "Total payments", "label": "Long-Term Debt, Gross", "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt." } } }, "auth_ref": [ "r387", "r1333", "r1334", "r1336" ] }, "us-gaap_DebtInstrumentInterestRateEffectivePercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentInterestRateEffectivePercentage", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual effective interest rate (as a percent)", "label": "Debt Instrument, Interest Rate, Effective Percentage", "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium." } } }, "auth_ref": [ "r389", "r628", "r629", "r949", "r1081", "r1083", "r1333", "r1334", "r1336" ] }, "us-gaap_DebtInstrumentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentLineItems", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument [Line Items]", "label": "Debt Instrument [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r115", "r125", "r126", "r127", "r128", "r129", "r131", "r361", "r362", "r363", "r364", "r365", "r367", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r385", "r405", "r572", "r684", "r685", "r691", "r704", "r900", "r901", "r902", "r903", "r904", "r949", "r1158", "r1159", "r1161", "r1165", "r1324", "r1326" ] }, "us-gaap_DebtInstrumentNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentNameDomain", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Debt Instrument, Name [Domain]", "label": "Debt Instrument, Name [Domain]", "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "auth_ref": [ "r114", "r115", "r121", "r125", "r126", "r127", "r128", "r129", "r131", "r361", "r362", "r363", "r364", "r365", "r367", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r405", "r684", "r685", "r691", "r900", "r901", "r902", "r903", "r904", "r949", "r1158", "r1159", "r1161", "r1165", "r1221", "r1222", "r1223", "r1324", "r1326", "r1339" ] }, "us-gaap_DebtInstrumentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentTable", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Long-term Debt Instruments [Table]", "label": "Schedule of Long-Term Debt Instruments [Table]", "documentation": "Disclosure of information about long-term debt instrument or arrangement." } } }, "auth_ref": [ "r18", "r39", "r40", "r41", "r115", "r125", "r126", "r127", "r128", "r129", "r131", "r361", "r362", "r363", "r364", "r365", "r367", "r372", "r373", "r374", "r375", "r377", "r378", "r379", "r380", "r381", "r382", "r385", "r405", "r572", "r684", "r685", "r691", "r704", "r900", "r901", "r902", "r903", "r904", "r949", "r1158", "r1159", "r1161", "r1165", "r1324", "r1326" ] }, "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet", "crdr": "debit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails": { "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Less: Unamortized debt-issuance costs and discounts", "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net", "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs." } } }, "auth_ref": [ "r372", "r388", "r627", "r628", "r629", "r901", "r902", "r949" ] }, "mms_DebtLongTermAndShortTermCombinedGross": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "DebtLongTermAndShortTermCombinedGross", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails": { "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total debt principal", "label": "Debt, Long-Term and Short-Term, Combined, Gross", "documentation": "Debt, Long-Term and Short-Term, Combined, Gross" } } }, "auth_ref": [] }, "us-gaap_DebtLongtermAndShorttermCombinedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DebtLongtermAndShorttermCombinedAmount", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails": { "parentTag": null, "weight": null, "order": null, "root": true }, "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails_1": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total debt", "label": "Debt, Long-Term and Short-Term, Combined Amount", "documentation": "Represents the aggregate of total long-term debt, including current maturities and short-term debt." } } }, "auth_ref": [] }, "us-gaap_DeferredCompensationLiabilityClassifiedNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredCompensationLiabilityClassifiedNoncurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation plan liabilities, non-current portion", "label": "Deferred Compensation Liability, Classified, Noncurrent", "documentation": "Aggregate carrying value as of the balance sheet date of the liabilities for all deferred compensation arrangements payable beyond one year (or the operating cycle, if longer)." } } }, "auth_ref": [] }, "us-gaap_DeferredIncomeTaxAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredIncomeTaxAssetsNet", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Assets, Net", "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting." } } }, "auth_ref": [ "r493", "r494" ] }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredIncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Expense (Benefit)", "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations." } } }, "auth_ref": [ "r5", "r47", "r1158", "r1164" ] }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DeferredIncomeTaxLiabilitiesNet", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred income taxes", "label": "Deferred Income Tax Liabilities, Net", "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting." } } }, "auth_ref": [ "r135", "r493", "r494", "r684", "r685", "r689", "r728" ] }, "us-gaap_DepreciationAndAmortization": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DepreciationAndAmortization", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization", "label": "Depreciation, Depletion and Amortization, Nonproduction", "documentation": "The current period expense charged against earnings on long-lived, physical assets not used in production, and which are not intended for resale, to allocate or recognize the cost of such assets over their useful lives; or to record the reduction in book value of an intangible asset over the benefit period of such asset; or to reflect consumption during the period of an asset that is not used in production." } } }, "auth_ref": [ "r5", "r1204", "r1209" ] }, "mms_DepreciationOfFixedAssetsAndAmortizationOfCapitalizedSoftware": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "DepreciationOfFixedAssetsAndAmortizationOfCapitalizedSoftware", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization of property, equipment, and capitalized software", "label": "Depreciation Of Fixed Assets And Amortization Of Capitalized Software", "documentation": "The current period expense charged against earnings for depreciation on property, plant and equipment and amortization of capitalized software." } } }, "auth_ref": [] }, "us-gaap_DerivativeAssetNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativeAssetNotionalAmount", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional value, asset", "label": "Derivative Asset, Notional Amount", "documentation": "Nominal or face amount used to calculate payments on the derivative asset." } } }, "auth_ref": [ "r834", "r837", "r839", "r841", "r1275", "r1276" ] }, "us-gaap_DerivativeContractTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativeContractTypeDomain", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails", "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Contract [Domain]", "label": "Derivative Contract [Domain]", "documentation": "Financial instrument or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset." } } }, "auth_ref": [ "r162", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r658", "r780", "r782", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r804", "r805", "r806", "r807", "r815", "r816", "r817", "r818", "r821", "r822", "r823", "r824", "r834", "r836", "r840", "r842", "r869", "r870", "r871", "r931", "r932", "r951", "r963", "r964", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1298", "r1299", "r1300", "r1301", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1315", "r1316" ] }, "us-gaap_DerivativeFixedInterestRate": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativeFixedInterestRate", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed Interest Rate", "label": "Derivative, Fixed Interest Rate", "documentation": "Fixed interest rate related to the interest rate derivative." } } }, "auth_ref": [ "r1297" ] }, "us-gaap_DerivativeInstrumentRiskAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativeInstrumentRiskAxis", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails", "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Derivative Instrument [Axis]", "label": "Derivative Instrument [Axis]", "documentation": "Information by type of derivative contract." } } }, "auth_ref": [ "r162", "r528", "r529", "r530", "r531", "r532", "r533", "r534", "r535", "r536", "r537", "r538", "r539", "r540", "r541", "r542", "r543", "r544", "r545", "r546", "r547", "r548", "r549", "r550", "r551", "r658", "r780", "r782", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r804", "r805", "r806", "r807", "r815", "r816", "r817", "r818", "r821", "r822", "r823", "r824", "r834", "r836", "r840", "r842", "r869", "r870", "r871", "r931", "r932", "r951", "r963", "r964", "r1093", "r1094", "r1095", "r1096", "r1097", "r1098", "r1099", "r1100", "r1101", "r1298", "r1299", "r1300", "r1301", "r1308", "r1309", "r1310", "r1311", "r1312", "r1313", "r1315", "r1316" ] }, "us-gaap_DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativeInstrumentsAndHedgingActivitiesDisclosureTextBlock", "presentation": [ "http://www.maximus.com/role/DebtAndDerivatives" ], "lang": { "en-us": { "role": { "terseLabel": "Debt And Derivatives", "label": "Derivative Instruments and Hedging Activities Disclosure [Text Block]", "documentation": "The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts." } } }, "auth_ref": [ "r400", "r401", "r403", "r517", "r518", "r519", "r520", "r521", "r522", "r523", "r524", "r525", "r526", "r527", "r559", "r560", "r561", "r562", "r563", "r564", "r565", "r566", "r567", "r568", "r569", "r570", "r571", "r576", "r931", "r932", "r933", "r934", "r935" ] }, "us-gaap_DerivativeLiabilityNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativeLiabilityNotionalAmount", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional value, liability", "label": "Derivative Liability, Notional Amount", "documentation": "Nominal or face amount used to calculate payments on the derivative liability." } } }, "auth_ref": [ "r835", "r837", "r838", "r841", "r1275", "r1276" ] }, "us-gaap_DerivativeNotionalAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DerivativeNotionalAmount", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Notional Amount", "label": "Derivative, Notional Amount", "documentation": "Nominal or face amount used to calculate payment on derivative." } } }, "auth_ref": [ "r931", "r1275", "r1276" ] }, "srt_DirectorMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "DirectorMember", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Member of Board of Directors", "label": "Director [Member]", "documentation": "Person serving on board of directors." } } }, "auth_ref": [ "r684", "r685", "r690", "r1070", "r1192", "r1383" ] }, "us-gaap_DisaggregationOfRevenueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisaggregationOfRevenueLineItems", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails", "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails", "http://www.maximus.com/role/RevenueRecognitionScheduleofEffectofChangesinContractEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Line Items]", "label": "Disaggregation of Revenue [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r434", "r435", "r907", "r908", "r909", "r910", "r911", "r912", "r913" ] }, "us-gaap_DisaggregationOfRevenueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisaggregationOfRevenueTable", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails", "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails", "http://www.maximus.com/role/RevenueRecognitionScheduleofEffectofChangesinContractEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disaggregation of Revenue [Table]", "label": "Disaggregation of Revenue [Table]", "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r434", "r435", "r907", "r908", "r909", "r910", "r911", "r912", "r913" ] }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisaggregationOfRevenueTableTextBlock", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Disaggregation of Revenue", "label": "Disaggregation of Revenue [Table Text Block]", "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor." } } }, "auth_ref": [ "r1241" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "presentation": [ "http://www.maximus.com/role/Equity" ], "lang": { "en-us": { "role": { "terseLabel": "Equity", "label": "Share-Based Payment Arrangement [Text Block]", "documentation": "The entire disclosure for share-based payment arrangement." } } }, "auth_ref": [ "r455", "r460", "r488", "r489", "r490", "r922" ] }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupClassificationAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupClassificationAxis", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Axis]", "label": "Disposal Group Classification [Axis]", "documentation": "Information by disposal group classification." } } }, "auth_ref": [ "r83", "r84", "r98", "r99", "r100", "r101", "r102", "r105", "r107", "r322", "r327", "r328", "r329", "r330", "r331", "r860", "r1208", "r1216", "r1217", "r1218", "r1219" ] }, "us-gaap_DisposalGroupClassificationDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupClassificationDomain", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Classification [Domain]", "label": "Disposal Group Classification [Domain]", "documentation": "Component or group of components disposed of, including but not limited to, disposal group held-for-sale or disposed of by sale, disposed of by means other than sale, and discontinued operations." } } }, "auth_ref": [ "r83", "r84", "r98", "r99", "r100", "r101", "r102", "r105", "r107", "r322", "r327", "r328", "r329", "r330", "r331", "r860", "r1208", "r1216", "r1217", "r1218", "r1219" ] }, "us-gaap_DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupDisposedOfBySaleNotDiscontinuedOperationsMember", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group, Disposed of by Sale, Not Discontinued Operations", "label": "Disposal Group, Disposed of by Sale, Not Discontinued Operations [Member]", "documentation": "Disposal group that has been sold. Excludes disposals classified as discontinued operations." } } }, "auth_ref": [ "r1208", "r1212", "r1213", "r1214", "r1215", "r1216", "r1217", "r1218", "r1219" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Disposal group, including discontinued operation, consideration", "label": "Disposal Group, Including Discontinued Operation, Consideration", "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation." } } }, "auth_ref": [ "r1212" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "negatedLabel": "Foreign currency exchange loss", "label": "Disposal Group, Including Discontinued Operation, Foreign Currency Translation Gains (Losses)", "documentation": "Amount of foreign currency translation gain (loss) in the disposal group, including discontinued operation, recognized in the statement of income as a result of the sale or complete or substantially complete liquidation of an investment in a foreign entity." } } }, "auth_ref": [ "r17" ] }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Annual revenue", "label": "Disposal Group, Including Discontinued Operation, Revenue", "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation." } } }, "auth_ref": [ "r857", "r858", "r859", "r861" ] }, "mms_DisposalGroupNotDiscontinuedOperationContingentConsideration": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "DisposalGroupNotDiscontinuedOperationContingentConsideration", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Contingent consideration", "label": "Disposal Group, Not Discontinued Operation, Contingent Consideration", "documentation": "Disposal Group, Not Discontinued Operation, Contingent Consideration" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupNotDiscontinuedOperationGainLossOnDisposal": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupNotDiscontinuedOperationGainLossOnDisposal", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gain on sale of business", "label": "Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal", "documentation": "Amount before tax of gain (loss) recognized on the sale or disposal of a disposal group. Excludes discontinued operations." } } }, "auth_ref": [ "r161", "r329", "r1155", "r1208" ] }, "mms_DisposalGroupNotDiscontinuedOperationSaleRelatedExpenses": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "DisposalGroupNotDiscontinuedOperationSaleRelatedExpenses", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Divestiture related charges", "label": "Disposal Group, Not Discontinued Operation, Sale Related Expenses", "documentation": "Disposal Group, Not Discontinued Operation, Sale Related Expenses" } } }, "auth_ref": [] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "presentation": [ "http://www.maximus.com/role/Divestitures" ], "lang": { "en-us": { "role": { "terseLabel": "Divestitures", "label": "Disposal Groups, Including Discontinued Operations, Disclosure [Text Block]", "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r82", "r87", "r88", "r89", "r321" ] }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DisposalGroupsIncludingDiscontinuedOperationsNameDomain", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Domain]", "label": "Disposal Group Name [Domain]", "documentation": "Name of disposal group." } } }, "auth_ref": [ "r90", "r91", "r92", "r93", "r94", "r95", "r96", "r330", "r332", "r919", "r920", "r1073", "r1074", "r1216", "r1217", "r1218", "r1219" ] }, "us-gaap_DividendsCommonStockCash": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DividendsCommonStockCash", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.maximus.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash dividends", "terseLabel": "Payments of dividends", "label": "Dividends, Common Stock, Cash", "documentation": "Amount of paid and unpaid common stock dividends declared with the form of settlement in cash." } } }, "auth_ref": [ "r1238", "r1239" ] }, "us-gaap_DividendsShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "DividendsShareBasedCompensation", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Dividends on RSUs", "label": "Dividend, Share-Based Payment Arrangement", "documentation": "Amount of paid and unpaid cash, stock, and paid-in-kind dividends declared for award under share-based payment arrangement." } } }, "auth_ref": [ "r1270" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Period Focus", "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Fiscal Year Focus", "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentQuarterlyReport", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Quarterly Report", "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r974" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentTransitionReport", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Transition Report", "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r1006" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "DocumentType", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year", "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]" } } }, "auth_ref": [ "r1017" ] }, "us-gaap_EarningsPerShareAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerShareAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings per share:", "label": "Earnings Per Share [Abstract]" } } }, "auth_ref": [] }, "us-gaap_EarningsPerShareBasic": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerShareBasic", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in dollars per share)", "label": "Earnings Per Share, Basic", "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period." } } }, "auth_ref": [ "r78", "r159", "r182", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r196", "r198", "r203", "r204", "r205", "r210", "r319", "r391", "r441", "r491", "r505", "r510", "r588", "r589", "r700", "r741", "r880" ] }, "us-gaap_EarningsPerShareDiluted": { "xbrltype": "perShareItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerShareDiluted", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations", "http://www.maximus.com/role/RevenueRecognitionScheduleofEffectofChangesinContractEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in dollars per share)", "verboseLabel": "Increase in diluted earnings per share recognized due to changes in contract estimates (in dollars per share)", "label": "Earnings Per Share, Diluted", "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period." } } }, "auth_ref": [ "r78", "r159", "r182", "r184", "r185", "r186", "r187", "r188", "r189", "r190", "r191", "r198", "r203", "r204", "r205", "r210", "r319", "r391", "r441", "r491", "r505", "r510", "r588", "r589", "r700", "r741", "r880" ] }, "us-gaap_EarningsPerShareTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EarningsPerShareTextBlock", "presentation": [ "http://www.maximus.com/role/EarningsPerShare" ], "lang": { "en-us": { "role": { "terseLabel": "Earnings Per Share", "label": "Earnings Per Share [Text Block]", "documentation": "The entire disclosure for earnings per share." } } }, "auth_ref": [ "r195", "r206", "r207", "r208", "r209", "r419" ] }, "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Effect of exchange rate changes on cash, cash equivalents, and restricted cash", "label": "Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation", "documentation": "Amount of increase (decrease) from effect of exchange rate change on cash and cash equivalent, and cash and cash equivalent restricted to withdrawal or usage; held in foreign currency; attributable to continuing operation. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r619" ] }, "mms_EmployeeMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "EmployeeMember", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employee", "label": "Employee [Member]", "documentation": "Employee" } } }, "auth_ref": [] }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmployeeRelatedLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation and benefits", "label": "Employee-related Liabilities, Current", "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer)." } } }, "auth_ref": [ "r1082" ] }, "us-gaap_EmployeeStockOptionMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EmployeeStockOptionMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Employee Stock Option", "label": "Share-Based Payment Arrangement, Option [Member]", "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time." } } }, "auth_ref": [ "r1244", "r1245", "r1246", "r1247", "r1248", "r1249", "r1250", "r1251", "r1252", "r1253", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269" ] }, "mms_EmploymentAndOtherMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "EmploymentAndOtherMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Employment & Other", "label": "Employment and Other [Member]", "documentation": "Employment and Other" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r972" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Common Stock, Shares Outstanding", "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Current Reporting Status", "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r972" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityFileNumber", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityFilerCategory", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Filer Category", "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r972" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Interactive Data Current", "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r1056" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityRegistrantName", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r972" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityShellCompany", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Shell Company", "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r972" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntitySmallBusiness", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Small Reporting Company", "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r972" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r972" ] }, "ecd_EqtyAwrdsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EqtyAwrdsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Footnote", "label": "Equity Awards Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r1011" ] }, "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table", "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]" } } }, "auth_ref": [ "r1052" ] }, "ecd_EqtyAwrdsAdjsMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EqtyAwrdsAdjsMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Awards Adjustments", "label": "Equity Awards Adjustments [Member]" } } }, "auth_ref": [ "r1052" ] }, "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table", "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]" } } }, "auth_ref": [ "r1052" ] }, "us-gaap_EquityComponentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "EquityComponentDomain", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Component [Domain]", "label": "Equity Component [Domain]", "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "auth_ref": [ "r77", "r78", "r109", "r138", "r139", "r155", "r156", "r157", "r179", "r180", "r181", "r183", "r190", "r192", "r194", "r212", "r285", "r286", "r318", "r319", "r320", "r390", "r404", "r409", "r410", "r411", "r414", "r416", "r418", "r439", "r440", "r442", "r443", "r491", "r499", "r500", "r502", "r503", "r504", "r506", "r509", "r510", "r573", "r574", "r575", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r620", "r621", "r622", "r623", "r624", "r625", "r630", "r634", "r677", "r684", "r685", "r694", "r695", "r725", "r737", "r763", "r764", "r765", "r777", "r827", "r1240" ] }, "ecd_EquityValuationAssumptionDifferenceFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "EquityValuationAssumptionDifferenceFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Valuation Assumption Difference, Footnote", "label": "Equity Valuation Assumption Difference, Footnote [Text Block]" } } }, "auth_ref": [ "r1021" ] }, "ecd_ErrCompAnalysisTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ErrCompAnalysisTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneous Compensation Analysis", "label": "Erroneous Compensation Analysis [Text Block]" } } }, "auth_ref": [ "r979", "r989", "r999", "r1031" ] }, "ecd_ErrCompRecoveryTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ErrCompRecoveryTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Erroneously Awarded Compensation Recovery", "label": "Erroneously Awarded Compensation Recovery [Table]" } } }, "auth_ref": [ "r976", "r986", "r996", "r1028" ] }, "ecd_ExecutiveCategoryAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ExecutiveCategoryAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Executive Category:", "label": "Executive Category [Axis]" } } }, "auth_ref": [ "r1027" ] }, "us-gaap_FairValueByBalanceSheetGroupingTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueByBalanceSheetGroupingTextBlock", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value of Assets and Liabilities", "label": "Fair Value, by Balance Sheet Grouping [Table Text Block]", "documentation": "Tabular disclosure of the fair value of financial instruments, including financial assets and financial liabilities, and the measurements of those instruments, assets, and liabilities." } } }, "auth_ref": [ "r614", "r615", "r947", "r948", "r1320" ] }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueByFairValueHierarchyLevelAxis", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Axis]", "label": "Fair Value Hierarchy and NAV [Axis]", "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient." } } }, "auth_ref": [ "r374", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r590", "r591", "r593", "r594", "r595", "r596", "r604", "r605", "r607", "r613", "r641", "r642", "r643", "r648", "r901", "r902", "r914", "r915", "r916", "r917", "r918", "r936", "r940", "r947", "r948" ] }, "us-gaap_FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueDisclosureAssetAndLiabilityNotMeasuredAtFairValueLineItems", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]", "label": "Fair Value Disclosure, Asset and Liability, Not Measured at Fair Value [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r604" ] }, "us-gaap_FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueDisclosureOfAssetAndLiabilityNotMeasuredAtFairValueTable", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]", "label": "Fair Value Disclosure of Asset and Liability Not Measured at Fair Value [Table]", "documentation": "Disclosure of information about fair value of asset and liability not measured at fair value." } } }, "auth_ref": [ "r604" ] }, "us-gaap_FairValueDisclosuresAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueDisclosuresAbstract", "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "auth_ref": [] }, "us-gaap_FairValueDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueDisclosuresTextBlock", "presentation": [ "http://www.maximus.com/role/FairValueMeasurements" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Measurements", "label": "Fair Value Disclosures [Text Block]", "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information." } } }, "auth_ref": [ "r594", "r600", "r602", "r603", "r604", "r607", "r608", "r609", "r610", "r611", "r683", "r936", "r941" ] }, "us-gaap_FairValueInputsLevel1Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueInputsLevel1Member", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 1", "label": "Fair Value, Inputs, Level 1 [Member]", "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date." } } }, "auth_ref": [ "r374", "r445", "r450", "r451", "r593", "r605", "r613", "r641", "r914", "r915", "r916", "r917", "r918", "r936", "r947", "r948" ] }, "us-gaap_FairValueInputsLevel2Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueInputsLevel2Member", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 2", "label": "Fair Value, Inputs, Level 2 [Member]", "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets." } } }, "auth_ref": [ "r374", "r445", "r450", "r451", "r453", "r593", "r594", "r605", "r613", "r642", "r901", "r902", "r914", "r915", "r916", "r917", "r918", "r936", "r947", "r948" ] }, "us-gaap_FairValueInputsLevel3Member": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueInputsLevel3Member", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Level 3", "label": "Fair Value, Inputs, Level 3 [Member]", "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r374", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r593", "r594", "r595", "r596", "r605", "r613", "r643", "r901", "r902", "r914", "r915", "r916", "r917", "r918", "r936", "r940", "r947", "r948" ] }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueMeasurementusingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInOtherComprehensiveIncome", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueMeasurementusingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Other Comprehensive Income (Loss)", "documentation": "Amount of gain (loss) recognized in other comprehensive income (OCI) from liability measured at fair value on recurring basis using unobservable input (level 3)." } } }, "auth_ref": [ "r598", "r606" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueMeasurementusingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Cash payments", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements", "documentation": "Amount of settlements of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r599", "r606" ] }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueMeasurementusingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value", "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r597", "r606" ] }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueMeasurementsFairValueHierarchyDomain", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value Hierarchy and NAV [Domain]", "label": "Fair Value Hierarchy and NAV [Domain]", "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "auth_ref": [ "r374", "r445", "r446", "r447", "r448", "r449", "r450", "r451", "r452", "r590", "r591", "r593", "r594", "r595", "r596", "r604", "r605", "r607", "r613", "r641", "r642", "r643", "r648", "r901", "r902", "r914", "r915", "r916", "r917", "r918", "r936", "r940", "r947", "r948" ] }, "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTableTextBlock", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Fair Value Measurement using Significant Unobservable Inputs (Level 3)", "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]", "documentation": "Tabular disclosure of financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing." } } }, "auth_ref": [ "r597", "r601", "r606" ] }, "us-gaap_FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList": { "xbrltype": "enumerationSetItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FairValueRecurringBasisUnobservableInputReconciliationLiabilityGainLossStatementOfOtherComprehensiveIncomeExtensibleList", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueMeasurementusingSignificantUnobservableInputsLevel3Details" ], "lang": { "en-us": { "role": { "terseLabel": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]", "label": "Fair Value, Liability, Recurring Basis, Unobservable Input Reconciliation, Liability, Gain (Loss), Statement of Other Comprehensive Income or Comprehensive Income [Extensible Enumeration]", "documentation": "Indicates line item in statement in which other comprehensive income (OCI) is reported that includes gain (loss) from liability measured at fair value using unobservable input (level 3)." } } }, "auth_ref": [ "r598", "r606" ] }, "us-gaap_FinancialInstrumentAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FinancialInstrumentAxis", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instrument [Axis]", "label": "Financial Instrument [Axis]", "documentation": "Information by type of financial instrument." } } }, "auth_ref": [ "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r288", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r385", "r402", "r572", "r612", "r616", "r618", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r650", "r651", "r652", "r653", "r654", "r655", "r659", "r660", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r726", "r738", "r894", "r936", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1196", "r1197", "r1198", "r1199", "r1303", "r1305", "r1306", "r1307", "r1314", "r1317", "r1318", "r1319" ] }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FiniteLivedIntangibleAssetsNet", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Intangible assets, net", "label": "Intangible Asset, Finite-Lived, after Accumulated Amortization", "documentation": "Amount, after accumulated amortization, of finite-lived intangible asset. Excludes goodwill and capitalized cost for software to be sold, leased, or marketed." } } }, "auth_ref": [ "r682", "r1203" ] }, "us-gaap_FixedPriceContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "FixedPriceContractMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fixed price", "label": "Fixed-Price Contract [Member]", "documentation": "Contract with customer in which amount of consideration is fixed." } } }, "auth_ref": [ "r906", "r910" ] }, "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount", "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount" } } }, "auth_ref": [ "r983", "r993", "r1003", "r1035" ] }, "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount", "label": "Forgone Recovery due to Expense of Enforcement, Amount" } } }, "auth_ref": [ "r983", "r993", "r1003", "r1035" ] }, "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount", "label": "Forgone Recovery due to Violation of Home Country Law, Amount" } } }, "auth_ref": [ "r983", "r993", "r1003", "r1035" ] }, "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Forgone Recovery, Explanation of Impracticability", "label": "Forgone Recovery, Explanation of Impracticability [Text Block]" } } }, "auth_ref": [ "r983", "r993", "r1003", "r1035" ] }, "ecd_ForgoneRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "ForgoneRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Forgone Recovery, Individual Name" } } }, "auth_ref": [ "r983", "r993", "r1003", "r1035" ] }, "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year", "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]" } } }, "auth_ref": [ "r1016" ] }, "us-gaap_GainLossOnSaleOfBusiness": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "GainLossOnSaleOfBusiness", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 7.0 } }, "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Divestiture-related charges/(gains)", "terseLabel": "Divestiture-related gains/(charges)", "label": "Gain (Loss) on Disposition of Business", "documentation": "Amount of gain (loss) from sale and disposal of integrated set of activities and assets capable of being conducted and managed for purpose of providing return in form of dividend, lower cost, or other economic benefit to investor, owner, member and participant." } } }, "auth_ref": [ "r514", "r1155" ] }, "us-gaap_Goodwill": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Goodwill", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Goodwill", "label": "Goodwill", "documentation": "Amount, after accumulated impairment loss, of asset representing future economic benefit arising from other asset acquired in business combination or from joint venture formation or both, that is not individually identified and separately recognized." } } }, "auth_ref": [ "r112", "r117", "r305", "r684", "r685", "r686", "r889", "r895", "r924", "r925", "r926", "r929", "r938", "r950", "r1201", "r1202", "r1271" ] }, "us-gaap_GrossProfit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "GrossProfit", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Gross profit", "terseLabel": "Gross profit", "label": "Gross Profit", "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity." } } }, "auth_ref": [ "r22", "r24", "r172", "r175", "r176", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r415", "r617", "r883", "r888", "r1075", "r1076", "r1172", "r1180", "r1186", "r1189", "r1190", "r1200", "r1231" ] }, "us-gaap_GuarantyLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "GuarantyLiabilities", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Indemnification liabilities", "label": "Guaranty Liabilities", "documentation": "This item represents a non-contingent liability for the fair value of an obligation to stand ready to perform over the term of a guaranty issued in the event that specified triggering events or conditions occur." } } }, "auth_ref": [ "r1229" ] }, "us-gaap_ImpairmentOfLongLivedAssetsHeldForUse": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ImpairmentOfLongLivedAssetsHeldForUse", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 9.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows", "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Capitalized software impairment charges", "verboseLabel": "Impairment charge", "label": "Long-Lived Asset, Held and Used, Impairment Loss", "documentation": "Amount of impairment loss for long-lived asset held and used. Includes, but is not limited to, impairment loss for long-lived asset to be disposed of other than by sale." } } }, "auth_ref": [ "r5", "r160", "r325", "r874", "r937", "r1207" ] }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Income before income taxes", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest." } } }, "auth_ref": [ "r23", "r36", "r701", "r703", "r735", "r856", "r875", "r877", "r879", "r883", "r888", "r1172", "r1180", "r1186", "r1189", "r1190" ] }, "us-gaap_IncomeStatementAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeStatementAbstract", "lang": { "en-us": { "role": { "terseLabel": "Income Statement [Abstract]", "label": "Income Statement [Abstract]" } } }, "auth_ref": [] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsAxis", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group Name [Axis]", "label": "Disposal Group Name [Axis]", "documentation": "Information by name of disposal group." } } }, "auth_ref": [ "r90", "r91", "r92", "r93", "r94", "r95", "r96", "r330", "r332", "r919", "r920", "r1073", "r1074", "r1216", "r1217", "r1218", "r1219" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsLineItems", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Group, Including Discontinued Operations [Line Items]", "label": "Disposal Group, Including Discontinued Operations [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r83", "r84", "r85", "r86", "r90", "r91", "r92", "r93", "r94", "r95", "r96", "r98", "r99", "r100", "r101", "r102", "r104", "r105", "r106", "r107", "r322", "r327", "r328", "r329", "r330", "r331", "r332", "r860", "r1073", "r1074", "r1208", "r1216", "r1217", "r1218", "r1219" ] }, "us-gaap_IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeStatementBalanceSheetAndAdditionalDisclosuresByDisposalGroupsIncludingDiscontinuedOperationsTable", "presentation": [ "http://www.maximus.com/role/DivestituresDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Disposal Groups, Including Discontinued Operations [Table]", "label": "Disposal Groups, Including Discontinued Operations [Table]", "documentation": "Disclosure of information about a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component." } } }, "auth_ref": [ "r84", "r85", "r86", "r90", "r91", "r92", "r93", "r94", "r95", "r96", "r98", "r99", "r100", "r101", "r102", "r104", "r105", "r106", "r107", "r322", "r327", "r328", "r329", "r330", "r331", "r332", "r860", "r1073", "r1074", "r1208", "r1216", "r1217", "r1218", "r1219" ] }, "us-gaap_IncomeTaxExpenseBenefit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxExpenseBenefit", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Provision for income taxes", "label": "Income Tax Expense (Benefit)", "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations." } } }, "auth_ref": [ "r43", "r48", "r172", "r193", "r194", "r211", "r230", "r244", "r495", "r496", "r501", "r742", "r856", "r875", "r877", "r879", "r923" ] }, "us-gaap_IncomeTaxReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxReceivable", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes receivable", "label": "Income Taxes Receivable", "documentation": "Carrying amount as of the balance sheet date of income taxes previously overpaid to tax authorities (such as U.S. Federal, state and local tax authorities) representing refunds of overpayments or recoveries based on agreed-upon resolutions of disputes. Also called income tax refund receivable." } } }, "auth_ref": [ "r1080", "r1088", "r1333", "r1334", "r1335" ] }, "us-gaap_IncomeTaxesPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncomeTaxesPaidNet", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Income tax payments", "label": "Income Tax Paid, after Refund Received", "documentation": "Amount, after refund, of cash paid to foreign, federal, state, and local jurisdictions as income tax." } } }, "auth_ref": [ "r38", "r170", "r497", "r498" ] }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 12.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accounts payable and accrued liabilities", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInAccountsReceivable", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 8.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Accounts receivable", "label": "Increase (Decrease) in Accounts Receivable", "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInContractWithCustomerLiability": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInContractWithCustomerLiability", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 14.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred revenue", "label": "Increase (Decrease) in Contract with Customer, Liability", "documentation": "Amount of increase (decrease) in obligation to transfer good or service to customer for which consideration has been received or is receivable." } } }, "auth_ref": [ "r679", "r1154" ] }, "us-gaap_IncreaseDecreaseInDeferredCharges": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInDeferredCharges", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 11.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Deferred contract costs", "label": "Increase (Decrease) in Deferred Charges", "documentation": "The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInEmployeeRelatedLiabilities", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 13.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Accrued compensation and benefits", "label": "Increase (Decrease) in Employee Related Liabilities", "documentation": "The increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 15.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Income taxes", "label": "Increase (Decrease) in Income Taxes Payable, Net of Income Taxes Receivable", "documentation": "The increase (decrease) during the reporting period in the amounts payable to taxing authorities for taxes that are based on the reporting entity's earnings, net of amounts receivable from taxing authorities for refunds of overpayments or recoveries of income taxes." } } }, "auth_ref": [ "r1154" ] }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Change in assets and liabilities, net of effects of business combinations and divestitures:", "label": "Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract]" } } }, "auth_ref": [] }, "mms_IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "IncreaseDecreaseInOperatingLeaseRightOfUseAssetsAndLiabilities", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 16.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets and liabilities", "label": "Increase (Decrease) In Operating Lease Right-Of-Use Assets And Liabilities", "documentation": "Increase (Decrease) In Operating Lease Right-Of-Use Assets And Liabilities" } } }, "auth_ref": [] }, "us-gaap_IncreaseDecreaseInOtherOperatingCapitalNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInOtherOperatingCapitalNet", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 17.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Other assets and liabilities", "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net", "documentation": "Amount of increase (decrease) in operating assets after deduction of operating liabilities classified as other." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": -1.0, "order": 10.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Prepaid expenses and other current assets", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other." } } }, "auth_ref": [ "r4" ] }, "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncreaseDecreaseInStockholdersEquityRollForward", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase (Decrease) in Shareholders' Equity", "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]", "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period." } } }, "auth_ref": [] }, "us-gaap_IncrementalCommonSharesAttributableToShareBasedPaymentArrangements": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "IncrementalCommonSharesAttributableToShareBasedPaymentArrangements", "calculation": { "http://www.maximus.com/role/EarningsPerShareScheduleofWeightedAverageNumberofSharesDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/EarningsPerShareScheduleofWeightedAverageNumberofSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Dilutive effect of unvested RSUs and PSUs (in shares)", "label": "Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements", "documentation": "Additional shares included in the calculation of diluted EPS as a result of the potentially dilutive effect of share based payment arrangements using the treasury stock method." } } }, "auth_ref": [ "r199", "r200", "r201", "r205", "r459" ] }, "ecd_IndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "IndividualAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure", "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure", "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements", "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Individual:", "label": "Individual [Axis]" } } }, "auth_ref": [ "r983", "r993", "r1003", "r1027", "r1035", "r1039", "r1047" ] }, "ecd_InsiderTradingArrLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "InsiderTradingArrLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Arrangements [Line Items]" } } }, "auth_ref": [ "r1045" ] }, "ecd_InsiderTradingPoliciesProcLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "InsiderTradingPoliciesProcLineItems", "lang": { "en-us": { "role": { "label": "Insider Trading Policies and Procedures [Line Items]" } } }, "auth_ref": [ "r975", "r1051" ] }, "ecd_InsiderTrdPoliciesProcAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "InsiderTrdPoliciesProcAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Adopted", "label": "Insider Trading Policies and Procedures Adopted [Flag]" } } }, "auth_ref": [ "r975", "r1051" ] }, "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc" ], "lang": { "en-us": { "role": { "terseLabel": "Insider Trading Policies and Procedures Not Adopted", "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]" } } }, "auth_ref": [ "r975", "r1051" ] }, "us-gaap_InterestExpenseNonoperating": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestExpenseNonoperating", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Interest expense", "label": "Interest Expense, Nonoperating", "documentation": "Amount of interest expense classified as nonoperating." } } }, "auth_ref": [ "r226", "r875", "r879", "r1105" ] }, "us-gaap_InterestPaidNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestPaidNet", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofSupplementalCashFlowInformationDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest payments", "label": "Interest Paid, Excluding Capitalized Interest, Operating Activity", "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount." } } }, "auth_ref": [ "r165", "r167", "r169" ] }, "us-gaap_InterestRateCashFlowHedgeAssetAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestRateCashFlowHedgeAssetAtFairValue", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivative asset", "label": "Interest Rate Cash Flow Hedge Asset at Fair Value", "documentation": "Fair value as of the balance sheet date of all interest rate derivative assets designated as cash flow hedging instruments." } } }, "auth_ref": [ "r1278", "r1282", "r1283", "r1285" ] }, "us-gaap_InterestRateCashFlowHedgeLiabilityAtFairValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestRateCashFlowHedgeLiabilityAtFairValue", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Fair value of derivative liability", "label": "Interest Rate Cash Flow Hedge Liability at Fair Value", "documentation": "Fair value as of the balance sheet date of all interest rate derivative liabilities designated as cash flow hedging instruments." } } }, "auth_ref": [ "r1278", "r1282", "r1283", "r1285" ] }, "us-gaap_InterestRateSwapMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "InterestRateSwapMember", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails", "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Interest Rate Swap", "label": "Interest Rate Swap [Member]", "documentation": "Forward based contracts in which two parties agree to swap periodic payments that are fixed at the outset of the swap contract with variable payments based on a market interest rate (index rate) over a specified period." } } }, "auth_ref": [ "r931", "r966", "r967", "r1278", "r1279", "r1280", "r1282", "r1283", "r1284", "r1285", "r1287", "r1288", "r1289", "r1290", "r1291", "r1292", "r1293", "r1294", "r1295" ] }, "mms_InternationalGovernmentAgenciesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "InternationalGovernmentAgenciesMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "International government agencies", "label": "International Government Agencies [Member]", "documentation": "International Government Agencies [Member]" } } }, "auth_ref": [] }, "us-gaap_Liabilities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "Liabilities", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities", "label": "Liabilities", "documentation": "Amount of liability recognized for present obligation requiring transfer or otherwise providing economic benefit to others." } } }, "auth_ref": [ "r97", "r103", "r172", "r175", "r176", "r284", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r415", "r512", "r515", "r516", "r617", "r789", "r882", "r905", "r970", "r1092", "r1231", "r1328", "r1329" ] }, "us-gaap_LiabilitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities:", "label": "Liabilities [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesAndStockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesAndStockholdersEquity", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total liabilities and shareholders' equity", "label": "Liabilities and Equity", "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any." } } }, "auth_ref": [ "r144", "r684", "r685", "r697", "r733", "r950", "r960", "r961", "r1158", "r1163", "r1200", "r1321" ] }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesAndStockholdersEquityAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Liabilities and Shareholders' Equity:", "label": "Liabilities and Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_LiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "totalLabel": "Total current liabilities", "label": "Liabilities, Current", "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer." } } }, "auth_ref": [ "r97", "r103", "r108", "r124", "r172", "r175", "r176", "r284", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r415", "r512", "r515", "r516", "r617", "r950", "r1231", "r1328", "r1329" ] }, "us-gaap_LiabilitiesFairValueDisclosure": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LiabilitiesFairValueDisclosure", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total liabilities", "label": "Liabilities, Fair Value Disclosure", "documentation": "Fair value of financial and nonfinancial obligations." } } }, "auth_ref": [ "r593", "r1304" ] }, "us-gaap_LineOfCreditFacilityIncreaseDecreaseForPeriodNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LineOfCreditFacilityIncreaseDecreaseForPeriodNet", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Increase in borrowing capacity", "label": "Line of Credit Facility, Increase (Decrease), Net", "documentation": "Amount of increase (decrease) of the credit facility." } } }, "auth_ref": [ "r1158", "r1161" ] }, "us-gaap_LineOfCreditMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LineOfCreditMember", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolver", "label": "Line of Credit [Member]", "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "LocalPhoneNumber", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "us-gaap_LongTermDebtCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtCurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails_1": { "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0, "order": 1.0 }, "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, current portion", "negatedTerseLabel": "Less: Current portion of long-term debt", "label": "Long-Term Debt, Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as current. Excludes lease obligation." } } }, "auth_ref": [ "r867", "r868" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year ended September 30, 2027", "label": "Long-Term Debt, Maturity, Year One", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r173", "r178", "r378", "r704" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year ended September 30, 2030", "label": "Long-Term Debt, Maturity, Year Four", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r173", "r178", "r378", "r704" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year ended September 30, 2029", "label": "Long-Term Debt, Maturity, Year Three", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r173", "r178", "r378", "r704" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Year ended September 30, 2028", "label": "Long-Term Debt, Maturity, Year Two", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach)." } } }, "auth_ref": [ "r6", "r173", "r178", "r378", "r704" ] }, "us-gaap_LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "July 1, 2026 through September 30, 2026", "label": "Long-Term Debt, Maturity, Remainder of Fiscal Year", "documentation": "Amount of long-term debt payable, sinking fund requirement, and other securities issued that are redeemable by holder at fixed or determinable price and date, maturing in remainder of current fiscal year." } } }, "auth_ref": [ "r1159", "r1165" ] }, "mms_LongTermDebtMaturityAfterYearFour": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "LongTermDebtMaturityAfterYearFour", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails": { "parentTag": "us-gaap_DebtInstrumentCarryingAmount", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofFutureMinimumPrincipalPaymentsDueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Years ended thereafter", "label": "Long Term Debt Maturity, After Year Four", "documentation": "Long Term Debt Maturity, After Year Four" } } }, "auth_ref": [] }, "us-gaap_LongTermDebtNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongTermDebtNoncurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails_1": { "parentTag": "us-gaap_DebtLongtermAndShorttermCombinedAmount", "weight": 1.0, "order": 2.0 }, "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term debt, non-current portion", "verboseLabel": "Long-term debt", "label": "Long-Term Debt, Excluding Current Maturities", "documentation": "Amount, after deduction of unamortized premium (discount) and debt issuance cost, of long-term debt classified as noncurrent. Excludes lease obligation." } } }, "auth_ref": [ "r1081", "r1084" ] }, "us-gaap_LongtermDebtTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongtermDebtTypeAxis", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Axis]", "label": "Long-Term Debt, Type [Axis]", "documentation": "Information by type of long-term debt." } } }, "auth_ref": [ "r115", "r125", "r126", "r127", "r128", "r129", "r684", "r685", "r691", "r1221", "r1222", "r1223" ] }, "us-gaap_LongtermDebtTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "LongtermDebtTypeDomain", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Long-term Debt, Type [Domain]", "label": "Long-Term Debt, Type [Domain]", "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer." } } }, "auth_ref": [ "r15", "r115", "r125", "r126", "r127", "r128", "r129", "r684", "r685", "r691", "r1221", "r1222", "r1223" ] }, "srt_MajorCustomersAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "MajorCustomersAxis", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Axis]", "label": "Customer [Axis]", "documentation": "Information by name or description of a single external customer or a group of external customers." } } }, "auth_ref": [ "r250", "r906", "r909", "r954", "r958", "r1341", "r1344", "r1345", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1381", "r1382" ] }, "us-gaap_MaterialReconcilingItemsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MaterialReconcilingItemsMember", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reconciling Items", "label": "Segment Reporting, Reconciling Item, Excluding Corporate Nonsegment [Member]", "documentation": "Items used in reconciling reportable segments' amounts to consolidated amount. Excludes corporate-level activity." } } }, "auth_ref": [ "r239", "r242", "r245", "r888", "r889" ] }, "srt_MaximumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "MaximumMember", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Maximum", "label": "Maximum [Member]", "documentation": "Upper limit of the provided range." } } }, "auth_ref": [ "r51", "r52", "r53", "r54", "r55", "r62", "r63", "r64", "r75", "r76", "r104", "r106", "r217", "r343", "r344", "r345", "r346", "r454", "r484", "r485", "r486", "r492", "r596", "r644", "r645", "r646", "r647", "r649", "r650", "r651", "r652", "r678", "r761", "r762", "r769", "r781", "r782", "r830", "r831", "r832", "r833", "r843", "r845", "r846", "r847", "r848", "r851", "r852", "r893", "r921", "r924", "r927", "r928", "r940", "r941", "r945", "r946", "r955", "r1233", "r1234" ] }, "ecd_MeasureAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "MeasureAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Measure:", "label": "Measure [Axis]" } } }, "auth_ref": [ "r1019" ] }, "ecd_MeasureName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "MeasureName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Measure Name" } } }, "auth_ref": [ "r1019" ] }, "srt_MinimumMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "MinimumMember", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Minimum", "label": "Minimum [Member]", "documentation": "Lower limit of the provided range." } } }, "auth_ref": [ "r51", "r52", "r53", "r54", "r55", "r62", "r63", "r64", "r75", "r76", "r104", "r106", "r217", "r343", "r344", "r345", "r346", "r454", "r484", "r485", "r486", "r492", "r596", "r644", "r645", "r646", "r647", "r649", "r650", "r651", "r652", "r678", "r761", "r762", "r769", "r781", "r782", "r830", "r831", "r832", "r833", "r843", "r845", "r846", "r847", "r848", "r851", "r852", "r893", "r921", "r924", "r927", "r928", "r940", "r941", "r945", "r955", "r1233", "r1234" ] }, "ecd_MnpiDiscTimedForCompValFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "MnpiDiscTimedForCompValFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "MNPI Disclosure Timed for Compensation Value", "label": "MNPI Disclosure Timed for Compensation Value [Flag]" } } }, "auth_ref": [ "r1038" ] }, "ecd_MtrlTermsOfTrdArrTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "MtrlTermsOfTrdArrTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Material Terms of Trading Arrangement", "label": "Material Terms of Trading Arrangement [Text Block]" } } }, "auth_ref": [ "r1046" ] }, "us-gaap_MutualFundMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "MutualFundMember", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Deferred compensation assets - Rabbi Trust", "label": "Mutual Fund [Member]", "documentation": "Regulated investment instrument that pools funds from multiple investors to invest principally in a portfolio of securities and money market instruments to match the investment objective." } } }, "auth_ref": [ "r1242", "r1243" ] }, "srt_NameOfMajorCustomerDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "NameOfMajorCustomerDomain", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Customer [Domain]", "label": "Customer [Domain]", "documentation": "Single external customer or group of external customers." } } }, "auth_ref": [ "r250", "r906", "r909", "r954", "r958", "r1341", "r1344", "r1345", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1381", "r1382" ] }, "ecd_NamedExecutiveOfficersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NamedExecutiveOfficersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Named Executive Officers, Footnote", "label": "Named Executive Officers, Footnote [Text Block]" } } }, "auth_ref": [ "r1020" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInFinancingActivities", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash provided by financing activities", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from financing activity, including, but not limited to, discontinued operation. Financing activity includes, but is not limited to, obtaining resource from owner and providing return on, and return of, their investment; borrowing money and repaying amount borrowed, or settling obligation; and obtaining and paying for other resource obtained from creditor on long-term credit." } } }, "auth_ref": [ "r166" ] }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from financing activities:", "label": "Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInInvestingActivities", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in investing activities", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from investing activity, including, but not limited to, discontinued operation. Investing activity includes, but is not limited to, making and collecting loan, acquiring and disposing of debt and equity instruments, property, plant, and equipment, and other productive assets." } } }, "auth_ref": [ "r166" ] }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from investing activities:", "label": "Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInOperatingActivities", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "totalLabel": "Net cash used in operating activities", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation", "documentation": "Amount of cash inflow (outflow) from operating activity, including, but not limited to, discontinued operation. Operating activity includes, but is not limited to, transaction, adjustment, and change in value not defined as investing or financing activity." } } }, "auth_ref": [ "r29", "r30", "r31" ] }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Cash flows from operating activities:", "label": "Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract]" } } }, "auth_ref": [] }, "us-gaap_NetIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NetIncomeLoss", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 1.0 }, "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 1.0 }, "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows", "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Net income", "terseLabel": "Net income", "label": "Net Income (Loss) Attributable to Parent", "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent." } } }, "auth_ref": [ "r25", "r31", "r37", "r78", "r97", "r103", "r150", "r153", "r157", "r172", "r175", "r176", "r177", "r182", "r186", "r187", "r188", "r189", "r190", "r193", "r194", "r202", "r284", "r319", "r349", "r350", "r352", "r353", "r354", "r355", "r356", "r358", "r359", "r391", "r394", "r396", "r398", "r415", "r441", "r491", "r505", "r510", "r589", "r617", "r736", "r810", "r825", "r826", "r875", "r877", "r879", "r968", "r1231" ] }, "mms_NewYorkStateGovernmentAgenciesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "NewYorkStateGovernmentAgenciesMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "New York state government agencies", "label": "New York State Government Agencies [Member]", "documentation": "New York State Government Agencies" } } }, "auth_ref": [] }, "ecd_NonGaapMeasureDescriptionTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonGaapMeasureDescriptionTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-GAAP Measure Description", "label": "Non-GAAP Measure Description [Text Block]" } } }, "auth_ref": [ "r1019" ] }, "ecd_NonNeosMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonNeosMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-NEOs", "label": "Non-NEOs [Member]" } } }, "auth_ref": [ "r983", "r993", "r1003", "r1027", "r1035" ] }, "ecd_NonPeoNeoAvgCompActuallyPaidAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonPeoNeoAvgCompActuallyPaidAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount", "label": "Non-PEO NEO Average Compensation Actually Paid Amount" } } }, "auth_ref": [ "r1010" ] }, "ecd_NonPeoNeoAvgTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonPeoNeoAvgTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO Average Total Compensation Amount", "label": "Non-PEO NEO Average Total Compensation Amount" } } }, "auth_ref": [ "r1009" ] }, "ecd_NonPeoNeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonPeoNeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Non-PEO NEO", "label": "Non-PEO NEO [Member]" } } }, "auth_ref": [ "r1027" ] }, "ecd_NonRule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonRule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted", "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1046" ] }, "ecd_NonRule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "NonRule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated", "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1046" ] }, "mms_NumberOfCitizensImpactedByServiceImprovements": { "xbrltype": "integerItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "NumberOfCitizensImpactedByServiceImprovements", "presentation": [ "http://www.maximus.com/role/OrganizationNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of citizens impacted by service improvements (more than)", "label": "Number Of Citizens Impacted By Service Improvements", "documentation": "Number Of Citizens Impacted By Service Improvements" } } }, "auth_ref": [] }, "us-gaap_NumberOfOperatingSegments": { "xbrltype": "integerItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "NumberOfOperatingSegments", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of operating segments", "label": "Number of Operating Segments", "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues." } } }, "auth_ref": [ "r889", "r1179" ] }, "mms_NumberOfReportableSegmentsNotDisclosedFlag": { "xbrltype": "stringItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "NumberOfReportableSegmentsNotDisclosedFlag", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Number of reportable segments not disclosed", "label": "Number Of Reportable Segments Not Disclosed Flag", "documentation": "Number Of Reportable Segments Not Disclosed Flag" } } }, "auth_ref": [] }, "us-gaap_OciBeforeReclassificationsNetOfTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OciBeforeReclassificationsNetOfTaxAttributableToParent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive income before reclassifications", "label": "OCI, before Reclassifications, Net of Tax, Attributable to Parent", "documentation": "Amount after tax, before reclassification adjustments, of other comprehensive income (loss), attributable to parent." } } }, "auth_ref": [ "r8", "r10" ] }, "us-gaap_OperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingIncomeLoss", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "totalLabel": "Operating income", "terseLabel": "Operating income", "label": "Operating Income (Loss)", "documentation": "The net result for the period of deducting operating expenses from operating revenues." } } }, "auth_ref": [ "r875", "r879", "r883", "r1075", "r1076", "r1172", "r1180", "r1186", "r1189", "r1190", "r1200" ] }, "us-gaap_OperatingLeaseLiabilityCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseLiabilityCurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities, current portion", "label": "Operating Lease, Liability, Current", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current." } } }, "auth_ref": [ "r632", "r866" ] }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseLiabilityNoncurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease liabilities, non-current portion", "label": "Operating Lease, Liability, Noncurrent", "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent." } } }, "auth_ref": [ "r632" ] }, "us-gaap_OperatingLeaseRightOfUseAsset": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingLeaseRightOfUseAsset", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Operating lease right-of-use assets", "label": "Operating Lease, Right-of-Use Asset", "documentation": "Amount of lessee's right to use underlying asset under operating lease." } } }, "auth_ref": [ "r631" ] }, "us-gaap_OperatingSegmentsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OperatingSegmentsMember", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Operating Segments", "label": "Operating Segments [Member]", "documentation": "Identifies components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r238", "r239", "r240", "r241", "r242", "r245", "r888", "r889" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "presentation": [ "http://www.maximus.com/role/SignificantAccountingPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Significant Accounting Policies", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block]", "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements." } } }, "auth_ref": [ "r34", "r1072", "r1156" ] }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock", "presentation": [ "http://www.maximus.com/role/Organization" ], "lang": { "en-us": { "role": { "terseLabel": "Organization", "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]", "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure." } } }, "auth_ref": [ "r34", "r79", "r80", "r81", "r772", "r773" ] }, "us-gaap_OtherAssetsNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherAssetsNoncurrent", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 10.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other assets", "label": "Other Assets, Noncurrent", "documentation": "Amount of noncurrent assets classified as other." } } }, "auth_ref": [ "r113", "r118" ] }, "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Foreign currency translation adjustments", "verboseLabel": "Foreign currency translation", "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity." } } }, "auth_ref": [ "r3", "r7", "r35" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Net gains/(losses) on cash flow hedges, net of tax provision/(benefit) of $28, $(561), $(206), and $(596), respectively", "verboseLabel": "Cash flow hedge, net of tax", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification and Tax, Parent", "documentation": "Amount, after tax and reclassification, of gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r147" ] }, "us-gaap_OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationTaxParent", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncomeParenthetical" ], "lang": { "en-us": { "role": { "terseLabel": "Net gains/(losses) on cash flow hedges, tax provision/(benefit)", "label": "Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), after Reclassification, Tax, Parent", "documentation": "Amount, after reclassification, of tax expense (benefit) for gain (loss) from derivative instrument designated and qualifying as cash flow hedge included in assessment of hedge effectiveness, attributable to parent." } } }, "auth_ref": [ "r148" ] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome" ], "lang": { "en-us": { "role": { "terseLabel": "Other comprehensive (loss)/income, net of tax:", "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]" } } }, "auth_ref": [] }, "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome": { "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax", "weight": 1.0, "order": 2.0 }, "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofComprehensiveIncome", "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Other comprehensive (loss)/income", "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent", "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity." } } }, "auth_ref": [ "r3", "r7", "r35", "r151", "r154", "r190" ] }, "mms_OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "OtherIncludingLocalMunicipalitiesAndCommercialCustomersMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other, including local municipalities and commercial customers", "label": "Other, Including Local Municipalities And Commercial Customers [Member]", "documentation": "Other, Including Local Municipalities And Commercial Customers [Member]" } } }, "auth_ref": [] }, "us-gaap_OtherLiabilitiesCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherLiabilitiesCurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other current liabilities", "label": "Other Liabilities, Current", "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r114", "r120", "r123", "r950" ] }, "us-gaap_OtherLiabilitiesNoncurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherLiabilitiesNoncurrent", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Liabilities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Other liabilities", "label": "Other Liabilities, Noncurrent", "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r133", "r1085" ] }, "us-gaap_OtherNonoperatingIncomeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherNonoperatingIncomeExpense", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other (income)/expense, net", "label": "Other Nonoperating Income (Expense)", "documentation": "Amount of income (expense) related to nonoperating activities, classified as other." } } }, "auth_ref": [ "r27", "r930" ] }, "us-gaap_OtherOperatingIncomeExpenseNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "OtherOperatingIncomeExpenseNet", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other", "label": "Other Operating Income (Expense), Net", "documentation": "The net amount of other operating income and expenses, the components of which are not separately disclosed on the income statement, from items that are associated with the entity's normal revenue producing operations." } } }, "auth_ref": [] }, "ecd_OtherPerfMeasureAmt": { "xbrltype": "decimalItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "OtherPerfMeasureAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Other Performance Measure, Amount", "label": "Other Performance Measure, Amount" } } }, "auth_ref": [ "r1019" ] }, "mms_OtherUnitedStateGovernmentAgenciesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "OtherUnitedStateGovernmentAgenciesMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other U.S. state government agencies", "label": "Other United State Government Agencies [Member]", "documentation": "Other United State Government Agencies" } } }, "auth_ref": [] }, "mms_OutsideTheUnitedStatesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "OutsideTheUnitedStatesMember", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Outside the U.S.", "label": "Outside The United States [Member]", "documentation": "Outside The United States [Member]" } } }, "auth_ref": [] }, "ecd_OutstandingAggtErrCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "OutstandingAggtErrCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount", "label": "Outstanding Aggregate Erroneous Compensation Amount" } } }, "auth_ref": [ "r981", "r991", "r1001", "r1033" ] }, "ecd_OutstandingRecoveryCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "OutstandingRecoveryCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Compensation Amount", "label": "Outstanding Recovery Compensation Amount" } } }, "auth_ref": [ "r984", "r994", "r1004", "r1036" ] }, "ecd_OutstandingRecoveryIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "OutstandingRecoveryIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Outstanding Recovery, Individual Name" } } }, "auth_ref": [ "r984", "r994", "r1004", "r1036" ] }, "ecd_PayVsPerformanceDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PayVsPerformanceDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Pay vs Performance Disclosure [Line Items]" } } }, "auth_ref": [ "r1008" ] }, "us-gaap_PaymentsForProceedsFromOtherInvestingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsForProceedsFromOtherInvestingActivities", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Other", "label": "Payment for (Proceeds from) Other Investing Activity", "documentation": "Amount of cash (inflow) outflow from investing activity, classified as other." } } }, "auth_ref": [ "r1149", "r1150" ] }, "us-gaap_PaymentsForRepurchaseOfCommonStock": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsForRepurchaseOfCommonStock", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of Maximus common stock", "label": "Payments for Repurchase of Common Stock", "documentation": "The cash outflow to reacquire common stock during the period." } } }, "auth_ref": [ "r28" ] }, "us-gaap_PaymentsOfFinancingCosts": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsOfFinancingCosts", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 4.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Payments for debt financing costs", "label": "Payments of Financing Costs", "documentation": "The cash outflow for loan and debt issuance costs." } } }, "auth_ref": [ "r13" ] }, "us-gaap_PaymentsOfOrdinaryDividends": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsOfOrdinaryDividends", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Cash dividends paid to Maximus shareholders", "label": "Payments of Ordinary Dividends", "documentation": "Cash outflow in the form of ordinary dividends to common shareholders, preferred shareholders and noncontrolling interests, generally out of earnings." } } }, "auth_ref": [ "r28" ] }, "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Tax withholding related to RSU vesting", "label": "Payment, Tax Withholding, Share-Based Payment Arrangement", "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement." } } }, "auth_ref": [ "r164" ] }, "us-gaap_PaymentsToAcquireProductiveAssets": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PaymentsToAcquireProductiveAssets", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": -1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedLabel": "Purchases of property and equipment and capitalized software", "label": "Payments to Acquire Productive Assets", "documentation": "The cash outflow for purchases of and capital improvements on property, plant and equipment (capital expenditures), software, and other intangible assets." } } }, "auth_ref": [ "r42", "r1272", "r1273", "r1274" ] }, "ecd_PeerGroupIssuersFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeerGroupIssuersFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Issuers, Footnote", "label": "Peer Group Issuers, Footnote [Text Block]" } } }, "auth_ref": [ "r1018" ] }, "ecd_PeerGroupTotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeerGroupTotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Peer Group Total Shareholder Return Amount", "label": "Peer Group Total Shareholder Return Amount" } } }, "auth_ref": [ "r1018" ] }, "ecd_PeoActuallyPaidCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeoActuallyPaidCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Actually Paid Compensation Amount", "label": "PEO Actually Paid Compensation Amount" } } }, "auth_ref": [ "r1010" ] }, "ecd_PeoMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeoMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO", "label": "PEO [Member]" } } }, "auth_ref": [ "r1027" ] }, "ecd_PeoName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeoName", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Name", "label": "PEO Name" } } }, "auth_ref": [ "r1020" ] }, "ecd_PeoTotalCompAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PeoTotalCompAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "PEO Total Compensation Amount", "label": "PEO Total Compensation Amount" } } }, "auth_ref": [ "r1009" ] }, "mms_PerformanceBasedContractsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "PerformanceBasedContractsMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance-based", "label": "Performance Based Contracts [Member]", "documentation": "Reflects the percentage that revenues during the period from performance-based contracts are to total revenues. May also reflect the percentage contribution the product made to operating results. Risk is materially adverse effects of a loss of sales of a significant product or line of products, which could occur upon loss of rights to sell, distribute or license others; loss of patent or copyright protection; or technological obsolescence." } } }, "auth_ref": [] }, "us-gaap_PerformanceSharesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PerformanceSharesMember", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Performance Shares", "label": "Performance Shares [Member]", "documentation": "Share-based payment arrangement awarded for meeting performance target." } } }, "auth_ref": [ "r1244", "r1245", "r1246", "r1247", "r1248", "r1249", "r1250", "r1251", "r1252", "r1253", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269" ] }, "ecd_PnsnAdjsPrrSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PnsnAdjsPrrSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Prior Service Cost", "label": "Pension Adjustments Prior Service Cost [Member]" } } }, "auth_ref": [ "r1011" ] }, "ecd_PnsnAdjsSvcCstMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PnsnAdjsSvcCstMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Adjustments Service Cost", "label": "Pension Adjustments Service Cost [Member]" } } }, "auth_ref": [ "r1055" ] }, "ecd_PnsnBnftsAdjFnTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PnsnBnftsAdjFnTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pension Benefits Adjustments, Footnote", "label": "Pension Benefits Adjustments, Footnote [Text Block]" } } }, "auth_ref": [ "r1010" ] }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PrepaidExpenseAndOtherAssetsCurrent", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0, "order": 4.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Prepaid expenses and other current assets", "label": "Prepaid Expense and Other Assets, Current", "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer." } } }, "auth_ref": [ "r1091" ] }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromDivestitureOfBusinesses", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from divestitures", "label": "Proceeds from Divestiture of Businesses", "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period." } } }, "auth_ref": [ "r12" ] }, "us-gaap_ProceedsFromIssuanceOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromIssuanceOfDebt", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 5.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Proceeds from borrowings", "label": "Proceeds from Issuance of Debt", "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt." } } }, "auth_ref": [ "r1152" ] }, "us-gaap_ProceedsFromPaymentsForOtherFinancingActivities": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ProceedsFromPaymentsForOtherFinancingActivities", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": 1.0, "order": 7.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Other, including customer escrowed funds", "label": "Proceeds from (Payment for) Other Financing Activity", "documentation": "Amount of cash inflow (outflow) from financing activity, classified as other." } } }, "auth_ref": [ "r1059", "r1151" ] }, "srt_ProductOrServiceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ProductOrServiceAxis", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Axis]", "label": "Product and Service [Axis]", "documentation": "Information by product and service, or group of similar products and similar services." } } }, "auth_ref": [ "r56", "r57", "r58", "r59", "r60", "r61", "r74", "r247", "r681", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r854", "r874", "r877", "r879", "r906", "r907", "r953", "r955", "r956", "r959", "r962", "r1071", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129", "r1130", "r1131", "r1132", "r1133", "r1134", "r1135", "r1136", "r1137", "r1138", "r1139", "r1140", "r1141", "r1142", "r1143", "r1145", "r1146", "r1147", "r1148", "r1227", "r1228", "r1341", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1370", "r1371", "r1372", "r1373", "r1374", "r1375", "r1376", "r1377", "r1378", "r1379", "r1380", "r1381", "r1382" ] }, "srt_ProductsAndServicesDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "ProductsAndServicesDomain", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Product and Service [Domain]", "label": "Product and Service [Domain]", "documentation": "Product or service, or a group of similar products or similar services." } } }, "auth_ref": [ "r56", "r57", "r58", "r59", "r60", "r61", "r74", "r247", "r681", "r754", "r755", "r756", "r757", "r758", "r759", "r760", "r854", "r874", "r877", "r879", "r906", "r907", "r953", "r955", "r956", "r959", "r962", "r1071", "r1106", "r1107", "r1108", "r1109", "r1110", "r1111", "r1112", "r1113", "r1114", "r1115", "r1116", "r1117", "r1118", "r1119", "r1120", "r1121", "r1122", "r1123", "r1124", "r1125", "r1126", "r1127", "r1128", "r1129", "r1130", "r1131", "r1132", "r1133", "r1134", "r1135", "r1136", "r1137", "r1138", "r1139", "r1140", "r1141", "r1142", "r1143", "r1145", "r1146", "r1147", "r1148", "r1227", "r1228", "r1341", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1370", "r1371", "r1372", "r1373", "r1374", "r1375", "r1376", "r1377", "r1378", "r1379", "r1380", "r1381", "r1382" ] }, "mms_ProgramOperationsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "ProgramOperationsMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Program Operations", "label": "Program Operations [Member]", "documentation": "Program Operations" } } }, "auth_ref": [] }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentByTypeAxis", "presentation": [ "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, Type [Axis]", "label": "Long-Lived Asset, Class [Axis]", "documentation": "Information by class of long-lived asset. Includes, but is not limited to, property, plant, and equipment; right-of-use asset from finance lease; long-lived asset of lessor subject to operating lease; proved oil and gas property accounted for under successful efforts method; and long-term prepaid asset." } } }, "auth_ref": [ "r323", "r324", "r633", "r896", "r897", "r898", "r899", "r1205", "r1206", "r1332" ] }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentLineItems", "presentation": [ "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant, and Equipment [Line Items]", "label": "Property, Plant, and Equipment [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r323", "r324", "r633", "r896", "r897", "r898", "r899", "r1205", "r1206", "r1332" ] }, "us-gaap_PropertyPlantAndEquipmentNet": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentNet", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_Assets", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Property and equipment, net", "label": "Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization", "documentation": "Amount, after accumulated depreciation, depletion, and amortization, of property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r633", "r684", "r685", "r698", "r723", "r724", "r734", "r950", "r1210" ] }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "PropertyPlantAndEquipmentTypeDomain", "presentation": [ "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant and Equipment, Type [Domain]", "label": "Long-Lived Asset, Class [Domain]", "documentation": "Class of long-lived asset. Includes, but is not limited to, property, plant, and equipment; right-of-use asset from finance lease; long-lived asset of lessor subject to operating lease; proved oil and gas property accounted for under successful efforts method; and long-term prepaid asset." } } }, "auth_ref": [ "r323", "r324", "r633", "r896", "r897", "r898", "r899", "r1205", "r1206", "r1332" ] }, "ecd_PvpTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PvpTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure", "label": "Pay vs Performance Disclosure [Table]" } } }, "auth_ref": [ "r1008" ] }, "ecd_PvpTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "PvpTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Pay vs Performance Disclosure, Table", "label": "Pay vs Performance [Table Text Block]" } } }, "auth_ref": [ "r1008" ] }, "srt_RangeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "RangeAxis", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Range [Axis]", "label": "Statistical Measurement [Axis]", "documentation": "Information by statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r51", "r52", "r53", "r54", "r55", "r62", "r63", "r64", "r75", "r76", "r104", "r106", "r217", "r343", "r344", "r345", "r346", "r444", "r454", "r484", "r485", "r486", "r490", "r492", "r596", "r644", "r645", "r646", "r647", "r649", "r650", "r651", "r652", "r661", "r678", "r761", "r762", "r769", "r781", "r782", "r830", "r831", "r832", "r833", "r843", "r845", "r846", "r847", "r848", "r851", "r852", "r893", "r921", "r924", "r927", "r928", "r940", "r941", "r945", "r946", "r955", "r964", "r1224", "r1233", "r1234", "r1306" ] }, "srt_RangeMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "RangeMember", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Range [Domain]", "label": "Statistical Measurement [Domain]", "documentation": "Statistical measurement. Includes, but is not limited to, minimum, maximum, weighted average, arithmetic average, and median." } } }, "auth_ref": [ "r51", "r52", "r53", "r54", "r55", "r62", "r63", "r64", "r75", "r76", "r104", "r106", "r217", "r343", "r344", "r345", "r346", "r444", "r454", "r484", "r485", "r486", "r490", "r492", "r596", "r644", "r645", "r646", "r647", "r649", "r650", "r651", "r652", "r661", "r678", "r761", "r762", "r769", "r781", "r782", "r830", "r831", "r832", "r833", "r843", "r845", "r846", "r847", "r848", "r851", "r852", "r893", "r921", "r924", "r927", "r928", "r940", "r941", "r945", "r946", "r955", "r964", "r1224", "r1233", "r1234", "r1306" ] }, "us-gaap_ReceivablesBillingStatusDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ReceivablesBillingStatusDomain", "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails", "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables Billing Status [Domain]", "label": "Receivables Billing Status [Domain]", "documentation": "Amounts due from customers (or dealers) within the next year (or operating cycle, if longer) for goods or services that have been delivered or used, but not yet paid." } } }, "auth_ref": [ "r1089" ] }, "us-gaap_ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ReclassificationFromAociCurrentPeriodNetOfTaxAttributableToParent", "crdr": "debit", "calculation": { "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails": { "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Amounts reclassified from accumulated other comprehensive loss", "label": "Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent", "documentation": "Amount after tax of reclassification adjustments of other comprehensive income (loss) attributable to parent." } } }, "auth_ref": [ "r8", "r10" ] }, "ecd_RecoveryOfErrCompDisclosureLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "RecoveryOfErrCompDisclosureLineItems", "lang": { "en-us": { "role": { "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]" } } }, "auth_ref": [ "r976", "r986", "r996", "r1028" ] }, "us-gaap_RepaymentsOfDebt": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RepaymentsOfDebt", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities", "weight": -1.0, "order": 6.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Principal payments for debt", "label": "Repayments of Debt", "documentation": "Amount of cash outflow for short-term and long-term debt. Excludes payment of lease obligation." } } }, "auth_ref": [ "r1153" ] }, "ecd_RestatementDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "RestatementDateAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date:", "label": "Restatement Determination Date [Axis]" } } }, "auth_ref": [ "r977", "r987", "r997", "r1029" ] }, "ecd_RestatementDeterminationDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "RestatementDeterminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement Determination Date", "label": "Restatement Determination Date" } } }, "auth_ref": [ "r978", "r988", "r998", "r1030" ] }, "ecd_RestatementDoesNotRequireRecoveryTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "RestatementDoesNotRequireRecoveryTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Restatement does not require Recovery", "label": "Restatement Does Not Require Recovery [Text Block]" } } }, "auth_ref": [ "r985", "r995", "r1005", "r1037" ] }, "us-gaap_RestrictedCashAndCashEquivalents": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RestrictedCashAndCashEquivalents", "crdr": "debit", "calculation": { "http://www.maximus.com/role/OtherItemsScheduleofCashCashEquivalentsandRestrictedCashDetails": { "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "weight": 1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofCashCashEquivalentsandRestrictedCashDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted cash", "label": "Restricted Cash and Cash Equivalent", "documentation": "Amount of cash and cash equivalent restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposit with financial institution, and account with general characteristic of demand deposit. Cash equivalent includes, but is not limited to, short-term, highly liquid investment that is both readily convertible to known amount of cash and so near maturity that it presents insignificant risk of change in value because of change in interest rate." } } }, "auth_ref": [ "r116", "r168", "r171", "r730", "r1333", "r1334" ] }, "us-gaap_RestrictedStockUnitsRSUMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RestrictedStockUnitsRSUMember", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Restricted Stock Units (RSUs)", "label": "Restricted Stock Units (RSUs) [Member]", "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met." } } }, "auth_ref": [ "r1244", "r1245", "r1246", "r1247", "r1248", "r1249", "r1250", "r1251", "r1252", "r1253", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269" ] }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RetainedEarningsAccumulatedDeficit", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_StockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Retained earnings", "label": "Retained Earnings (Accumulated Deficit)", "documentation": "Amount of accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r141", "r143", "r412", "r684", "r685", "r696", "r732", "r766", "r768", "r776", "r792", "r950" ] }, "us-gaap_RetainedEarningsMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RetainedEarningsMember", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Retained Earnings", "label": "Retained Earnings [Member]", "documentation": "Accumulated undistributed earnings (deficit)." } } }, "auth_ref": [ "r77", "r78", "r179", "r180", "r181", "r183", "r190", "r192", "r194", "r285", "r286", "r318", "r319", "r320", "r390", "r409", "r418", "r439", "r440", "r442", "r443", "r491", "r499", "r500", "r502", "r503", "r504", "r506", "r509", "r510", "r573", "r574", "r575", "r577", "r579", "r580", "r582", "r587", "r630", "r677", "r725", "r763", "r765", "r777", "r1238", "r1239", "r1385" ] }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenueFromContractWithCustomerAbstract", "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "auth_ref": [] }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_GrossProfit", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/ConsolidatedStatementsofOperations", "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails", "http://www.maximus.com/role/RevenueRecognitionScheduleofEffectofChangesinContractEstimatesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue", "netLabel": "Total revenue", "verboseLabel": "Increase/(decrease) in revenue recognized due to changes in contract estimates", "label": "Revenue from Contract with Customer, Excluding Assessed Tax", "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise." } } }, "auth_ref": [ "r211", "r223", "r224", "r238", "r244", "r247", "r249", "r250", "r433", "r434", "r435", "r681", "r875", "r879" ] }, "us-gaap_RevenueFromContractWithCustomerTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenueFromContractWithCustomerTextBlock", "presentation": [ "http://www.maximus.com/role/RevenueRecognition" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Recognition", "label": "Revenue from Contract with Customer [Text Block]", "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts." } } }, "auth_ref": [ "r49", "r423", "r425", "r426", "r427", "r428", "r429", "r431", "r432", "r435", "r438" ] }, "us-gaap_RevenueRemainingPerformanceObligation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenueRemainingPerformanceObligation", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, remaining performance obligation, amount", "label": "Revenue, Remaining Performance Obligation, Amount", "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue." } } }, "auth_ref": [ "r46" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, remaining performance obligation, expected timing of satisfaction, period", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period", "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days." } } }, "auth_ref": [ "r430" ] }, "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]", "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format." } } }, "auth_ref": [ "r430" ] }, "us-gaap_RevenueRemainingPerformanceObligationPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevenueRemainingPerformanceObligationPercentage", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue, remaining performance obligation, percentage (as a percent)", "label": "Revenue, Remaining Performance Obligation, Percentage", "documentation": "Percentage of remaining performance obligation to total remaining performance obligation not recognized as revenue." } } }, "auth_ref": [ "r1060" ] }, "us-gaap_RevolvingCreditFacilityMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "RevolvingCreditFacilityMember", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revolver", "label": "Revolving Credit Facility [Member]", "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount." } } }, "auth_ref": [] }, "ecd_Rule10b51ArrAdoptedFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "Rule10b51ArrAdoptedFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Adopted", "label": "Rule 10b5-1 Arrangement Adopted [Flag]" } } }, "auth_ref": [ "r1046" ] }, "ecd_Rule10b51ArrTrmntdFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "Rule10b51ArrTrmntdFlag", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Rule 10b5-1 Arrangement Terminated", "label": "Rule 10b5-1 Arrangement Terminated [Flag]" } } }, "auth_ref": [ "r1046" ] }, "us-gaap_SalesRevenueNetMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SalesRevenueNetMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Revenue Benchmark", "label": "Revenue Benchmark [Member]", "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation." } } }, "auth_ref": [ "r250", "r1174", "r1175" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTable", "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table]", "label": "Accounts and Financing Receivables [Table]", "documentation": "Disclosure of information about accounts and financing receivables. Includes, but is not limited to, amount of receivable and allowance for credit loss." } } }, "auth_ref": [ "r252", "r1090", "r1195" ] }, "us-gaap_ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfAccountsNotesLoansAndFinancingReceivableTextBlock", "presentation": [ "http://www.maximus.com/role/OtherItemsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accounts Receivable, Net", "label": "Schedule of Accounts, Notes, Loans and Financing Receivable [Table Text Block]", "documentation": "Tabular disclosure of the various types of trade accounts and notes receivable and for each the gross carrying value, allowance, and net carrying value as of the balance sheet date. Presentation is categorized by current, noncurrent and unclassified receivables." } } }, "auth_ref": [ "r1193", "r1194" ] }, "us-gaap_ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfAccumulatedOtherComprehensiveIncomeLossTableTextBlock", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Accumulated Other Comprehensive Loss", "label": "Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]", "documentation": "Tabular disclosure of the components of accumulated other comprehensive income (loss)." } } }, "auth_ref": [ "r10", "r1322", "r1323" ] }, "us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfCashAndCashEquivalentsTableTextBlock", "presentation": [ "http://www.maximus.com/role/OtherItemsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Cash and Cash Equivalents", "label": "Schedule of Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of the components of cash and cash equivalents." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfCashFlowSupplementalDisclosuresTableTextBlock", "presentation": [ "http://www.maximus.com/role/OtherItemsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Supplementary Cash Flow Information", "label": "Schedule of Cash Flow, Supplemental Disclosures [Table Text Block]", "documentation": "Tabular disclosure of supplemental cash flow information for the periods presented." } } }, "auth_ref": [ "r1057" ] }, "us-gaap_ScheduleOfDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfDebtTableTextBlock", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Debt", "label": "Schedule of Debt [Table Text Block]", "documentation": "Tabular disclosure of information pertaining to short-term and long-debt instruments or arrangements, including but not limited to identification of terms, features, collateral requirements and other information necessary to a fair presentation." } } }, "auth_ref": [] }, "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock", "presentation": [ "http://www.maximus.com/role/EarningsPerShareTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Weighted Average Number of Shares used to Compute Earnings Per Share", "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]", "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations." } } }, "auth_ref": [ "r1171" ] }, "us-gaap_ScheduleOfInterestRateDerivativesTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfInterestRateDerivativesTableTextBlock", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Interest Rate Derivative Instruments", "label": "Schedule of Interest Rate Derivatives [Table Text Block]", "documentation": "Tabular disclosure of interest rate derivatives, including, but not limited to, the fair value of the derivatives, statement of financial position location, and statement of financial performance location of these instruments." } } }, "auth_ref": [ "r1277", "r1281", "r1286", "r1296" ] }, "us-gaap_ScheduleOfMaturitiesOfLongTermDebtTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfMaturitiesOfLongTermDebtTableTextBlock", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Future Minimum Principal Payments Due", "label": "Schedule of Maturities of Long-Term Debt [Table Text Block]", "documentation": "Tabular disclosure of maturity and sinking fund requirement for long-term debt." } } }, "auth_ref": [ "r6" ] }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "presentation": [ "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Property, Plant, and Equipment [Table]", "label": "Property, Plant, and Equipment [Table]", "documentation": "Disclosure of information about property, plant, and equipment. Includes, but is not limited to, land and land improvement; building; machinery and equipment; furniture and fixture; and work of art, historical treasure, or similar asset classified as collection." } } }, "auth_ref": [ "r323", "r324", "r633", "r896", "r897", "r898", "r899", "r1205", "r1206", "r1332" ] }, "us-gaap_ScheduleOfRestrictedCashAndCashEquivalentsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfRestrictedCashAndCashEquivalentsTextBlock", "presentation": [ "http://www.maximus.com/role/OtherItemsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Restricted Cash and Cash Equivalents", "label": "Restrictions on Cash and Cash Equivalents [Table Text Block]", "documentation": "Tabular disclosure of cash and cash equivalents restricted as to withdrawal or usage." } } }, "auth_ref": [ "r1058", "r1340" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfSegmentReportingInformationBySegmentTable", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Table]", "label": "Segment Reporting [Table]", "documentation": "Disclosure of information about segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total." } } }, "auth_ref": [ "r219", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246" ] }, "us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfSegmentReportingInformationBySegmentTextBlock", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsTables" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Results of Operations by Business Segment", "label": "Segment Reporting [Table Text Block]", "documentation": "Tabular disclosure of segment reporting. Includes, but is not limited to, reconciliation of reportable segment amount to corresponding consolidated total." } } }, "auth_ref": [ "r1178", "r1180", "r1181", "r1182", "r1183", "r1184", "r1185", "r1187", "r1188", "r1191" ] }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]", "documentation": "Disclosure of information about share-based payment arrangement." } } }, "auth_ref": [ "r456", "r458", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r490" ] }, "us-gaap_SecuredDebtMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SecuredDebtMember", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan", "verboseLabel": "Secured Debt", "label": "Secured Debt [Member]", "documentation": "Collateralized debt obligation backed by, for example, but not limited to, pledge, mortgage or other lien on the entity's assets." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "Security12bTitle", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r971" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "SecurityExchangeName", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r973" ] }, "mms_SegmentCostOfRevenueAsPercentOfSegmentRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "SegmentCostOfRevenueAsPercentOfSegmentRevenue", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cost of revenue (as a percent)", "label": "Segment Cost of Revenue as Percent of Segment Revenue", "documentation": "Segment Cost of Revenue as Percent of Segment Revenue" } } }, "auth_ref": [] }, "mms_SegmentDepreciationAndAmortizationAsPercentOfSegmentRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "SegmentDepreciationAndAmortizationAsPercentOfSegmentRevenue", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Depreciation and amortization (as a percent)", "label": "Segment Depreciation and Amortization as Percent of Segment Revenue", "documentation": "Segment Depreciation and Amortization as Percent of Segment Revenue" } } }, "auth_ref": [] }, "us-gaap_SegmentDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentDomain", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Domain]", "label": "Segments [Domain]", "documentation": "Components of an entity that engage in business activities from which they may earn revenue and incur expenses, including transactions with other components of the same entity." } } }, "auth_ref": [ "r85", "r211", "r219", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r250", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r317", "r326", "r332", "r339", "r340", "r507", "r508", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r885", "r888", "r889", "r895", "r957", "r1341", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1381", "r1382" ] }, "mms_SegmentGrossProfitAsPercentOfSegmentRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "SegmentGrossProfitAsPercentOfSegmentRevenue", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Gross profit (as a percent)", "label": "Segment Gross Profit as Percent of Segment Revenue", "documentation": "Represents segment gross profit expressed as a percentage of segment revenues." } } }, "auth_ref": [] }, "mms_SegmentOperatingIncomeLoss": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "SegmentOperatingIncomeLoss", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment operating income/(loss)", "label": "Segment Operating Income (Loss)", "documentation": "Segment Operating Income (Loss)" } } }, "auth_ref": [] }, "mms_SegmentOperatingIncomeLossAsPercentOfSegmentRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "SegmentOperatingIncomeLossAsPercentOfSegmentRevenue", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segment operating income/(loss) (as a percent)", "label": "Segment Operating Income (Loss) as Percent of Segment Revenue", "documentation": "Represents segment operating income expressed as a percentage of segment revenues." } } }, "auth_ref": [] }, "mms_SegmentOtherExpenseAsPercentOfSegmentRevenue": { "xbrltype": "percentItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "SegmentOtherExpenseAsPercentOfSegmentRevenue", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other segment items (as a percent)", "label": "Segment Other Expense as Percent of Segment Revenue", "documentation": "Segment Other Expense as Percent of Segment Revenue" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingAbstract", "lang": { "en-us": { "role": { "terseLabel": "Segment Reporting [Abstract]", "label": "Segment Reporting [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SegmentReportingDisclosureTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingDisclosureTextBlock", "presentation": [ "http://www.maximus.com/role/BusinessSegments" ], "lang": { "en-us": { "role": { "terseLabel": "Business Segments", "label": "Segment Reporting [Text Block]", "documentation": "The entire disclosure for segment reporting." } } }, "auth_ref": [ "r211", "r218", "r219", "r220", "r221", "r222", "r234", "r236", "r237", "r242", "r243", "r244", "r245", "r246", "r247", "r248", "r250", "r884", "r886", "r887", "r888", "r890", "r891", "r892" ] }, "us-gaap_SegmentReportingInformationLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingInformationLineItems", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial information for each of the Company's business segments", "label": "Segment Reporting [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r219", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246" ] }, "us-gaap_SegmentReportingOtherItemAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SegmentReportingOtherItemAmount", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Other segment items", "label": "Segment Reporting, Other Segment Item, Amount", "documentation": "Amount of other expense (income) and loss (gain) calculated as difference between segment revenue and separately disclosed expense category to arrive at segment profit (loss)." } } }, "auth_ref": [ "r211", "r236", "r237", "r244", "r888" ] }, "us-gaap_SellingGeneralAndAdministrativeExpense": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SellingGeneralAndAdministrativeExpense", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofOperations": { "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0, "order": 2.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Selling, general, and administrative expenses", "label": "Selling, General and Administrative Expense", "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc." } } }, "auth_ref": [ "r26", "r874", "r875", "r876", "r879", "r1144" ] }, "us-gaap_ShareBasedCompensation": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensation", "crdr": "debit", "calculation": { "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows": { "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0, "order": 6.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofCashFlows" ], "lang": { "en-us": { "role": { "terseLabel": "Stock compensation expense", "label": "Share-Based Payment Arrangement, Noncash Expense", "documentation": "Amount of noncash expense for share-based payment arrangement." } } }, "auth_ref": [ "r4" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "xbrltype": "durationItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting period", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period", "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition." } } }, "auth_ref": [ "r922" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock-based compensation", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r456", "r458", "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r482", "r483", "r484", "r485", "r486", "r487", "r490" ] }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Shares issued (in shares)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period", "documentation": "Number of shares issued under share-based payment arrangement." } } }, "auth_ref": [ "r16" ] }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "presentation": [ "http://www.maximus.com/role/EquityDetails", "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Award [Domain]", "label": "Award Type [Domain]", "documentation": "Award under share-based payment arrangement." } } }, "auth_ref": [ "r461", "r462", "r463", "r464", "r465", "r466", "r467", "r468", "r469", "r470", "r471", "r472", "r473", "r474", "r475", "r476", "r477", "r478", "r479", "r480", "r481", "r483", "r484", "r485", "r486", "r487" ] }, "mms_ShareRepurchaseProgramExciseTaxPercent": { "xbrltype": "percentItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "ShareRepurchaseProgramExciseTaxPercent", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Excise tax (as a percent)", "label": "Share Repurchase Program, Excise Tax, Percent", "documentation": "Share Repurchase Program, Excise Tax, Percent" } } }, "auth_ref": [] }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage": { "xbrltype": "percentItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting rights (as a percent)", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Rights, Percentage", "documentation": "Percentage of vesting of award under share-based payment arrangement." } } }, "auth_ref": [ "r1244" ] }, "us-gaap_StatementBusinessSegmentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementBusinessSegmentsAxis", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Segments [Axis]", "label": "Segments [Axis]", "documentation": "Information by business segments." } } }, "auth_ref": [ "r85", "r211", "r219", "r222", "r223", "r224", "r225", "r226", "r227", "r228", "r229", "r230", "r231", "r232", "r233", "r235", "r236", "r237", "r238", "r239", "r240", "r241", "r242", "r244", "r245", "r246", "r250", "r306", "r307", "r308", "r309", "r310", "r311", "r312", "r313", "r314", "r317", "r326", "r332", "r339", "r340", "r507", "r508", "r743", "r744", "r745", "r746", "r747", "r748", "r749", "r750", "r751", "r752", "r753", "r885", "r888", "r889", "r895", "r957", "r1341", "r1344", "r1345", "r1346", "r1347", "r1348", "r1349", "r1350", "r1351", "r1352", "r1353", "r1354", "r1355", "r1356", "r1357", "r1358", "r1359", "r1360", "r1361", "r1362", "r1363", "r1364", "r1365", "r1366", "r1367", "r1368", "r1369", "r1381", "r1382" ] }, "us-gaap_StatementEquityComponentsAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementEquityComponentsAxis", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Equity Components [Axis]", "label": "Equity Components [Axis]", "documentation": "Information by component of equity." } } }, "auth_ref": [ "r77", "r78", "r109", "r138", "r139", "r155", "r156", "r157", "r179", "r180", "r181", "r183", "r190", "r192", "r194", "r212", "r285", "r286", "r318", "r319", "r320", "r390", "r404", "r409", "r410", "r411", "r414", "r416", "r418", "r439", "r440", "r442", "r443", "r491", "r499", "r500", "r502", "r503", "r504", "r506", "r509", "r510", "r573", "r574", "r575", "r577", "r578", "r579", "r580", "r581", "r582", "r583", "r584", "r585", "r586", "r587", "r620", "r621", "r622", "r623", "r624", "r625", "r630", "r634", "r677", "r684", "r685", "r694", "r695", "r725", "r737", "r763", "r764", "r765", "r777", "r827", "r1240" ] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementLineItems", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement", "label": "Statement [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [ "r109", "r110", "r114", "r115", "r120", "r130", "r132", "r136", "r137", "r138", "r139", "r143", "r179", "r180", "r181", "r212", "r392", "r393", "r395", "r397", "r399", "r404", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r416", "r417", "r418", "r420", "r630", "r681", "r684", "r685", "r693", "r694", "r695", "r774", "r778", "r779", "r783", "r784", "r785", "r786", "r787", "r788", "r791", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r804", "r805", "r806", "r807", "r808", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r827", "r864", "r877", "r879", "r965", "r1384" ] }, "us-gaap_StatementOfCashFlowsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfCashFlowsAbstract", "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfFinancialPositionAbstract", "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfFinancialPositionLocationBalanceAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfFinancialPositionLocationBalanceAxis", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Balance Sheet Location [Axis]", "label": "Location, Statement of Financial Position, Balance [Axis]", "documentation": "Information by location in statement of financial position line item where disaggregated cumulative balance is reported." } } }, "auth_ref": [ "r338", "r528", "r531", "r532", "r533", "r534", "r552", "r553", "r554", "r555", "r556", "r557", "r558", "r616", "r931", "r932", "r1342", "r1343" ] }, "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract", "lang": { "en-us": { "role": { "label": "Statement of Comprehensive Income [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementOfStockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementOfStockholdersEquityAbstract", "lang": { "en-us": { "role": { "label": "Statement of Stockholders' Equity [Abstract]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StatementTable", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "Statement [Table]", "label": "Statement [Table]", "documentation": "Presentation of information about comprehensive income, income, other comprehensive income, financial position, cash flows, and shareholders' equity." } } }, "auth_ref": [ "r83", "r109", "r110", "r114", "r115", "r120", "r130", "r132", "r136", "r137", "r138", "r139", "r143", "r179", "r180", "r181", "r212", "r251", "r392", "r393", "r395", "r397", "r399", "r404", "r406", "r407", "r408", "r409", "r410", "r411", "r412", "r413", "r414", "r416", "r417", "r418", "r420", "r630", "r681", "r684", "r685", "r693", "r694", "r695", "r725", "r774", "r778", "r779", "r783", "r784", "r785", "r786", "r787", "r788", "r791", "r794", "r795", "r796", "r797", "r798", "r799", "r800", "r801", "r802", "r804", "r805", "r806", "r807", "r808", "r811", "r812", "r813", "r814", "r815", "r816", "r817", "r818", "r819", "r820", "r821", "r822", "r823", "r824", "r827", "r864", "r877", "r879", "r965", "r1384" ] }, "ecd_StkPrcOrTsrEstimationMethodTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "StkPrcOrTsrEstimationMethodTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Price or TSR Estimation Method", "label": "Stock Price or TSR Estimation Method [Text Block]" } } }, "auth_ref": [ "r980", "r990", "r1000", "r1032" ] }, "us-gaap_StockAppreciationRightsSARSMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockAppreciationRightsSARSMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Stock Appreciation Rights (SARs)", "label": "Stock Appreciation Rights (SARs) [Member]", "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period." } } }, "auth_ref": [ "r1244", "r1245", "r1246", "r1247", "r1248", "r1249", "r1250", "r1251", "r1252", "r1253", "r1254", "r1255", "r1256", "r1257", "r1258", "r1259", "r1260", "r1261", "r1262", "r1263", "r1264", "r1265", "r1266", "r1267", "r1268", "r1269" ] }, "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensationGross": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockIssuedDuringPeriodSharesShareBasedCompensationGross", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "terseLabel": "RSUs vested (in shares)", "label": "Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture", "documentation": "Number, before forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP)." } } }, "auth_ref": [ "r1079", "r1086", "r1087", "r1235", "r1236", "r1237" ] }, "srt_StockRepurchaseProgramAuthorizedAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "StockRepurchaseProgramAuthorizedAmount1", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Stock repurchase programs, authorized amount", "label": "Share Repurchase Program, Authorized, Amount", "documentation": "Amount authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [ "r1240" ] }, "us-gaap_StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Amount remaining available for future stock repurchases", "label": "Share Repurchase Program, Remaining Authorized, Amount", "documentation": "Amount remaining authorized for purchase of share under share repurchase plan. Includes, but is not limited to, repurchase of stock and unit of ownership." } } }, "auth_ref": [ "r1240" ] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockRepurchasedAndRetiredDuringPeriodShares", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of Maximus common stock (in shares)", "label": "Stock Repurchased and Retired During Period, Shares", "documentation": "Number of shares that have been repurchased and retired during the period." } } }, "auth_ref": [ "r1079", "r1086", "r1087", "r1235", "r1236", "r1237", "r1238", "r1239", "r1333", "r1334", "r1337", "r1338" ] }, "us-gaap_StockRepurchasedAndRetiredDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockRepurchasedAndRetiredDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity" ], "lang": { "en-us": { "role": { "negatedTerseLabel": "Purchases of Maximus common stock", "label": "Stock Repurchased and Retired During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased and retired during the period. The excess of the purchase price over par value can be charged against retained earnings (once the excess is fully allocated to additional paid in capital)." } } }, "auth_ref": [ "r1079", "r1086", "r1087", "r1235", "r1236", "r1237", "r1238", "r1239", "r1333", "r1334", "r1337", "r1338" ] }, "us-gaap_StockRepurchasedDuringPeriodShares": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockRepurchasedDuringPeriodShares", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares repurchased (in shares)", "label": "Stock Repurchased During Period, Shares", "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r775", "r827", "r844", "r1079", "r1086", "r1087", "r1235", "r1236", "r1237", "r1238", "r1239", "r1333", "r1334", "r1337", "r1338" ] }, "us-gaap_StockRepurchasedDuringPeriodValue": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockRepurchasedDuringPeriodValue", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Common shares repurchased, value", "label": "Stock Repurchased During Period, Value", "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock." } } }, "auth_ref": [ "r777", "r827", "r844", "r969", "r1079", "r1086", "r1087", "r1235", "r1236", "r1237", "r1238", "r1239", "r1333", "r1334", "r1337", "r1338" ] }, "us-gaap_StockholdersEquity": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquity", "crdr": "credit", "calculation": { "http://www.maximus.com/role/ConsolidatedBalanceSheets": { "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0, "order": 3.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets", "http://www.maximus.com/role/ConsolidatedStatementsofChangesinShareholdersEquity", "http://www.maximus.com/role/FairValueMeasurementsScheduleofAccumulatedOtherComprehensiveLossDetails" ], "lang": { "en-us": { "role": { "totalLabel": "Total shareholders' equity", "periodStartLabel": "Beginning balance", "periodEndLabel": "Ending balance", "label": "Equity, Attributable to Parent", "documentation": "Amount of equity (deficit) attributable to parent. Excludes temporary equity and equity attributable to noncontrolling interest." } } }, "auth_ref": [ "r32", "r793", "r809", "r828", "r829", "r950", "r970", "r1092", "r1158", "r1162", "r1163", "r1200", "r1321", "r1385" ] }, "us-gaap_StockholdersEquityAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "StockholdersEquityAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedBalanceSheets" ], "lang": { "en-us": { "role": { "terseLabel": "Shareholders' equity:", "label": "Equity, Attributable to Parent [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventLineItems", "presentation": [ "http://www.maximus.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Line Items]", "label": "Subsequent Event [Line Items]", "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event." } } }, "auth_ref": [ "r626", "r636" ] }, "us-gaap_SubsequentEventMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventMember", "presentation": [ "http://www.maximus.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Event [Member]", "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r626", "r636" ] }, "us-gaap_SubsequentEventTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventTable", "presentation": [ "http://www.maximus.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event [Table]", "label": "Subsequent Event [Table]", "documentation": "Disclosure of information about significant event or transaction occurring between statement of financial position date and date when financial statements were issued." } } }, "auth_ref": [ "r626", "r636" ] }, "us-gaap_SubsequentEventTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventTypeAxis", "presentation": [ "http://www.maximus.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Axis]", "label": "Subsequent Event Type [Axis]", "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r626", "r636" ] }, "us-gaap_SubsequentEventTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventTypeDomain", "presentation": [ "http://www.maximus.com/role/SubsequentEventDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event Type [Domain]", "label": "Subsequent Event Type [Domain]", "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "auth_ref": [ "r626", "r636" ] }, "us-gaap_SubsequentEventsAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventsAbstract", "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "auth_ref": [] }, "us-gaap_SubsequentEventsTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SubsequentEventsTextBlock", "presentation": [ "http://www.maximus.com/role/SubsequentEvent" ], "lang": { "en-us": { "role": { "terseLabel": "Subsequent Event", "label": "Subsequent Events [Text Block]", "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business." } } }, "auth_ref": [ "r635", "r637" ] }, "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "SupplementalBalanceSheetDisclosuresTextBlock", "presentation": [ "http://www.maximus.com/role/OtherItems" ], "lang": { "en-us": { "role": { "terseLabel": "Other Items", "label": "Supplemental Balance Sheet Disclosures [Text Block]", "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity." } } }, "auth_ref": [ "r1077" ] }, "ecd_TabularListTableTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TabularListTableTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Tabular List, Table", "label": "Tabular List [Table Text Block]" } } }, "auth_ref": [ "r1026" ] }, "us-gaap_TechnologyEquipmentMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TechnologyEquipmentMember", "presentation": [ "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Technology Equipment", "label": "Technology Equipment [Member]", "documentation": "Equipment used in the creation, maintenance and utilization of information systems which include computers and peripherals." } } }, "auth_ref": [ "r1210", "r1211" ] }, "mms_TechnologySolutionsMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TechnologySolutionsMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Technology Solutions", "label": "Technology Solutions [Member]", "documentation": "Technology Solutions [Member]" } } }, "auth_ref": [] }, "mms_TermLoanADue2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TermLoanADue2029Member", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan A (TLA)", "label": "Term Loan A, Due 2029 [Member]", "documentation": "Term Loan A, Due 2029" } } }, "auth_ref": [] }, "mms_TermLoanADueMay2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TermLoanADueMay2029Member", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan A", "label": "Term Loan A, Due May 2029 [Member]", "documentation": "Term Loan A, Due May 2029" } } }, "auth_ref": [] }, "mms_TermLoanADueSeptember2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TermLoanADueSeptember2027Member", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Term Loan A", "label": "Term Loan A, Due September 2027 [Member]", "documentation": "Term Loan A, Due September 2027" } } }, "auth_ref": [] }, "mms_TermLoanADueSeptember2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TermLoanADueSeptember2028Member", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Term Loan A", "label": "Term Loan A, Due September 2028 [Member]", "documentation": "Term Loan A, Due September 2028" } } }, "auth_ref": [] }, "mms_TermLoanBDueSeptember2026Member": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TermLoanBDueSeptember2026Member", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Term Loan B", "label": "Term Loan B, Due September 2026 [Member]", "documentation": "Term Loan B, Due September 2026" } } }, "auth_ref": [] }, "mms_TermLoanBDueSeptember2027Member": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TermLoanBDueSeptember2027Member", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "verboseLabel": "Term Loan B", "label": "Term Loan B, Due September 2027 [Member]", "documentation": "Term Loan B, Due September 2027" } } }, "auth_ref": [] }, "mms_TermLoanBDueSeptember2028Member": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TermLoanBDueSeptember2028Member", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan B", "label": "Term Loan B, Due September 2028 [Member]", "documentation": "Term Loan B, Due September 2028" } } }, "auth_ref": [] }, "mms_TermLoanBDueSeptember2029Member": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TermLoanBDueSeptember2029Member", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesScheduleofInterestRateDerivativeInstrumentsDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan B", "label": "Term Loan B, Due September 2029 [Member]", "documentation": "Term Loan B, Due September 2029" } } }, "auth_ref": [] }, "mms_TermLoanBMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TermLoanBMember", "presentation": [ "http://www.maximus.com/role/DebtAndDerivativesNarrativeDetails", "http://www.maximus.com/role/DebtAndDerivativesScheduleofDebtDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Term Loan B (TLB)", "label": "Term Loan B [Member]", "documentation": "Term Loan B" } } }, "auth_ref": [] }, "us-gaap_TimeAndMaterialsContractMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TimeAndMaterialsContractMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Time and materials", "label": "Time-and-Materials Contract [Member]", "documentation": "Contract with customer in which amount of consideration is based on time and materials consumed." } } }, "auth_ref": [ "r906", "r910" ] }, "srt_TitleOfIndividualAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "TitleOfIndividualAxis", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Title of Individual [Axis]", "label": "Title and Position [Axis]", "documentation": "Information by title and position of individual or group within organization." } } }, "auth_ref": [ "r1192", "r1327" ] }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/srt/2026", "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "presentation": [ "http://www.maximus.com/role/EquityDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Relationship to Entity [Domain]", "label": "Title and Position [Domain]", "documentation": "Title and position of individual or group within organization." } } }, "auth_ref": [] }, "ecd_TotalShareholderRtnAmt": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TotalShareholderRtnAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Amount", "label": "Total Shareholder Return Amount" } } }, "auth_ref": [ "r1018" ] }, "ecd_TotalShareholderRtnVsPeerGroupTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TotalShareholderRtnVsPeerGroupTextBlock", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Total Shareholder Return Vs Peer Group", "label": "Total Shareholder Return Vs Peer Group [Text Block]" } } }, "auth_ref": [ "r1025" ] }, "mms_TotalUnitedStatesStateGovernmentAgenciesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TotalUnitedStatesStateGovernmentAgenciesMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Total U.S. state government agencies", "label": "Total United States State Government Agencies [Member]", "documentation": "Total United States State Government Agencies [Member]" } } }, "auth_ref": [] }, "ecd_TradingArrAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TradingArrAxis", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangement:", "label": "Trading Arrangement [Axis]" } } }, "auth_ref": [ "r1045" ] }, "ecd_TradingArrByIndTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TradingArrByIndTable", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Arrangements, by Individual", "label": "Trading Arrangements, by Individual [Table]" } } }, "auth_ref": [ "r1047" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2026", "localname": "TradingSymbol", "presentation": [ "http://www.maximus.com/role/CoverPage" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TransferOfFinancialAssetsAccountedForAsSalesAmountDerecognized", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/OtherItemsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Transfer of financial assets, accounted for as sales", "label": "Transfer of Financial Assets Accounted for as Sales, Amount Derecognized", "documentation": "Amount of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction, at the date of derecognition." } } }, "auth_ref": [ "r656", "r951" ] }, "us-gaap_TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TransferOfFinancialAssetsAccountedForAsSalesCashProceedsReceivedForAssetsDerecognizedAmount", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/OtherItemsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Cash received from transfer of financial assets", "label": "Transfer of Financial Assets Accounted for as Sales, Cash Proceeds Received for Assets Derecognized, Amount", "documentation": "Amount, before counterparty netting, of cash proceeds received in transfers of derecognized financial assets from transactions which comprise an initial transfer and an agreement entered into in contemplation of the initial transfer resulting in retention of substantially all of the exposure to the economic return throughout the term of the transaction." } } }, "auth_ref": [ "r657", "r951" ] }, "mms_TransferOfFinancingAssetsMaximumAmountAuthorizedForSale": { "xbrltype": "monetaryItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "TransferOfFinancingAssetsMaximumAmountAuthorizedForSale", "crdr": "credit", "presentation": [ "http://www.maximus.com/role/OtherItemsNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Receivables purchase agreement, maximum sales amount", "label": "Transfer of Financing Assets, Maximum Amount Authorized for Sale", "documentation": "Transfer of Financing Assets, Maximum Amount Authorized for Sale" } } }, "auth_ref": [] }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "presentation": [ "http://www.maximus.com/role/FairValueMeasurementsScheduleofFairValueofAssetsandLiabilitiesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Financial Instruments [Domain]", "label": "Financial Instruments [Domain]", "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "auth_ref": [ "r254", "r255", "r256", "r257", "r258", "r259", "r260", "r261", "r262", "r263", "r264", "r265", "r266", "r267", "r268", "r269", "r270", "r271", "r272", "r273", "r274", "r275", "r276", "r277", "r278", "r279", "r280", "r281", "r282", "r283", "r289", "r290", "r291", "r292", "r293", "r294", "r295", "r296", "r297", "r298", "r299", "r300", "r385", "r402", "r572", "r612", "r616", "r618", "r638", "r639", "r640", "r641", "r642", "r643", "r645", "r646", "r647", "r648", "r650", "r651", "r652", "r653", "r654", "r655", "r659", "r660", "r662", "r663", "r664", "r665", "r666", "r667", "r668", "r669", "r670", "r671", "r672", "r673", "r674", "r675", "r676", "r705", "r706", "r707", "r708", "r709", "r710", "r711", "r712", "r713", "r714", "r715", "r716", "r717", "r718", "r719", "r720", "r721", "r722", "r726", "r738", "r936", "r939", "r940", "r941", "r942", "r943", "r944", "r945", "r946", "r952", "r1061", "r1062", "r1063", "r1064", "r1065", "r1066", "r1067", "r1196", "r1197", "r1198", "r1199", "r1303", "r1305", "r1306", "r1307", "r1314", "r1317", "r1318", "r1319" ] }, "ecd_TrdArrAdoptionDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrAdoptionDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Adoption Date", "label": "Trading Arrangement Adoption Date" } } }, "auth_ref": [ "r1048" ] }, "ecd_TrdArrDuration": { "xbrltype": "durationItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrDuration", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Arrangement Duration", "label": "Trading Arrangement Duration" } } }, "auth_ref": [ "r1049" ] }, "ecd_TrdArrExpirationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrExpirationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Expiration Date", "label": "Trading Arrangement Expiration Date" } } }, "auth_ref": [ "r1049" ] }, "ecd_TrdArrIndName": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrIndName", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Name", "label": "Trading Arrangement, Individual Name" } } }, "auth_ref": [ "r1047" ] }, "ecd_TrdArrIndTitle": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrIndTitle", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Title", "label": "Trading Arrangement, Individual Title" } } }, "auth_ref": [ "r1047" ] }, "ecd_TrdArrSecuritiesAggAvailAmt": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrSecuritiesAggAvailAmt", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Aggregate Available", "label": "Trading Arrangement, Securities Aggregate Available Amount" } } }, "auth_ref": [ "r1050" ] }, "ecd_TrdArrTerminationDate": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "TrdArrTerminationDate", "presentation": [ "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements" ], "lang": { "en-us": { "role": { "terseLabel": "Termination Date", "label": "Trading Arrangement Termination Date" } } }, "auth_ref": [ "r1048" ] }, "mms_U.S.FederalServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "U.S.FederalServicesMember", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Federal Services", "label": "U.S. Federal Services [Member]", "documentation": "U.S. Federal Services [Member]" } } }, "auth_ref": [] }, "mms_USServicesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "USServicesMember", "presentation": [ "http://www.maximus.com/role/BusinessSegmentsScheduleofResultsofOperationsbyBusinessSegmentDetails", "http://www.maximus.com/role/SignificantAccountingPoliciesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. Services", "label": "US Services [Member]", "documentation": "US Services" } } }, "auth_ref": [] }, "us-gaap_UnbilledContractsReceivable": { "xbrltype": "monetaryItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "UnbilledContractsReceivable", "crdr": "debit", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unbilled contracts receivable", "label": "Unbilled Contracts Receivable", "documentation": "Unbilled amounts due for services rendered or to be rendered, actions taken or to be taken, or a promise to refrain from taking certain actions in accordance with the terms of a legally binding agreement between the entity and, at a minimum, one other party. An example would be amounts associated with contracts or programs where the recognized revenue for performance thereunder exceeds the amounts billed under the terms thereof as of the date of the balance sheet." } } }, "auth_ref": [ "r680" ] }, "us-gaap_UnbilledRevenuesMember": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "UnbilledRevenuesMember", "presentation": [ "http://www.maximus.com/role/OtherItemsScheduleofAccountsReceivableNetDetails", "http://www.maximus.com/role/RevenueRecognitionNarrativeDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Unbilled receivables", "label": "Unbilled Revenues [Member]", "documentation": "Unbilled amounts due for services rendered or products shipped. This element is distinct from unbilled contracts receivables because this is based on noncontract transactions." } } }, "auth_ref": [ "r1089" ] }, "ecd_UndrlygSecurityMktPriceChngPct": { "xbrltype": "pureItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "UndrlygSecurityMktPriceChngPct", "presentation": [ "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Underlying Security Market Price Change", "label": "Underlying Security Market Price Change, Percent" } } }, "auth_ref": [ "r1044" ] }, "mms_UnitedStatesFederalGovernmentAgenciesMember": { "xbrltype": "domainItemType", "nsuri": "http://www.maximus.com/20260630", "localname": "UnitedStatesFederalGovernmentAgenciesMember", "presentation": [ "http://www.maximus.com/role/RevenueRecognitionScheduleofDisaggregationofRevenueDetails" ], "lang": { "en-us": { "role": { "terseLabel": "U.S. federal government agencies", "label": "United States Federal Government Agencies [Member]", "documentation": "United States Federal Government Agencies [Member]" } } }, "auth_ref": [] }, "us-gaap_UseOfEstimates": { "xbrltype": "textBlockItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "UseOfEstimates", "presentation": [ "http://www.maximus.com/role/SignificantAccountingPoliciesPolicies" ], "lang": { "en-us": { "role": { "terseLabel": "Use of Estimates", "label": "Use of Estimates, Policy [Policy Text Block]", "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles." } } }, "auth_ref": [ "r44", "r45", "r213", "r215", "r216", "r217", "r701", "r703", "r881" ] }, "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year", "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]" } } }, "auth_ref": [ "r1014" ] }, "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WeightedAverageNumberOfDilutedSharesOutstanding", "calculation": { "http://www.maximus.com/role/EarningsPerShareScheduleofWeightedAverageNumberofSharesDetails": { "parentTag": null, "weight": null, "order": null, "root": true } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations", "http://www.maximus.com/role/EarningsPerShareScheduleofWeightedAverageNumberofSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Diluted (in shares)", "totalLabel": "Denominator for diluted earnings per share (in shares)", "label": "Weighted Average Number of Shares Outstanding, Diluted", "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period." } } }, "auth_ref": [ "r197", "r205" ] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WeightedAverageNumberOfSharesOutstandingAbstract", "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations" ], "lang": { "en-us": { "role": { "terseLabel": "Weighted average shares outstanding:", "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]" } } }, "auth_ref": [] }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "xbrltype": "sharesItemType", "nsuri": "http://fasb.org/us-gaap/2026", "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "calculation": { "http://www.maximus.com/role/EarningsPerShareScheduleofWeightedAverageNumberofSharesDetails": { "parentTag": "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding", "weight": 1.0, "order": 1.0 } }, "presentation": [ "http://www.maximus.com/role/ConsolidatedStatementsofOperations", "http://www.maximus.com/role/EarningsPerShareScheduleofWeightedAverageNumberofSharesDetails" ], "lang": { "en-us": { "role": { "terseLabel": "Basic (in shares)", "verboseLabel": "Basic weighted average shares outstanding (in shares)", "label": "Weighted Average Number of Shares Outstanding, Basic", "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period." } } }, "auth_ref": [ "r196", "r205" ] }, "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/ecd/2026", "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember", "presentation": [ "http://xbrl.sec.gov/ecd/role/PvpDisclosure" ], "lang": { "en-us": { "role": { "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested", "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]" } } }, "auth_ref": [ "r1012" ] } } } }, "std_ref": { "r0": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "1", "SubTopic": "230", "Topic": "830", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477401/830-230-45-1" }, "r1": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r2": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r3": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "20", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-20" }, "r4": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r5": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r6": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "SubTopic": "10", "Topic": "470", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-1" }, "r7": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1A", "Subparagraph": "(c)(3)", "SubTopic": "10", "Topic": "810", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481203/810-10-50-1A" }, "r8": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Section": "55", "Paragraph": "15", "SubTopic": "10", "Topic": "220", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482739/220-10-55-15" }, "r9": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14" }, "r10": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "14A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-14A" }, "r11": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "220", "SubTopic": "10", "Section": "45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-5" }, "r12": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "12", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-12" }, "r13": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "230", "SubTopic": "10", "Section": "45", "Paragraph": "15", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r14": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "270", "SubTopic": "10", "Section": "45", "Paragraph": "14", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482989/270-10-45-14" }, "r15": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "470", "SubTopic": "10", "Section": "50", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481544/470-10-50-5" }, "r16": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "718", "SubTopic": "10", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2" }, "r17": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "830", "SubTopic": "30", "Section": "45", "Paragraph": "20", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481694/830-30-45-20" }, "r18": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Name": "Accounting Standards Codification", "Topic": "942", "SubTopic": "470", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147477734/942-470-50-3" }, "r19": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r20": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10A", "Subparagraph": "(c)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-10A" }, "r21": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-11" }, "r22": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(1))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r23": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(10))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r24": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(2))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r25": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(20))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r26": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(4))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r27": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "220", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SX 210.5-03(9))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2" }, "r28": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "15", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-15" }, "r29": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "24", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-24" }, "r30": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "25", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-25" }, "r31": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "28", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28" }, "r32": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "310", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "2", "Subparagraph": "(SAB Topic 4.E)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480418/310-10-S99-2" }, "r33": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "470", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/470/tableOfContent" }, "r34": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/810/tableOfContent" }, "r35": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "810", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "19", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481231/810-10-45-19" }, "r36": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(15))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r37": { "role": "http://fasb.org/us-gaap/role/ref/legacyRef", "Topic": "942", "SubTopic": "220", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.9-04(22))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1" }, "r38": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "230", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "2", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482913/230-10-50-2" }, "r39": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "6", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-6" }, "r40": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "7", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-7" }, "r41": { "role": "http://fasb.org/us-gaap/role/ref/otherTransitionRef", "Topic": "505", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "8", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481112/505-10-50-8" }, "r42": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "13", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "230", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-13" }, "r43": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "2", "Subparagraph": "(a)", "SubTopic": "20", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482659/740-20-45-2" }, "r44": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r45": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(c)", "SubTopic": "10", "Topic": "275", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482861/275-10-50-1" }, "r46": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "13", "Subparagraph": "(a)", "SubTopic": "10", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479806/606-10-50-13" }, "r47": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "9", "Subparagraph": "(b)", "SubTopic": "10", "Topic": "740", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147482685/740-10-50-9" }, "r48": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "1", "Subparagraph": "(SX 210.4-08(h))", "SubTopic": "10", "Topic": "235", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1" }, "r49": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Accounting Standards Codification", "Topic": "606", "Publisher": "FASB", "URI": "https://asc.fasb.org/606/tableOfContent" }, "r50": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "04", "Paragraph": "a", "Publisher": "SEC" }, "r51": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r52": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12A", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r53": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(a)", "Footnote": "4", "Publisher": "SEC" }, "r54": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "12B", "Paragraph": "Column A", "Subparagraph": "(b)", "Footnote": "4", "Publisher": "SEC" }, "r55": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "14", "Paragraph": "Column A", "Footnote": "2", "Publisher": "SEC" }, "r56": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column A", "Publisher": "SEC" }, "r57": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column B", "Publisher": "SEC" }, "r58": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column C", "Publisher": "SEC" }, "r59": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column D", "Publisher": "SEC" }, "r60": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column E", "Publisher": "SEC" }, "r61": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "17", "Paragraph": "Column F", "Publisher": "SEC" }, "r62": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column A", "Footnote": "3", "Publisher": "SEC" }, "r63": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column B", "Publisher": "SEC" }, "r64": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "12", "Subsection": "29", "Paragraph": "Column C", "Publisher": "SEC" }, "r65": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r66": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r67": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r68": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "01", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r69": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(i)", "Publisher": "SEC" }, "r70": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(A)", "Publisher": "SEC" }, "r71": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(B)", "Publisher": "SEC" }, "r72": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iii)(C)", "Publisher": "SEC" }, "r73": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Regulation S-X (SX)", "Number": "210", "Section": "13", "Subsection": "02", "Paragraph": "a", "Subparagraph": "(4)(iv)", "Publisher": "SEC" }, "r74": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 11", "Section": "L", "Publisher": "SEC" }, "r75": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 2", "Publisher": "SEC" }, "r76": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Name": "Staff Accounting Bulletin (SAB)", "Number": "Topic 5", "Section": "Y", "Paragraph": "Question 4", "Publisher": "SEC" }, "r77": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r78": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "105", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "65", "Paragraph": "9", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147479343/105-10-65-9" }, "r79": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205/tableOfContent" }, "r80": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S45", "Paragraph": "5", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147481034/205-10-S45-5" }, "r81": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "10", "Name": "Accounting Standards Codification", "Section": "S99", "Paragraph": "3", "Subparagraph": "(SX 210.4-03(c))", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147480922/205-10-S99-3" }, "r82": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Publisher": "FASB", "URI": "https://asc.fasb.org/205-20/tableOfContent" }, "r83": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "10", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-10" }, "r84": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "45", "Paragraph": "11", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483475/205-20-45-11" }, "r85": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "1", "Subparagraph": "(d)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-1" }, "r86": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3" }, "r87": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "3A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-3A" }, "r88": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4A" }, "r89": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(a)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r90": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r91": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r92": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(c)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r93": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)(1)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r94": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)(2)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r95": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)(3)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r96": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "4B", "Subparagraph": "(d)(4)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-4B" }, "r97": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5A", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5A" }, "r98": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(b)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r99": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section": "50", "Paragraph": "5B", "Subparagraph": "(e)", "Publisher": "FASB", "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-5B" }, "r100": { "role": "http://www.xbrl.org/2003/role/disclosureRef", "Topic": "205", "SubTopic": "20", "Name": "Accounting Standards Codification", "Section":